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FOREWORD
"Morbid Anatomy" and "Histopathology" imply morphological 
studies and relate to the appearance of a disease process at 
a particular moment in time. However, disease is a dynamic 
process and the morphologist examining static appearances of a 
disease must interpret these features as part of a continuing 
sequence of biochemical and physiological abnormalities. In 
other words he must make a functional extrapolation from 
morphological aberrations. Such an extrapolation can only be 
made if the normal physiological and biochemical processes are 
understood, and the clinical sequelae of the abnormalities are 
known.
Descriptive pathology has led to a better understanding 
of disease and has enabled great advances to be made in the 
fields of clinical assessment, diagnosis and treatment. The 
giants of descriptive pathology have made their contribution 
to modern medicine and it is now becoming more and more 
important for the functional pathologists to stand on their 
shoulders in order to increase our understanding of disease.
The functional interpretation of morphology is becoming less 
subjective and we are now at a stage when the clinician, the 
morphologist, the chemical pathologist and the experimentalist 
must pool their resources in order to make advances.
The theme of this thesis is "Functional Pathology", or 
function in relation to morphology. Two organs will be 
considered: the human adrenal cortex, and the testis. The 
function of both of these in health and disease can be
“ zz
assessed readily and alterations may be reflected in morpho­
logical changes.
The adrenal cortex produces steroid hormones and the 
production rate of these increases in times of stress. The 
well known morphological changes of hyperplasia and lipid 
depletion of the adrenal cortex occur in association with 
increased steroid output (Symington, 1969). However, in 
primary adrenocortical pathological states, morphological 
changes do not always accurately reflect functional aberrations. 
Hyperactivity of the adrenal cortex due to hyperplasia or 
neoplasia of steroid-producing cells would be expected to 
produce the clinical effects of Cushing's syndrome, and in 
many cases this relationship is true. However, hyperactivity 
of the inner cortical zones may occur in the absence of clinic­
al symptoms, or may produce Conn's syndrome or the adrenogenital 
syndrome. The explanation of this lies in the fact that 
individual cells are capable of producing different classes of 
steroid hormones notably glucocorticoids, sex steroids, and 
mineralocorticoids, as well as many biologically inactive 
steroids. The clinical syndrome produced depends on the amount 
of steroid produced, and the relative proportion of the 
different classes of steroids. Therefore, the hormonal effects 
of adrenocortical hyperplasia or neoplasia cannot be surmised 
on morphological features alone, and a single morphological 
pattern may be associated with many different syndromes.
The interstitial tissue of the testis is another 
steroid— producing endocrine gland secreting androgenic 
(virilising) steroids including testosterone.
—  2 3 “
Therefore a functdoning tumour of testicular interstitial 
cells would be expected to cause virilisation. This often 
happens, especially noticeable in prepubertal subjects, but 
some interstitial cell tumours of similar morphology may result 
in féminisation(Neville, 1976; Symington & Cameron, 1976).
It is clear, therefore that although functional inter­
pretation of morphological changes is often valid, the two 
are not always related and the pathologist's assessment must 
always be guarded. In the field of tumour pathology, many, if 
not all, tumours produce substances which are abnormal quali­
tatively, quantitatively, or temporally. These substances, 
usually hormones, enzymes or antigens, may be secreted appro­
priately or inappropriately. The functional tumour pathologist 
must be aware of the secretory activity of the tumour he is 
examining, and if possible should try to ascertain which morpho­
logical features are associated with which particular secretory 
products, and should determine if a consistent relationship 
exists.
In my studies I have attempted to correlate function with 
morphology considering both normal and neoplastic tissue.
The normal developing foetal testis undergoes a series of 
morphological changes and this is related temporally and 
spatially to the developing genital ducts and tracts. I have 
tried to correlate steroidogenic function with these changes.
I have also examined neoplastic adrenal and testicular tissue 
with special reference to their function - or lack of overt 
function - and the associated clinical effects.
I hope to illustrate the concept that functional differ­
entiation of cells can occur irrespective of histological
appearances. As examples I shall describe the function of 
foetal testicular cells in the developing rat foetus in utero, 
and also in tissue culture. I shall also present data cor­
relating the production of alpha-fetoprotein with specific 
cell types in testicular tumours, and I shall describe the 
functional capacity of certain adrenocortical carcinomas.
—SECTION I : EXPERIMENTAL STUDIES
CHAPTER 1
INTRODUCTION
CHAPTER 1 
INTRODUCTION 
FUNCTIONAL ASPECTS OF THE FOETAL TESTIS .
1, Embrvoloaical development of the male urogenital system
The genetic sex of mammals is determined at conception, 
the heterozygous (XY) state being the male genotype. The 
early embryo first passes through a non-sexual phase before 
the genital apparatus appears. This is followed by an 
indifferent sexual phase when gonadal tissue appears in both 
sexes but shows no ovarian or testicular differentiation, 
and there is no phenotypic difference between male and female 
genotypes. Testicular differentiation of the indifferent 
gonad is determined by the Y chromosome probably interacting 
with the X chromosome. Federman (1973) states that structural 
gene information for testicular differentiation is carried on 
the X chromosome but this is under the regulating control of 
genes in the Y chromosomes. Thereafter, the foetal testis 
stimulates male phenotypic development. In the female geno^ 
type(XX)ovarian differentiation does not occur until after 
sexual differentiation of the genital ducts, and the foetal 
ovary apparently plays no part in foetal sexual development. 
Female development of the genital ducts occurs in the absence 
of testes, that is, if the ovaries are present, or if no gonad 
is present.
The internal and external genitalia are derived from the 
genital tracts and the urogenital sinus (Fig. 1.1). The 
chronological events in sexual differentiation are represented

Fig. 1.1. Development of the internal genitalia in the 
human embryo.
(a) Sexually undifferentiated stage. An indifferent gonad 
is present in both sexes medial to the mesonephros 
(primitive kidney) , and paired genital tracts extend 
from the urogenital ridge down the dorsolateral aspect 
of the coelomic cavity to the urogenital sinus.
Each genital tract contains 2 genital ducts: the 
Wolffian duct derived from the mesonephric duct, and 
the Mullerian duct which originates de novo.
(b) Male differentiation is first evidenced by the
indifferent gonad developing into a recognisable 
testis. Testicular secretions cause degeneration of 
the Mullerian duct and stabilisation of the Wolffian 
duct. Under the action of testicular androgens, the 
Wolffian duct develops into the epididymis, vas deferens 
and seminal vesicle; and the urogenital sinus develops 
into the orostate.
(c) Female differentiation does not require a functioning 
embryonic gonad. The gonad remains indifferent, the 
Wolffian duct regresses and the Mullerian duct, which 
is not under any inhibitory influence, develops into 
the fallopian tube, uterus and upper vagina, the 
urogenital sinus forming the vagina below the hymen.
(after Jost, 19 71)
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in Fig. 1.2. The Wolffian duct is primarily an excretory 
duct (pronephric and mesonephric duct) but In the mammal. It 
does not retain any excretory function and becomes Incorpo­
rated Into the developing genital system. The Mullerian duct, 
however, Is primarily a genital duct and has no excretory 
function. It appears firstly as a groove In the lateral 
aspect of the cranial end of the mesonephric ridge lateral to 
the pre-existing Wolffian duct. The groove deepens, becomes 
tubular(remaining open at the cranial end) and extends towards 
the urogenital sinus. It crosses over to the medial aspect 
of the Wolffian duct just before It reaches the urogenital 
sinus. In the male, the Mullerian duct regresses and persists 
only as the appendix of the testis and the prostatic utricle- 
Regression commences anteriorly before the caudal end meets 
the urogenital sinus, therefore a wave of development and 
regression of the Mullerian duct passes along the genital tract 
with both processes occurring simultaneously.
2. Endocrine activity of the, foetal testis
The role of the testis In the development and regression of 
the genital ducts has been examined extensively since Bouln 
and Ancel (1903 a&b) first suggested that the foetal testis 
secreted hormones which controlled foetal sexual development.
In 1947, Jost described a method for castrating foetal rabbits 
In utero without terminating pregnancy. He demonstrated that 
the foetal testis Is required for stabilisation and further 
development of the Wolffian duct; for the differentiation of 
the urogenital sinus Into the prostate gland and external 
genitalia; and also for the regression of the Mullerian duct 
(Jost, 1947b).

Fig. 1.2. Chronological events in sexual differentiation of 
the rat embryo
The Wolffian develops at 9h days gestation as the 
pronephric duct, and later the mesonephric duct. The. *
indifferent gonad appears at 11% days. The first sign of 
sexual differentiation occurs at 14% days when, in the male, 
the testis enlarges and becomes histologically differentiated, 
as evidenced by the presence of primitive seminiferous 
tubules and interstitial cells. The Mullerian duct commences 
its development at its anterior end at 13% days, and then 
progresses posteriorly meeting the urogenital sinus at 
16% days. In the male, Mullerian duct regression commences 
anteriorly at 14% days; that is, before posterior development 
has been completed. However, in the female, this duct 
persists and develops into female genitalia. At 17% days, 
the Wolffian duct is stabilised in the male and develops into 
male genitalia, but in the female, the Wolffian duct regresses 
because of lack of stabilising androgens.
(Data from Jost, 1967; Price & Pannabecker, 1959; 
Morishge et al., 1973; Torrey, 1943, 1945)
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A single testis ts sufficient requirement for the 
development of the prostate and external genitalia.
However, unilateral castration demonstrates that each testis 
only acts on its adjacent genital ducts and not the contra­
lateral ducts. Stabilisation of the Wolffian ducts in the 
castrated male foetus (Jost, 1947c) or in the intact female 
foetus (Jost, 1947a&b) can be achieved by exogenous androgenic 
steroids, but these fail to cause regression of the Mullerian 
ducts.
Reviewing experiments on foetal testicular endocrinology, 
Jost (1953) postulated that the foetal testis secretes at 
least 2 hormones: firstly, an androgenic steroid which 
stabilises the Wolffian ducts and stimulates the development 
of the Wolffian ducts and urogenital sinus into internal and 
external genitalia; and secondly, a. non-androgenic Mullerian 
inhibitory factor (MIF) whose chemical nature is unknown. 
Testosterone* is the main androgenic steroid produced by the 
testis, and this steroid is probably responsible for Wolffian 
duct stabilisation, whereas its 5«-reduced metabolite 
(dihydrotestosterone) is probably responsible for male differ­
entiation of the urogenital sinus (Schultz & Wilson, 19 74). 
Androgens not only fail to inhibit the Mullerian duct, but in 
the opossum large doses of testosterone propionate cause 
enlargement of the Mullerian derivatives (Burns, 1945). Jost 
(195 3) showed that deoxycorticosterone acetate (DOCA) prepared 
in a solution containing 5% benzyl alcohol causes Mullerian duct 
regression in vitro in foetal rabbits.
* Trivial names or abbreviated names of steroids and steroido­
genic enzymes are used in the text. A full list of abbreviated 
names, trivial names and systematic names are given in Appendices 
I & II.
—  J  j  “
Pure DOCA is devoid of Mullerian inhibitory activity but 
5% benzyl alcohol alone is active. This is probably due to 
non-specific toxicity.
Many substances have been examined for Mullerian 
inhibitory activity (Table l.I) but none has been shown to 
have the same specific effect as natural MIF,
3. In vitro assay system for Mullerian inhibitory factor (MIF)
An in vitro organ culture technique has been developed 
by Picon (1969).for the study of Mullerian inhibition. Rat 
foetal genital tracts are explanted from 14)^  days post coitus 
embryos and maintained in organ culture for 3 days- Normal 
development of the genital ducts takes place in culture.
At 14^ days the Mullerian ducts have formed anteriorly and 
are sensitive to inhibition by testicular MIF (Fig. 1.2).
After 3 days in culture, equivalent to 17^ gestation, Mullerian 
inhibition is evident if MIF is present, and the Wolffian ducts 
remain intact in both sexes or show only early anterior regression, 
The state of the genital ducts is determined histologically.
These experiments show that the procedure involved in explant­
ing foetal genital tracts do not interfere with subsequent 
development and differentiation of the genital ducts if the 
tracts are cultured in a suitable environment.
Using this system Picon and Josso (vide infra) have 
studied facets of the Mullerian inhibitory factor- The 
Mullerian ducts are inhibited unilaterally by the presence of 
autologous (Picon, 1969) or heterologous (Picon, 19 70) foetal 
rat testes. There is interspecific activity of MIF, the foetal 
testes of rabbit (Ficon, 1971), human (Josso, 1970b,1971b) or 
ox (Josso, 1973) being able to inhibit the Mullerian ducts of 
rat. MIF is produced by the foetal rat testis from 13^ days
Table 1.1. Effect of various substances on the genital ducts of mammals.
Effect on the
Substance * Reference
Wolffian duct Mullerian duct
testosterone stabilisation no regression Jost, 1947(c), 1971 (a)
17 methyl testosterone stabilisation no regression Jost, 1947(b)
9o(-fluorO"llj3-hydroxy- 
17-methyl testosterone stabilisation no regression
3^-androstauediol not stated no regression Josso, 1971(a)
3«-androstanecliol not stated no regression Josso, 1971(a)
androstenediol stabilisation no regression Josso, 1970(a)
5tf “dihydrotestosterone stabilisation no regression Schultz and Wilson, 1974; 
Josso, 1971(a)
SjB-dihydrotestosterone inactive no regression Josso, 1971(a)
dehydroepiandrosterone (DHA) partial
slabilisation
no regression Josso, 1970(a) ■
DHA sulphate (DHAS) no effect no regression Josso, 1970(a)
17 ethinyl testosterone not stated no regression Jost, 1947(b)
o estradiol slightstabilisation maintenance
Jost, 1971/72 
Forsberg et al. ,1968
deoxycorticosterone acetate 
(DOCA) no effect no regression Jost, 1953
prostaglandins E, Eg, no effect no regression Jost, 1973
prostaglandins Ag, 13 not stated reduced diameter but not same as 
natural MIF
Josso, 1974(a)
prostaglandin E^ not stated no regression Josso, 1974(a)
olive oil /  benzyl alcohol not stated regression (toxic) Jost, 1953
cyproterono acetate preventsdifferentiation no regression
Forsberg et a l . , 1968; 
Jost, 1967,1971/72
cyanoketone does not
inhibit
stabilisation
not stated Josso, 1970(c); 
Jost, 1971/72
cyclic AMP not stated prevents
regression
Picon, 1976(b)
* Systematic nomenclature of steroids is given in Appendix I
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post coitus to 13 days post partum (Picon, 1970); by the 
human foetal testis from 7 to 24 weeks gestation (Josso,
1970b); and by the foetal calf testis (Josso, 1973).
In the human foetus, MIF production after 24 weeks 
gestation falls off towards term, and is not produced by 
the post partum, prepubertal, or pubertal testis (Josso,
1972b). Foetal calf testis does not produce MIF in late 
pregnancy (Josso, 1973).
The Mullerian ducts are not inhibited by testosterone, 
dihydrotesterone, 3«- or 33~androstanediol, or prostaglandins 
E^, A^, or in organ culture (Josso, 1971b, 1974a), nor are 
they inhibited by the human foetal adrenal or ovary (Josso, 
1971b). Human MIF is permeable through the vitelline membrane 
of a hen's egg, but not through Visking cellulose, a membrane 
which is permeable to testosterone but impermeable to molecules 
greater than 15,000 Daltons (Josso, 1972a). This indicates that 
MIF is not a steroid in the free form. MIF, but not testo­
sterone, can be concentrated by dialysis and ultracentrifugation 
(Josso, 1974d); and it can be partially purified by gel 
filtration on sephadex G200 or by column chromatography on 
Bio-gel A-5m. These data indicate a molecular weight of between 
200,000 and 295,000 Daltons (Picard & Josso, 1976).
MIF is produced in tissue culture by whole foetal calf 
testes, or isolated foetal calf Sertoli cells, but not by 
isolated foetal calf Leydig cells (Josso, 1973). Human foetal 
testes made devoid of germ cells by exposure to irradiation 
in vitro produce MIF in culture (Josso, 1974b). Monolayer 
culture of isolated, foetal calf Sertoli cells, but not 
isolated foetal calf Leydig cells, produce MIF (Josso, 1974c).
—  J b  —
These experiments indicate that Sertoli cells produce MIF.
MIF is present in the protein rich fraction of dialysed 
culture medium (Josso, 1974d) and is destroyed by heating 
(Josso, 1974d; Josso et al., 1975) or by blockade of sulphydryl 
groups by 0.5M iodoacetic acid (Josso et al., 1975). It is 
not produced in culture if protein synthesis is inhibited by 
cycloheximide (Josso et al., 1975). MIF activity is stable 
to 0.01 M  dithioerythritol, a reducing agent, but is destroyed 
by 8M urea or by 0.1% SDS depolymerising agents (Picard & Josso, 
1976).
4. Possible role of progesterone in Mullerian duct inhibition 
The above, experiments clearly indicate that MIF is not 
an androgenic steroid; is not a steroid in free form; and is 
probably a protein or protein complex whose production requires 
Sertoli cells. It is possible, however, that MIF may be a 
steroid combined to a steroid binding protein, and that this 
steroid may be progesterone. The ; possibility that progesterone 
may be involved in the Mullerian inhibition has not been 
previously postulated, and the effects of progesterone on the 
Mullerian ducts in culture have not been published.
The following points support the hypothesis that progesterone 
may be part of the Mullerian inhibitory factor:-
a) The foetal testis, having the enzymes necessary for
synthesis of testosterone (Acevedo, et al .,1963; Lipsett & 
Tullner, 1965 ; Picon, 1976; Rice et al., 1966; Warren et al., 
1972), has the capability of producing progesterone (Fig.1,3)
b) The enzyme system 3g-hydroxysteroid dehydrogenase-
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isornerase (3B-HSD-I), required for conversion of pregnenolone 
to progesterone (Fig. 1.3) is present in the very early 
stages of testicular development, before the time when the 
testis exerts its inhibitory action on the Mullerian duct 
Baillie, 1965; Baillie & Griffiths, 1964; Baillie et a l ., 
1966ab&c; Bloch et al., 1971; Haffen, 1969; Hart, et a l ., 
1966; Jirasek, 1970; Lipsett & Tullner, 1965; Moon & Raeside, 
1972; Picon, 1976a).
c) At the start of Mullerian duct inhibition, the 36-HSD-I 
acts preferentially on pregnenolone as substrate. Preference 
for 17«-hydr -oxypregnenolone and DHA is not attained until 
later in embryonic life when androgens are required for 
Wolffian duct stabilisation (Baillie, 1965; Baillie & 
Griffiths, 1964; Baillie et a l ., 1966b&cl,
d) The foetal testis produces progesterone, but not testo­
sterone, at the time of Mullerian duct inhibition (Bloch
et al., 1971b; Haffen, 1969; Jirasek, 1970; Siiteri & Wilson, 
1974; Warren et al., 1973; Wilson and Siiteri, 19731.
e) After Mullerian duct inhibition, when stabilisation of
the Wolffian duct occurs, the secretion of MIF by the foetal 
testis falls progressively as the output of testosterone 
rises (Baillie & Griffiths, 1964; Josso, 1970b; Lipsett
& Tullner, 1965 ; Noumura et a l ., 1966; Pointis & Mahoudean, 
1977; Picon, 1970,1976a; Siiteri & Wilson, 1974; Warren 
et al.,1973; Wilson & Siiteri, 1973). If this is due to 
conversion of MIF to testosterone, then progesterone is a 
likely candidate for MIF.
f) Progesterone has an inhibitory effect on the prepubertal 
and mature endometrium, a Mullerian duct derivative, causing
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reduction of cell division (Martin et al . , 1973; Trains 
et al., 1973a&b).
g) Premature and mature endometrium and myometrium contain
specific progesterone receptors (McGuire et a l ., 1974; 
Philibert & Raynaud, 1973,1974; Trams et al., 1973b; 
Warembourg, 1974).
h) Oestrogens can stabilise the Mullerian duct (Forsberg
et al., 1968; Jean, 1966) and therefore have an anti-MIF 
action. Oestrogens and progesterone have known antagonistic 
activities (Lerner et al., 1966; Trams et al., 1973a&b).
j) Dibutyryl cyclic AMP prevents the inhibitory effect of
testicular MIF in vitro (Picon, 1976b). Cyclic AMP is 
known to stimulate steroidogenesis and may act by causing 
metabolism of progesterone to another steroid, for example 
testosterone.
It is difficult to examine the effects of progesterone 
on the Mullerian ducts in vivo. To achieve this, two different 
experiments are required: the first preventing endogenous 
progesterone reaching the Mullerian ducts; and the second 
subjecting them to excess exogenous progesterone.
All mammals require progesterone for the maintenance of 
pregnancy (Davies & Ryan, 19 72). If the Mullerian ducts are 
to be deprived of endogenous progesterone stimulation, complete 
inhibition of progesterone synthesis must be achieved and this 
results in abortion of the developing foetuses. Therefore, 
examination of further foetal sexual development in a pro­
gesterone-free environment in vivo is not possible.
Cyanoketone (2«-cyano-4,4,17«-trimethylandrost-5-ene- 
17B-ol-3-one) is an inhibitor of 33-hydroxysteroid dehydrogenase
— 4tU —
and steroid A-isomerase (Goldman, 1971/72; Goldman et al.,
1966; Neville & Engel, 1968a&b). In the mouse, small doses 
of cyanoketone given to pregnant mothers have no effect 
on sexual development of the foetuses and do not prevent 
Mullerian duct regression in the male; and large doses result 
in foetal resorption (Bloch et al., 1971a). Cyanoketone has 
been shown to be a more effective enzyme inhibitor in the 
adrenal cortex than in the testis in vivo (Di Frisco et al ., 
1971/72); and cyanoketone given to pregnant rats fail to block 
completely 33-HSD-I in the foetal testes (Bloch, et al,, 1971b). 
Therefore, when Mullerian ducts regress normally in male foetuses 
of pregnant rats treated with cyanoketone, it cannot be con­
cluded that regressed Mullerian ducts were not exposed to 
progesterone.
Foetal testicular MIF has a very localised effect and 
only influences the adjacent genital tract. This suggests 
that MIF is not a systemically acting humoral agent, but passes 
directly from the testis to the ipsilateral Mullerian duct.
MIF injected into the pregnant mother may not cross the placental 
barrier, or may be metabolised by maternal tissue, placental 
tissue or foetal tissue. Any residual MIF in the foetal cir­
culation will then act as a systemic hormone and will therefore 
most likely be devoid of Mullerian inhibitory activity. This 
means that if progesterone has Mullerian inhibitory activity, 
such an action will not be demonstrated by injecting the 
pregnant motherswith excess quantities of progesterone.
Progestogens have been given to pregnant humans and 
experimental animals, and these substances do not cause 
Mullerian inhibition in female foetuses. In some cases they
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produce a certain degree of masculinisation of the urogenital 
sinus (Foote et al.> 1968; Jones & Wilkins, 1960; Revesz et al., 
1960; Suchowsky & Junkman, 1961; Suchowsky et al., 1967; Wilkins, 
1960; Wilkins et al., 1958), and synthetic progestogens are 
more virilising than progesterone itself. This androgenicity 
of progesterone on urogenital derivatives has been known for 
a long time (Clausen, 1942; Green et al., 1940). Progesterone 
and progestogens are virilising compounds and Mullerian inhi­
bition is a virilising effect of the foetal testis- This is 
further evidence that a Mullerian inhibitory effect of 
progesterone should be considered and examined.
In this thesis an attempt has been made to determine if 
progesterone is the Mullerian inhibitory factor. This has been 
tackled in two ways. Firstly, progesterone was added to foetal 
rat genital tracts in organ culture to see if this could cause 
Mullerian inhibition in vitro. Secondly, foetal rat testes 
were maintained in monolayer tissue culture, and the endogenously 
produced steroids examined by radioimmunoassay and high pressure 
liquid chromatography. The results are present in chapters 3 
and 4. The organ culture studies follow the methods of Picon 
(1969) and Josso (1970a) already described (vide supra). The 
monolayer culture studies are new and will be described in 
detail.
5. Foetal testicular steroidogenesis
The foetal testis is a steroid-producing organ and there 
are many direct and indirect methods of demonstrating steroid 
synthesis, in particular androgen production (Zaaijer, 1975), 
viz : -
a) The foetal testis has an androgenic (virilising) effect
on foetal target organs, and this effect has been demonstrated 
in vitro and in vivo.
b) Target organs have androgenic receptors, and these 
receptors develop roughly about the same time as the testis 
begins to produce steroids; and just before morphological 
changes occur in the target organs as a result of androgenic 
stimulation.
c) The level of androgens in the foetal serum has been 
measured, and extracts of foetal testes have been shown 
to contain steroids. The nature and quantity of these 
steroids have been examined.
d) Steroidogenic enzymes have been demonstrated in foetal 
testes by histochemical techniques and these enzymes are 
required in the biosynthesis of testosterone.
e) The presence of testicular interstitial cells, which are 
known to be associated with androgen production, can be 
detected histologically at a certain stage of development, 
and electron microscopy has shown that these cells have the 
ultrastructural characteristics of steroid-producing cells.
f) The synthesis of androgens from added precursors has
been demonstrated in incubations of foetal testicular slices
and homogenates.
g) Endogenous production of androgens by foetal testes
in tissue culture, either organ culture or monolayer culture, 
has been demonstrated.
An attempt has been made in this thesis to examine the 
stage at which foetal testicular steroidogenesis is first 
evident, and to study the changing profile of steroid output 
at various gestational ages in the rat foetus. The various 
methods for examining these facets of foetal testicular steroido­
genesis as outlined by Zaaijer are not completely satisfactory 
for the following reasons:-
a) jost (1953, vide supra) examined the androgenic effect 
of the foetal testis on sexual differentiation and clearly 
demonstrated that the foetal testis produces androgens.
However, the sex ducts (Wolffian ducts) are not responsive to 
androgens until a certain stage of embryonic development. It 
follows,therefore, that the time of morphological changes in 
the sex ducts does not necessarily indicate the precise time 
when androgenic secretion commences: this is because any 
androgenic secretion occurring before the sex ducts are 
responsive will not be associated with morphological changes.
b) Androgens- can only have their effect on target organs 
after such organs have developed androgen receptors (Zaaijer,
19 75), but the time of appearance of receptors need not 
necessarily coincide exactly with the time when androgen secretion 
commences. Similarly, the time of appearance of gonadotrophin 
receptors on foetal testicular cells can be measured, but this 
too is not an absolute indication of steroidogenic activity.
George et al., (1978) demonstrated HCG receptors in foetal
rabbit teatea at 18 daya gestation, but auch receptors are 
apparently not functional till 20 days gestation.
It is known that foetal testicular steroidogenesis is 
stimulated by HCG (Abramovich et al. , 1974; Ahluvralia et al. , 
1974; Huhtaniemi et al. , 1977a&b; Wenigér et al ., 1967;
Weniger & Zeis, 1975) and by LH (Weniger et al.,1967; Weniger 
& Zeis, 1975). However, steroidogenesis can occur in the 
absence of trophic hormone (Picon, 1976a), and the exact role 
of chorionic gonadotrophin and of foetal pituitary gonado­
trophin on the development of the foetal testis and its 
subsequent steroidogenic activity is not yet clear. George 
et al., (19 78) have demonstrated that the development of
33-HSD-I activity and the morphological appearance of inter­
stitial cells can occur in vitro in the absence of trophic 
stimulation,
c) Steroids can be extracted and identified from foetal 
testes,indicating in vivo steroid production. Veyssiere et 
al. (1976) extracted testosterone from foetal rabbit testes.
Reyes et al. (19 73) extracted testosterone from human foetal 
testes and demonstrated the presence of this steroid at 10 
weeks gestation with peak levels at 11-14 weeks. These authors 
(Reyes et al., 1974) also demonstrated corresponding levels of 
testosterone in human foetal serum. Huhtaniemi et al.(19 70) 
extracted steroids from human foetal testes and showed that 
testes from 12-24 weeks gestation foetuses contained mainly 
pregnenolone and testosterone. They claim to have been the 
first group to prove that human foetal testes synthesise 
testosterone in vivo, but this method cannot exclude the 
possibility that the steroids may have been produced elsewhere
and taken up by the testes. These authors tried but failed to 
identify progesterone in these relatively mature foetal testes.
d) A good indication of the steroidogenic capacity of 
the foetaltestis is given by the demonstration of steroidogenic 
enzymes within foetal testicular cells. Such enzymes can be 
demonstrated histochemically by staining techniques or bio­
chemically using tissue homogenates. The steroidogenic enzyme 
studied most extensively by histochemistry is 33-HSD-I which 
is present in the mouse testis at 11 days gestation, the stage 
at which the mouse foetal gonad is first recognisable as a 
testis (Hart et al., 19 66). This enzyme acts preferentially on 
different substrates at different gestational ages. It acts 
on pregnenolone in the early foetal testis, and on DHA later 
in foetal life, but it, does not act preferentially on 17- 
hydroxy pregnenolone till after parturition (Baillie, 1965;
Baillie & Griffiths, 1964; Baillie et al., 1966ab&c). Bio­
chemical demonstration,of -33-HSD-l activity in foetal rat 
testes has been described by Picon (1967). It must be stressed 
that the demonstration of steroidogenic enzyme activity in 
tissues does not necessarily imply that the tissue is actively 
secreting steroids in vivo. Moreover, identification of the 
various enzymes present does not give a true indication of the 
profile of steroids produced and released.
e) The interstitial (Leydig) cells are the main steroido­
genic cells of the testis; however, demonstration of steroido­
genic type structures on electron microscopy does not necessarily 
imply that steroidogenic activity has started. In fact, 
steroidogenic enzymes are present in the foetal testis before 
Leydig cells are recognizable (Baillie, 1965; Baillie & Griffiths,
1964 ; Baillie et al., 1966a&b) and these enzymes are even 
demonstrable in the genital ridge before germ cell migration 
(Baillie et al■, 1966a).
f) Many workers have demonstrated the steroidogenic 
capacity of foetal testes by showing that labelled precursors 
are converted into steroid hormones in vitro. These precursors 
are incubated with tissue slices or homogenates in metabolic 
flasks, and the metabolic products are extracted and identified 
at the end of the incubation period. Incubations of human 
foetal testes have demonstrated testosterone synthesis from 
labelled acetate, cholesterol, pregnenolone, pregnenolone 
sulphate or progesterone (Acevedo et al., 1963; Ahluwalia et al., 
1974; Bloch, 1966; Bloch et al., 1962; Huhtaniemi et al., 1977a; 
Payne et al., 1975; Siiteri & Wilson, 1974). Similar results 
have been obtained with incubations of foetal testes from mouse 
(Bloch et al., 1971a; Weniger et al., 1967; Weniger & Zeis, 
1972,1975), rat (Bloch et al., 1971b; Noumura et al., 1966;
Warren et al.,1972,1973) monkey (Huhtaniemi et a l ., 1977b), 
rabbit (Bloch et al., 1971b; Lipsett & Tullner, 1965; Wilson 
& Siiteri, 1973), and horse (MacArthur et al., 1967). In these 
incubations, steroidogenic activity is stimulated by HCG 
(Ahluwalia et al., 1974; Huhtaniemi et al., 1977a&b; Weniger 
& Zeis, 1975), LH (Weniger & Zeis, 1975) or cyclic AMP (Ahluwalia 
et al.,1974).
Incubations of foetal testes demonstrate the pattern of 
steroid synthesis, and this pattern is seen to be dependent on 
gestational age. Early foetal testes produce progesterone in 
greater quantities than testosterone, whereas foetal testes 
later in gestation produce testosterone and androstenedione as
the main steroid secretory products, and very little 
progesterone is detected CAhluwalia et al., 1974; Bloch, 1966; 
Bloch et al., 1962; Bloch & Benirschke, 1965; Lipsett & Tullner, 
1965; MacArthur et a l ., 1967; Noumura et al. , 1966; Siiteri 
& Wilson, 1974; Warren et al., 1972,1973; Weniger & Zeis, 1972, 
1975; Wilson & Siiteri, 1973).
Examination of steroid synthesis from added precursors 
in short term incubations has the disadvantage that the tissue 
under examination may not be in a steady state because of the 
trauma and disruption caused by preparing the tissue slices 
or homogenates. Also, the effects of endogenous precursors 
stored within the cells or the effect of trophic hormone attached 
to the tissue cannot be assessed. Many of the unknown variables 
of short term incubations can be avoided by examining the 
steroidogenic synthesis from basic molecules using long term 
tissue cultures of foetal testes, either in organ culture or 
monolayer culture.
g) Ortiz et al .(1966) maintained foetal guinea pig testes 
in organ culture. These authors demonstrated that androgenic 
substances were secreted by the testes in culture and these 
androgens stimulated the growth of rat ventral prostate glands 
placed adjacent to the foetal testes in the same organ culture 
dish. However, this is a bioassay system with an imprecise 
histological end-point which is dependent on morphological 
changes in the prostatic acini. This end-point is not quanti­
tative, and also it lacks specificity because substances such 
as progesterone are also known to stimulate the prostate (vide 
supra). Picon (1967) kept rat foetal testes in long term organ 
culture and she was able to detect 3g-HSD—1 activity in the 
cultured tissue by biochemical methods.
Weniger and co-workers showed that foetal mouse testes 
in organ culture for 24 hours could convert acetate or 
progesterone to testosterone (Weniger et al., 1967; Weniger 
& Zeis, 19 72); and also that similar cultures were stimulated 
in vitro by LH and HCG to produce increased amounts of 
testosterone and androstenedione from added acetate (Weniger 
& Zeis, 1975). Rice et al.(1966) showed that foetal human 
testes at 6^ months gestation produced pregnenolone, proges­
terone and DHA from acetate after 9 days in culture: smaller 
amounts of testosterone and androstenedione were also found. 
Abramovich et al. (19 74) also using organ culture techniques 
demonstrated testosterone output by human foetal testes 
maintained in culture for one day: this was endogenous 
testosterone production without added precursors, and testo­
sterone synthesis was stimulated by HCG.
Picon (19 76a) prepared and maintained foetal rat testes 
in organ culture for 3 days. Cultures prepared from 13^ days 
gestation foetuses showed no detectable testosterone production 
in the first day of culture, but subsequently testosterone 
output from these cultures developed and increased in vitro. 
Cultures prepared from 14!^  days gestation foetuses showed 
slight initial testosterone output, and this increased over the 
3 days in culture. However, cultures prepared from older 
foetuses showed maximum testosterone output in day 1 of culture, 
and this diminished in subsequent days in vitro. Maximum day 1 
output was observed in cultures prepared from 17^-18^ days 
foetuses. Brinkman (1975) found similar results with organ 
cultures of foetal guinea pig testes, and demonstrated that in 
this species, foetal testicular testosterone synthesis was
demonstrable at 25 days gestation, 4 days before differen­
tiation of the Wolffian duct.
George et al. (1978) examined organ cultures of foetal 
rabbit testes and demonstrated that early foetal testes devoid 
of recognizable interstitial cells, and without evidence of 
3^-HSD-I activity, could develop both of these characteristics 
in culture in the absence of trophic hormones. The 33-HSD-I 
activity developed at 18 days gestation at which time testi­
cular cells developed HCG receptors. However, testosterone 
synthesis was not apparent till 20 days gestation.
6, Monolayer culture of foetal testes
In our laboratory, monolayer culture is preferred to 
organ culture because there is less chance of artifact arising 
due to diffusion of nutrients or products through the lumps of 
tissue. Also, the immediate cellular environment can be 
controlled more accurately, and viable individual cells can be 
observed readily by inverted phase-contrast microscopy. It has 
been shown that adrenal cells in monolayer culture retain many 
of their in vivo functions, but these functions are influenced 
by cell density in culture and also by the presence or absence 
of trophic hormone in the culture medium (O'Hare & Neville, 1973a, 
b&c; O'Hare et al., 1978). Having gained experience with 
adrenocortical cells in culture, the function of testicular cells 
in culture was then examined. As a marker of steroidogenic 
activity, a radioimmunoassay for testosterone was developed. 
However, detection of testosterone secretion gave no indica­
tion of the synthesis and release of steroid precursors, in 
particular progesterone.
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Therefore, I developed a radioimmunoassay for progesterone 
in order to detect if this steroid - a precursor of testo­
sterone - was released by the cells in culture. In addition, 
culture media were examined by high pressure liquid chroma­
tography (HPLC) in order to examine the complete profile of 
steroids released.
Rat adult interstitial cells of the testis in monolayer 
culture initially produce testosterone, but after a few days 
in culture, testosterone secretion diminishes and progesterone 
secretion increases (Khatim & O'Hare, 1976), a situation 
analogous to the "spontaneous lutéinisation" of ovarian granu­
losa cells in culture (O'Hare et al., 1978). Interstitial 
cells from adult and prepubertal human testes behave similarly 
in monolayer culture to adult rat testicular interstitial cells, 
viz.initial testosterone secretion being replaced by progesterone 
secretion. However, cultures prepared from human foetal and 
neonatal testes continue to produce testosterone in vitro 
(O'Hare et al., 1976a).
Unlike the adrenocortical cells in monolayer culture, 
addition of trophic hormones (HCG or cyclic AMP) to the cultures 
of testicular interstitial cells does not produce morphological 
changes in the cells. This is at variance with the results of 
Davis (1978) who reported that testicular cells in monolayer 
culture spontaneously produce tubules and spheres in the tissue 
culture flask. In our laboratory, culture conditions are 
arranged to suppress cell proliferation, whereas this is not 
so for the studies of Davis (1978). This probably explains 
the discrepancy.
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Testes removed from some patients with testicular 
féminisation were available for study. Monolayer cultures 
prepared from these behaved like foetal testicular cells with 
prolonged testosterone production in vitro.
My interest in the function of the foetal rat testis 
at the time of sexual differentiation led me to postulate 
that progesterone may be an important testicular secretory 
product involved with Mullerian duct inhibition(vide supra^
My organ culture studies gave circumstantial evidence that 
progesterone had a deleterious effect on the Mullerian duct.
During the course of these experiments I had gained experience 
at dissecting the small rat foetal testes at the time of early 
gonadal differentiation. It was therefore logical that I 
should next prepare monolayer cultures of foetal rat testes 
and examine the daily output of endogenously synthesised steroids.
I prepared cultures from foetal rat testes ranging in gesta­
tional age from 14i^  to 20^ days, and collected and replaced 
the culture medium daily. I then examined the daily steroid 
output by radioimmunoassay and high pressure liquid chromato­
graphy over a 20 day period in monolayer culture, during which 
time I stimulated the cells with HCG or cyclic AMP. I used the 
testosterone radioimmunoassay already developed in the laboratory, 
and I developed a similar assay progesterone. The high
pressure liquid chromatograph was a recent aquisition to our 
laboratory and many of the parameters required to give optimal 
steroid separation had to be established.
The results of these experiments are presented in 
Chapter 4.
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SECTION I : EXPERIMENTAL STUDIES
CHAPTER 2
MATERIALS AND METHODS
CHAPTER 2
IN VITRO STUDIES: MATERIAL AND METHODS
A . ANIMALS
1. Strain of rats
Wistar rats with a gestational period of approximately 
22 days, and an oestrous cycle of 5 days, were used in the 
present experiments.
2. Preparing foetal rats of known gestational age
An excess of mature virgin female rats were housed 
overnight with males and separated the following morning whether 
or not there was evidence of copulation. This was designated 
as day ^ . After 7-10 days, pregnancy could be detected by 
palpation of the mothers, and non-pregnant rats were used for 
further mating.
B. TISSUE CULTURE TECHNIQUES
Organ culture and monolayer techniques were developed 
for the experimental part of this thesis. Foetal rat genital 
tracts were explanted and maintained whole in organ culture. 
In other experiments, the cells of foetal rat testes were 
dissociated into single cell suspensions and subsequently 
maintained in monolayer cultures.
1. Organ culture of foetal rat genital tracts
Foetal rat genital tracts were cultured either on solid 
culture medium containing 0.8% agar, or on stainless steel 
grids overlying liquid culture medium. The constituents of 
the culture media used are shown in Table 2.1 and the prepa­
ration of these media is presented in Appendix VII.
a) Addition of steroid or polypeptide hormones to culture medium
Solutions of testosterone or progesterone in ethanol, and HCG 
(Human chorionic gonadotrophin: "Pregnyl", Organon) in sterile 
saline were prepared 100 times the final concentration required, 
and 200yl was added to 20ml of culture medium as required. 
Because addition of steroids resulted in 1% ethanolic solution 
in the culture medium, a similar concentration of ethanol 
was used in control cultures. However, a 1% concentration 
of ethanol was found to be toxic to some cultured genital 
tracts, and subsequently more concentrated stock steroid
Table 2 .1. Concentrations of constituents of tissue culture media used 
for organ culture of foetal rat genital tracts on solid media.
Constituent Medium B Medium C
Medium 199 (with Hanlt’s salts) X 1 X 1
HE PE 8 buffer 20 mM 20 mM
Agar 0 0.8  %
Bicarbonate 0, 56 g/1 0. 56 g/1
Foetal calf seium 20% 20%
Penicillin /  streptomycin 25 units/m l 25 units/m l
Neomycin 50 jug/ml 50 jLtg/ml
Amphotericin 1. 25 p g /m l 1. 25 jug/ml
steroid solutions in ethanol were prepared so that the 
desired concentration of steroid in the medium could be 
obtained without producing a concentration of ethanol greater 
than 0.2% in the culture medium.
The following final concentrations of hormone were used 
in the experiments :-
Progesterone 10 5X 10”^M; 10
Testosterone 10"^M
HCG 10 iu/ml
b) Dissection of foetal rat genital tracts
Pregnant wistar rats at 14^ to 17^ days gestation were killed 
by cervical dislocation and the uteri, containing 5 to 15 
foetuses, were transferred to a large sterile Petri dish.
Each embryo, with placenta and foetal membranes intact, was 
removed in turn from the uterus and transferred to a sterile 
Petri dish. Under a Wild M5 stereoscopic dissecting micro­
scope, the genital tracts were exposed, carefully dissected 
free, and placed on a square of Millipore filter approximately
0.5cm in length. In some instances, the gonads were removed 
from the genital tracts before the genital tracts were 
dissected free. By 14^ days gestation, the foetal testis 
is larger and more vascular than the ovary, and the two are 
readily differentiated under the dissecting microscope.
All dissecting instruments were sterilised before use, 
and aseptic techniques were used throughout.
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c) Maintaining rat foetal genital tracts in organ culture
When using solid tissue culture medium, the Millipore 
filter with genital tract was laid on top of the solid 
ridge of medium C, and approximately 2ml of medium B was 
placed in the Petri dish around the gel to keep it moist.
Any substances added to medium C (e.g. steroids or HCG) 
were also added to medium B. The Petri dishes with genital 
tracts were loosely covered and incubated at 37° c for 3 days 
in a covered sandwich box containing a little distilled 
water to reduce evaporation. The HEPES buffer maintains a 
physiological pH in an atmosphere of air.
In the liquid culture medium system, approximately 2ml 
of medium D was placed in the well of a Falcon tissue culture 
dish and a sterile steel wire grid was placed over the 
liquid so that the top of the fluid touched the bottom of the 
grid* The Millipore filter with genital tract was placed on 
the grid exposing the tissue to culture medium. The porous 
paper in the outer well of the tissue culture dish was 
moistened to reduce evaporation and the culture dishes were 
incubated at 37°C for 3 days in a covered sandwich box con­
taining a little distilled water as before.
d) Assessing genital duct development or regression in organ 
culture
It was assumed that all the foetuses in one litter had 
reached to same stage of genital duct development at the 
time of the start of the tissue culture. One male and one 
female genital tract were dissected free, placed on Millipore
filter and immediately fixed in Bonin's fixative to give 
an indication of the stage of development at the time of 
explanation. After 3 days in organ culture, the remaining 
genital tracts on Millipore filter were fixed in Bouin's 
fixative. Because the genital tracts are so small, complete 
fixation occured in 2 hours after which time the tissue was 
transferred to 70% ethanol to prevent over-fixation which 
made the delicate tissue brittle and difficult to section.
The genital tracts and Millipore filter were embedded 
together in paraffin wax with the Millipore perpendicular 
to the face of the block. The block was then sectioned 
serially at 10 microns through the whole length of the genital 
tracts, each lOth section being mounted, stained with 
haematoxylin and eosin, and examined histologically. There 
were approximately 300 transverse sections of genital tract 
in each block, therefore the tissue was examined at 30 
different levels. Each histological section contains 2 
genital tracts (left and right) and each tract contains 2 
genital ducts (Mullerian and Wolffian). The condition of each 
duct, and gonad if still attached, was assessed histologically 
at every level so that the extent of in vitro development or 
regression could be determined.
Using this system, the effects of castration (removal 
of gonads before explanting the genital tracts), or the 
effect of added hormones, can be studied in vitro.
2. Monolayer culture of foetal testes
The preparation and constituents of the culture media 
used in these experiments are shown in Appendix VII.
Preparation, of monolayer, cultures
Foetal rat testes contain histologically recognizable 
interstitial (Leydig) cells from 14^ days gestation onwards 
(Fig. 2.1). Older foetal testes have relatively more semini­
ferous tubular tissue than interstitial tissue, but there is 
no reduction in absolute number of Leydig cells. It is assumed 
that the Leydig cells are mainly responsible for the steroido­
genic activity of the foetal testes. No attempt was made to 
separate the interstitial and tubular tissue. Because foetal 
rat testes are so small, up to 40 testes were used to prepare 
a single monolayer culture. Therefore, foetal rats from up to 
4 litters were required for each culture. Cultures were prepared 
from foetal rat testes ranging from 14^ to 203^  days gestation.
Two to 4 pregnant Wistar rats of identical gestational age 
were killed one at a time by cervical dislocation, and the uteri 
containing the foetuses removed aseptically and placed in sterile 
Petri dish. The genital tracts of each foetus were exposed 
aseptically under a dissecting microscope and the sex of the gonad 
determined. Female gonads were discarded. The larger more 
vascular testes were identified, removed, and stored in HEPES 
buffered "dissecting medium" at 4°C for up to 3 hours till all 
the testes were collected.

Fig. 2.1. Photomicrographs of foetal testes.
Fig. 2.1a. Human foetal testis (22 weeks gestation) showing 
solid primary sex cords consisting of primitive germ cells 
and Sertoli cells. There are many plump interstitial cells 
of Leydig between the sex cords. (H & E X 475).
Fig. 2.1b. Rat foetal testis (18% days gestation).
The features are similar to those of the human foetal 
testis with solid primary sex cords and many Leydig cells 
in the interstitium. (H & E X 475).
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«
Fig. 2.1b
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Fig. 2.1. Photomicrographs of foetal testes
Fig. 2.1c. Colour photomicrograph of human foetal testis 
(22 weeks gestation; same as Fig. 2.1a). (H & E X 450).
When all the testes had been removed, each was cut into 
4-5 pieces under the dissecting microscope in "dissecting 
medium", and transferred to a sterile universal container 
where they were allowed to settle to the conical apex. The 
supernatant "dissecting medium" was sucked off with a Pasteur 
pipette and replaced by 5ml of enzyme solution" (hyaluronidase 
and collagenase in "dissecting medium") at 37°C. After 2 hours 
incubation at 37°C the "enzyme solution was sucked off and 
discarded, and replaced by 5ml of "dissecting medium". The 
testes and medium were vigorously agitated approximately 10 
times with a Pasteur pipette, and allowed to settle for 2 minutes 
during which time undissociated clumps of testicular tissue and 
capsule sedimented to the bottom,while dissociated cell remained 
in suspension. The supernatant medium containing dissociated 
cells was transferred to a clean sterile universal container and 
the remaining clumps of tissue were again agitated 10 times in 
5ml of "dissecting medium" using a Pasteur pipette. After 2 
minutes settling time, the supernatant cell suspension was removed 
and pooled with the cells from the first dissociation. The clumps 
were agitated a third time in "dissecting medium", and the cells 
suspension (after settling for 2 minutes) again pooled with the 
previous dissociations. It was assumed that the 15ml pool of 
dissociated cells contained most of the interstitial and tubular 
cells, whereas solid clumps of capsule and undissociated testi­
cular tissue were discarded in the sediment.
The 15ml cell suspension was gently centrifuged for 5 minutes 
in a MSE bench centrifuge at a setting of 2^. The supernatant 
was decanted and discarded, and 5ml of bicarbonate buffered 
"cultured medium" added to the pellet at the bottom of the univer­
sal container.
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The cells in the pellet were resuspended by gentle agitation 
with a Pasteur pipette for approximately 1 minute, transferred 
to a Falcon tissue culture flask, gassed for 30 seconds with 
10% CO^ in air (BOC), tightly stoppered, and incubated at 37°C.
After 24 hours incubation, many cells had adhered to the 
foot of the flask, and others remained in suspension. It is 
thought that viable Leydig and Sertoli cells adhere to the 
bottom of the flask while non-viable cells and the less dense 
germ cells remain in suspension. The supernatant fluid was 
decanted into a stoppered 5ml plastic Bijoux bottle (Falcon) and 
stored at -20^C, Five ml of fresh "culture medium" was pipetted 
into the tissue culture flask, then gassed with 10% CO2 in air, 
stoppered and replaced in the 37^0 incubator. The culture medium 
was changed and collected daily. After 10 days in a non-hormonal 
environment, the monolayer culture was maintained for a further 
5 days in the presence of culture medium containing 50 iu HCG 
per 5ml (changed daily), then a further 5 days in culture medium 
containing 2l0pg monobutyryl cyclic adenosine monophosphate 
(cAMP: Sigma) per ml (0.5mM).
Each culture was examined daily, with a Wild M40 phase- 
contrast inverted microscope to check viability of culture cells, 
plating density, and to ensure that there was no bacterial over­
growth. The appearances of a typical culture is shown in Fig. 2,2 
One culture was prepared from twenty 183^  days rat foetal 
testes, the total weight of the testes being approximately 8mg.
No other attempt was made at quantitation for several reasons
a) It was difficult to remove excess fluid and weigh the foetal 
testes without jeopardising cell viability by dehydration.
0  3 -
Fig. 2.2. Phase-contrast photomicrograph of monolayer 
culture of rat foetal testes. The culture was prepared 
from 19% days gestation foetal testes and photographed 
after 5 days in culture. { X 150)
n D
Fig. 2.2
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b) Not all the testicular tissue was used for cell culture.
The capsule, undissociated clumps of testes, damaged cells 
and probably germ cells were discarded.
c) The proportion of Leydig cells in the testis varied 
greatly with gestational age, therefore the proportion of 
steroidogenically active cells is unknown.
d) A cell count was not feasible because of marked variability 
of plating density within single cultures.
e) The number of cells in each culture was not static. In 
some cases there was gradual cell loss but in some others 
definite proliferative activity occurred.
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c. ASSAY OF CULTURE MEDIA
1. High pressure liquid chromatography (HPLC):
Description and separating capacity
A Du Pont model 830 high pressure liquid chromatograph 
(Du Pont, Wilmington, Dela., USA), equipped with a model 837 
variable wavelength spectrophotometer, and a model 838 program­
mable gradient elution module, was used to detect endogenous 
steroid production from the rat testes cells in monolayer culture. 
Extracted samples were injected via a Rheodyne septumless valve. 
The spectrophotometer was operated in the double beam mode with 
an air reference cell, and chromatographs were recorded in a 
Phillips PM 8000 flat-bed recorder. The apparatus is shown in 
Fig. 2.3.
Steroids are relatively non-polar compounds and are best 
separated by liquid-liquid partition column chromatography.
The stationary liquid phase is a non-polar liquid which absorbs 
steroid molecules. This liquid is chemically bonded to inert 
silaceous particles which are packed into a column. The silaceous 
particles are small in order to increase the surface area of a 
small volume of stationary phase, and therefore to increase the 
efficiency of separation. The absorbed steroids are eluted from 
the column by gradient elution using a polar mobile phase liquid. 
The flow rate of the mobile phase is increased by applying it to 
the column under very high pressure (up to 4,500 pounds per 
square inch), and by heating the column to 40-45°c in order to 
reduce viscosity. Further increase in temperature causes 
increased activity of the porous sites and increased polarity of 
the stationary phase thus increasing retention volume.

Fig. 2.3. Photograph of Du Pont Model 830 high pressure 
liquid chromatograph.
Fig. 2.3.
An optimum balance between flow rate and retention volume is 
determined experimentally in order to achieve maximum resolution 
without thermal instability.
HPLC has the advantages of speed, versatility, high 
sensitivity, good resolution, and both quantitative and quali­
tative analysis of steroids without their destruction. The 
steroids can therefore be recovered at the end of the separation. 
Small bore columns packed with small sized particles give best 
results in high speed chromatographic separations [Brown, 1973). 
HPLC is better than thin layer chromatography [TLC) which is 
time-consuming, lacks sensitivity, and is difficult to quantitate 
HPLC i s also superior to gas liquid chromatography (GLC) in which 
the steroids often required to be derivativised prior to 
application to the column so that they can be applied in a 
gaseous phase.
In the present experiments, the steroids produced by the 
foetal rat testes in monolayer culture and released into the 
tissue culture media were extracted and analysed by HPLC.
Gradient elution with 2 different solvent systems [acetonitrile/ 
water and dioxane/water) were used. The method of extracting 
steroids from the tissue culture media for HPLC, and the full 
HPLC procedure, are given in Appendix IX. The capacity to 
separate different standard steroids is shown in Figs. 2.4,&2.5 
and the retention times of 47 different steroids are given in 
Table 2.II. The resolving power of HPLC to separate the 
steroids produced by the foetal testes in monolayer culture 
is shown in Table 2.III. It was found that in the HPLC systems 
used in our laboratory, the peak height in the chromatogram is 
linearly proportional to the mass of steroid applied to the

Fig. 2.4. Separation of steroid standards (330-750 ng) by- 
high pressure liquid chromatography. The standard steroids 
used are those expected to be produced by the testis in 
monolayer culture. (From O'Hare et al., 1976b),
  solvent gradient optical density at 240nm
Chromatographic conditions:
Column :
Solvent (start): 
Solvent (finish): 
Gradient:
Time:
Temperature : 
Pressure :
Flow rate (start): 
Flow rate (finish): 
Attenuation :
Zorbax-ODS
32% (v/v) acetonitrile:water
100% acetonitrile 
3
y  =  X  
50 minutes
45°C
2,000 Ibs/sguare inch 
0.3 8 ml/min 
0.80 ml/min
0.32 absorption units full scale
Abbreviations (full systematic nomenclature - Appendix I)
AD:
DHA:
DHP:
DHT:
17a-0HP: 
17a-0H DHP: 
16a-0HP:
P:
7a-0HT:
T:
Androstenedione
Dehydroepiandrosterone
20a-Dihydroprogesterone
5a-Dihydrotestosterone
17a-Hydroxyprogesterone
17a-Hydroxy-20a-dihydroprogesterone
16cx-Hydroxyprogesterone
Progesterone
7a-Hydroxytestosterone
Testosterone
73
Chrom atogram  of te s t is  stero id  standards
OD
Zorbax-ODS 
A ceton itrile-w ater  
2000psi 45°C  
0 . 3 2  AUFS(DOC)
AD
DHP
240
DHA %CHoCN
DHT
48 36 24 12 0
Retention tim e (min)
Fig. 2.4.

Fig. 2.5. Separation of polar steroid standards (250-750ng) by 
high pressure liquid chromatography. The standard steroids 
used are those expected to be produced by the adrenal in 
monolayer culture. (From O'Hare et al., 1976b).
solvent gradient optical density at 240nm
Chromatographic conditions:
Column:
Solvent (start): 
Solvent (finish): 
Gradient :
Time :
Temperature : 
Pressure:
F 1 o v 7 rate (start) : 
Flow rate (finish): 
Attenuation :
Zorbax-ODS
20% (v/v) dioxane:water
100% dioxane 
3
y  =  X  
50 minutes 
45°C
2 f500 lbs/square inch 
0,3 8 ml/min 
0.3 4 ml/min
0.16 absorption units full scale
Abbreviations (full systematic nomenclature - Appendix I)
ALDO:
B:
F:
E:
DHALDO:
llpOH-AD:
180H-B:
6 POH-F: 
laOH-A: 
180H-D0C:
Aldosterone
Corticosterone
Cortisol
Cortisone
11-Dehydroaldosterone 
llp-Hydroxyandrostenedione 
18-Hydroxycorticosterone 
6|3 -Hydroxycortisol
18-Hydroxy-11-dehydrocorticosterone 
18-Hydroxy-ll-deoxycorticosterone
180H-A
Zorbax-ODS 
Dioxane-water
2500psi 45°C 
0.16AUFS180H
-DOC
DHALDO
ALDO
OD254
180H
-B
Retention time (min)
60
% (C2H^ )g02
40
20
Table 2. II. Retention times in minutesfor 47 standard steroids on 
Zorbax - ODS using acetonitrile or dioxane as mobile phase.
Steroid *
Retention time (min)
Acetonitrile 
(32 - 100 %)
Dioxane 
(20 - 100 %)
6/3-hydroxycortisol 3. 5 4
11-dehydroaldosterone 5 15
17-isoaldosterone 6 15
18 - hy droxy-1 1 -dehydro cortic o st erone 6. 5 17. 5
prednisone 9 23
aldosterone 8 19
oestriol 8 25
cortisone 9 25. 5
19-hydroxyandrostenedione 11. 5 20
17qi-hydroxy testosterone 9 19. 5
18-hydroxycorticosterone 7 21
prednisolone 9 26. 5
cortisol 9 27
adrenosterone 17 28
19-hy droxytestosterone 10 24
16o! -hydroxy testosterone 11 27
11-dehydrocorticosterone 15 29. 5
dexam ethasone 13 35
llj3-hydroxyandrostenedione 17 32
21 “deoxycortisol 16 34. 5
corticosterone 18 36
lljS-hydroxy testosterone 15 33. 5
18-hydroxydeoxy corticosterone 16 34. 5
11-deoxycortisol 20 37. 5
6ce-hydroxyprogesterone 24. 5 38. 5
1 -hydroxyprogesterone ** 24 38
11 -ketoprogesterone 30 40
77 -
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Retention time (min)
steroid * Acetonitrile 
(32 - 100 %)
Dioxane 
(20 - 100 %)
oestrone 30. 5 42. 5
11 j3 - hy d r 0 xy - 2 0 O'- di hy d r 0- 
progesterone 26 39
androstenedione ** 36 42
6/3-hydroxyprogesterone 30 41
oestradiol 29 43
llj3-hy droxyprogesterone 33 43
11 -deoxycorticosterone 36 43. 5
17a-hydroxyprogesterone ** 38 45
testosterone ** 35 43. 5
17a -hydroxy-20a-dihydro- 
progesterone ** 32 42
17a -hydroxy - 2 0/3- dihydro­
progesterone 32. 5 43. 5
dehydroepiandrosterone 41 44
androstenedlol 38 -
17a -hydroxypregneneolone 39 -
5a - dihydrotestosterone 42 -
progesterone ** 45 49
20a - dihydroprogesterone ** 43. 5 47. 5
2 0j3 - dihy drop ro ge s ter on e 46 49. 5
pregnenolone 47 50
cholesterol > 6 0 -
* Systematic names of steroids are given in Appendix I
** These steroids were detected in foetal testes monolayer culture 
media. A standard solution containing a mixture of these 7 steroids 
was applied to the HPLC daily to check retention times.
Table 2. III. Retention tim es in minutes of standard steroids 
corresponding to steroids produced by foetal rat testes in monolayer 
culture.
Retention time (min)
Steroid * Acetonitrile 
(32 - 100 %)
Dioxane 
(20 - 100 %)
16a "hydroxyprogesterone 24 38
androstenedione 36 42
17a-liydroxyprogesterone 38 45
testosterone 35 43. 5
17a-hydroxy-20a “dihydro­
progesterone 32 42
progesterone 45 49
20a-dihydroprogesterone 43. 5 47. 5
* Nomenclature of steroids is  given in Appendix I.
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column (Fig. 2.6) oyer the range 40-2000 ng CO'Hare et al.,
1976) .
HPLC is less sensitive than radioimmunoassay (RIA) for 
detecting steroids, and cannot cope with large numbers of samples 
In the present studies, HPLC was used to verify the nature of 
the steroids detected by RIA, and helped in their quantitation. 
HPLC was also used to detect steroids not measured by RIA.
2. Radioimmunoassay (RIA) of steroids
Radioimmunoassay of steroids has been possible since 
antisera to seroids have been available. Antibodies can be 
raised to steroids which have been coupled to antigenic proteins, 
and these form the basis of highly sensitive and specific radio­
immunoassays (Cameron & Scarisbrick, 1973). All culture media 
collected from foetal rat testicular monolayer cultures were 
assayed by RIA for progesterone and testosterone.
Antiserum to progesterone-ll«-hemisuccinyl-bovine serum 
albumin was raised in rabbits and kindly donated by Dr. K. McNatty; 
and antiserum to testosterone-3-oxime-bovine serum albumin was 
raised in rabbits and kindly donated by Mr. M. Mansfield. 
Anti-progesterone serum was diluted 1 in 5 in PBS "assay buffer" 
(Appendix IV) and stored at -2QOC in 0.5ml aliquots. Anti­
testosterone serum was stored undiluted at -20^C in 0.5ml aliquots
bO -
Fig. 2.6. Graph to show the relationship between mass of 
steroid applied to the column of the high pressure liquid 
chromatograph, and the peak height of the chromatogram. The 
peak height is linearly related to the mass injected over 
the range 40-2000ng for progesterone and testosterone.
Progesterone2501
200-
8 150-
Testosterone
50-
500 20001000 1500
mass steroid injected (ng)
Fig. 2.6.
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Progesterone RIA
The progesterone RIA method used in the present series is
similar to that described by Cameron & Scarisbrick (1973).
The reagents/ solutions and final procedure developed for 
of
the assay progesterone in the tissue culture media are given 
in Appendix IV.
In the final stage of the assay, separation of free and 
bound progesterone was achieved using either dextran coated 
charcoal, which adsorbs free progesterone, or a solution of 
polyethylene glycol (PEG) which precipitates the progesterone 
bound to antibody. Figs. 2.7 (a&b) show standard curves for 
progesterone RIA using dextran coated charcoal and PEG. Fig 2.8 
compares the use of dextran coated charcoal with PEG in the 
antibody dilution curves. These figures demonstrate that both 
dextran coated charcoal and PEG can be used effectively in the 
RIA of progesterone.
Dextran coated charcoal suspension is easier to pipette, 
and after centrifugation the supernatant is easier to decant 
than the more viscous PEG solution. Also PEG supernatant mixes 
less readily with Instagel. On the other hand the PEG solution 
does not require constant stirring before and during the pipetting 
stage (step vi), and is more stable to storage* Also, PEG is less 
liable to strip the labelled progesterone off the antibody than 
the dextran charcoal. If dextran charcoal is in contact with the 
antibody-bound progesterone for more than about 10 minutes, marked 
stripping of the label from the antibody occurs giving a falsely 
low reading for the percentage of label bound at the end of the 
incubation. For this reason, the total time taken to add the

Fig. 2.7. Standard curves for progesterone radioimmuno­
assay. The comparison of different agents used for 
separating free and bound progesterone is seen in 
Figs. 2.7a&b. Fig. 2.7c (over) shows a typical standard 
curve produced once optimal conditions had been established
Fig. 2.7a. Dextran charcoal separation of free and bound 
progesterone after overnight incubation with antiserum. 
Each point is the mean of three readings, the individual 
values being represented by small dots.
Fig. 2.7b. Polyethylene glycol (PEG) separation of free 
and bound progesterone after overnight incubation with 
antiserum. Each point is the mean of three readings, the 
individual values being represented by small dots.
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Fig. 2.7c. Standard curve for radioimmunoassay of 
progesterone using optimal parameters.
Standard steroid (in ethanol) dried under at 40^C 
lOOpl of progesterone label (22,000 DPM) in assay buffer 
lOOpi of 1/4000 antiserum in assay buffer 
lOOpl of 0.5% gelatin in PBS 
Incubated overnight at 4^C
1 ml of dextran coated charcoal suspension
Free and bound progesterone separated by centrifugation 
5 minutes after dextran charcoal addition
Supernatant (with bound progesterone) added to 10ml of 
Instagel to detect radioactivity by scintillation 
counting of beta emissions.
Each point is the mean of four readings.
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Progesterone RIA ; antibody dilution curve. 
Comparison of dextran charcoal and PEG as agents for 
separating free and bound progesterone at the end of the 
incubation with antiserum.
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dextran charcoal . to all the tubes should not
exceed 5 minutes [limiting the total number of assay tubes to 
about 80), and 5 minutes should elapse between addition of 
the dextran charcoal to the last tube and the start of the 
centrifugation. These times are less critical when using 
PEG because of the less severe stripping caused by PEG, 
therefore triplicate points show less scatter.
On balance, it was considered that dextran charcoal 
was more convenient than PEG. The precision of the Assay 
was therefore determined by the amount of stripping between 
the addition of the dextran charcoal and the separation of 
free and bound progesterone by centrifugation. Stripping was 
lessened by keeping the tubes at 4^C.
The dilution of antiserum used should give approximately 
50% binding when no unlabelled progesterone is added, and less 
than 20% binding in the presence of SOOpg progesterone.
Fig. 2.8 shows that when using dextran charcoal a dilution of 
1:6000 of anti-progesterone serum is suitable. The concentrated 
antiserum was stable when frozen, but the diluted (1:1001 stock 
serum deteriorated slowly at 4°C and less dilute antiserum was 
required in later experiments.
In the standard curves for progesterone RIA (Fig.2.7), 
plotting the percentage of labelled progesterone bound to anti­
body against the amount of unlabelled progesterone added gives 
aconcave curve on linear axes, The amount of progesterone in an 
unknown sample can then be determined by extrapolation. 
Alternatively, plotting the ratio, free-labelled-progesterone : 
bound-labelled-progesterone (F/B). against the amount of unlabelled 
progesterone gives an approximate straight line in the range
0-500pg progesterone. This is perferable because the 
progesterone in the unknown sample can be then determined 
by calculation rather than extrapolation.
Cross-reactivity of antiproqesterone antiserum
Standard solutions of many steroids which may have cross­
reacted with the antiprogesterone antiserum were prepared in 
ethanol. From each, SOOpg of steroid was compared with the 
standard curve for progesterone over the range 0~500pg. Table 
2.IV lists the steroids tested and their cross-reactivity.
Testosterone RIA
The testosterone RIA method used is similar to that 
described by Collins et al. (1972). Unlike the progesterone
RIA which was developed for the present thesis, the RIA method 
for testosterone had already been established by other members 
of our department and optimum parameters had already been worked 
out for our laboratory conditions. The procedure is given in 
Appendix V.
The testosterone antibody binds testosterone more strongly 
than the antiprogesterone serum binds progesterone, therefore, 
there is less stripping of the testosterone by the dextran 
coated charcoal. For this reason, 20 minutes is allowed to 
elapse between addition of dextran charcoal and the start of 
the centrifugation (step vi). compared to the 5 minutes in the 
progesterone assay. As a result, testosterone assay is more 
reproducible than the progesterone assay. A typical standard 
curve is shown in Fig. 2.9.
Table 2. IV. Cross-reactivity of various steroids with anti-progesterone- 
lloi-hemisuccinyl-BSA serum in the progesterone radioimmunoassay.
500  pg of each steroid was assayed and the "progesterone equivalent" 
determined from the progesterone standard curve.
Dextran charcoal separation . PE G  separation
steroid (SOOpg) * % tge 
bound
progesterone
equivalent
(pg)
. cross 
reactivity 
(% tge)
% tge 
bound
progesterone
equivalent
(pg)
cross 
reactivity 
(% tge)
progesterone 9.2 500 100 25. 5 500 100
11-ketoprogesterone 12. 5 300 60 26. 5 450 90
pregnanedione 20.7 105 21 40.7 173 35
Sor-dihydrotestosterone 23.8 66 13 48 82 ,16
Sa-androstanedione 24. 5 57 11 46. 5 96 19
5|3 ■'dihydrotestosterone 2 5 .. 52 10 47.4 88 18
160-hydroxy- 
progesterone 25 52 10
oestrone 26.3 40 8 49.7 66 13
testosterone 27.7 32 6 45.4 108 22
2 OcV “hydroxy- 
pregnenolone 27.7 32 6
17ti!-hydroxy-20«- 
dihydroprogesterone 27.7 32 6 '
17a“hydroxy-
preghenolone 28.8 25 5
5a-pregnan-3, 20-dione 28.8 25 5
16cv-hydroxy- 
testosterone 30 18 4
2 0/3-dihydro- 
progesterone 30 18 4 57.2 22 4
androstenedione 30.5 15 3 46. 5 96 19
7a-hydroxy testosterone 31 12 2.5
17a, 2 Oa-dihydroxy- 
pregnenolone 31. 5 9 2
androsterone 31.6 8 2 59. 5 12 2
DHA 30.8 12 2 51 54 11
17a-hydroxy-
progesterone 31.6 .‘8 2 51.1 52 10
pregnenolone 31. 5 9 2 51. 3 . 50 10
5a"pregnan-3)3, 20a- 
diol 33 5 1
5a -pz’egnanolone 37. 5 0 0 53.2 40 8
5/3-pr egnanolone 34.8 0 0 54. 5 35 7
20a-dihydrO“
progesterone
37. 5 0 0 56.8 25 5
-  -
Fig. 2.9, Standard curve for testosterone RIA.
Each point is the mean of three readings, the individual 
values being represented by small dots.
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Aa before, the ratio of free: bound tritlated testosterone 
(F/b ) is plotted against unlabelled testosterone added to 
give an approximate straight line from which the amount of 
testosterone in an unknown sample can be calculated.
Steroids tested for cross-reactivity with the antitestosterone 
antiserum are shown in Table 2.V.
Tissue culture medium was collected daily from monolayer 
cultures of foetal rat testes, and each medium was assayed for 
both progesterone and testosterone using RIA. Those media with 
a high concentration of steroid, as detected by RIA, were 
extracted for HPLC. This gave qualitative and quantitative 
confirmation of the presence of progesterone and testosterone, 
and also gave an indication of other steroids produced endo­
genously by the cultured cells.
Table 2. V. Cross "reactivity of various steroids with anti-testosterone- 
3-BSA antibody.
Steroid * Cross reaction (% tge)
testosterone 100
7û! -hydroxy testosterone 250
5a -dihydrotestosterone 150
dehydroepiandrosterone (DHA) 2
3j3,17j3-androstandlol 2
androstenedione 1
16a-hydroxy testosterone 1
progesterone 0.1
17 a -hy droxyprogesterone 0 .4
17a -hydroxy- 20a -dihydroprogesterone 0.1
20a-dihydroprogesterone 0. 5
16a-hy droxyprogesterone 0.1
* Nomenclature of steroids is  given in Appendix I
Data from M. S. El-Khatim, Ph.D. thesis. University of London, 1976.
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CHAPTER 3
RESULTS AND DISCUSSION 
ORGAN CULTURE OF GENITAL TRACTS AND GONADS 
A. RESULTS
Forty-six pregnant Wistar rats yielding 479 foetal rats 
(mean;- lO foetuses per pregnant rat) were used in this survey.
These pregnant rats were supposed to be at 14^ days gestation, 
but it became clear that many of the rats were at a different 
gestational age. Therefore, gestational age had to be assessed 
by the stage of development of the foetal gonads and genital 
ducts as shown in Table 3.1. A rat was acceptable as being at 
14^ days gestation if the following criteria for the foetuses 
were met:-
(i) gonadal differentiation: The testes were just noticeably
larger than the ovaries of female sibs under the dissecting 
microscope, and had a well marked surface vascular network. 
Histologically, at this time, there was little difference 
between the ovary and testis, the testicular tubules 
(primary sex cords) being poorly developed.
(ii) Wolffian duct: Histological sections showed fully developed
Wolffian ducts in both sexes with no evidence of regression. 
(iii) Mullerian duct: In both sexes, early anterior development 
of the Mullerian ducts was seen histologically but there 
was no evidence of canalisation and no regression had 
occurred.
- y o
Table 3 .1. Development of rat foetal gonads and genital ducts at 
different gestational ages.
Gestational
age
Foetal
testis
Foetal
ovary
Wolffian
duct
Mullerian
duct
111 days gonad not identified as a separate structure
fully
developed
not present
1 2 | days indifferent gonad just developed
fully
developed not present
13 | days indifferent gonad fullydeveloped
very early
anterior
development
14 | days
just recogn­
isable under 
dissecting 
microscope
indifferent: 
sm aller 
than testis
fully
developed
present 
anteriorly 
but not 
canalised
15 | days
well
developed 
primary 
cords seen 
histologic­
ally
indifferent: 
smaller 
than testis
fully
developed
almost
completely
developed
almost
reaching
urogenital
sinus
16 | days
well
developed 
primary 
cords seen 
histologic­
ally
indifferent: 
smaller 
than testis
fully
developed
posterior
development
complete:
anterior
regression
in males
17 | days
well
developed 
primary 
cords seen 
histologic­
ally
sm aller 
than testis: 
ovarian 
tissue  
recognised 
by meiotic 
figures in 
secondary 
cords
fully
developed: 
anterior 
regression  
in some 
fem ales
regressed  
anteriorly 
in males: 
no regression  
in females
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TVenty-three pregnant rats containing 230 foetuses were 
accepted as being at days gestation and of these, 48 foetal
genital tracts were fixed for histology without culture to act 
as controls, and 153 were cultured for 3 days. The number of 
rats at different gestational ages is shown in Table 3.II.
Normal embrvological development in vitro
a) Mullerian duct development in vitro
Mullerian duct development in vitro was observed in 129 
cultures of genital tracts. In 29 cases, genital tracts were 
removed from foetal rats of 111^  to 131$ days gestation, at which 
time Mullerian duct development had not commenced, but after 
3-4 days in culture they were detected histologically. A further 
100 genital tracts were removed from older rat foetuses at a time 
when Mullerian duct development had just commenced: after 3 days 
in culture, their development had been completed in vitro 
(Fig, 3.1).
b) Mullerian duct regression in vitro
Male genital tracts with attached testes were explanted 
from 13 foetal rats of gestational age 141$ days (X9) , 151$ days 
(XI) or 171$ days (X3) and maintained in organ culture for 2-4 days 
At the end of this culture period, anterior Mullerian duct 
regression had occurred in vitro in the presence of the attached
J . U U -
Table 3. II. Gestational age of foetal rats whose genital tracts were 
used for organ culture.
Gestational 
age (days)
Number of
pregnant
mothers
Total 
number 
of foetal 
rats
Controls
fixed
without
culture
Number 
of genital 
tracts 
cultured
Number 
of genital
tracts not 
examined
H i 1 13 1 6 6
12| 2 24 3 21 0
13i 9 109 20 67 22
I4 i 23 230 48 153 29
15| 4 39 5 29 5
16| 1 9 2 7 0
17i 6 55 10 22 23
Totals 46 479 89 305 85
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Fig. 3.1. Development of the foetal rat Mullerian duct
in vitro.
Fig. 3.1a. Genital tract removed from a 14^ days gestation 
female foetal rat and fixed immediately in Bouin's fixative. 
This section, from the posterior portion of the genital 
tract,shows only one genital duct - the Wolffian duct. .
The Mullerian duct has not yet reached this level.
(H & E X 570 )
Fig. 3.1b. Genital tract from a female litter-mate of above, 
removed at 14% days gestation and maintained in organ 
culture for 3 days. Both genital ducts are now present, 
the Mullerian duct having developed in vitro.
(H & E X 570 )
jjL V
Fig. 3.1a
m
Fig. 3.1b.
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testîs whereas in 40 similar male genital tracts, removal 
of the testes prior to culture prevented in vitro Mullerian 
duct regression. Female genital tracts cultured with or 
without, attached indifferent gonads did not show Mullerian duct 
regression. Regression of the Mullerian duct in vitro only 
occurred if a foetal testis was adjacent to the genital tract, 
and if the gestational age at the start of the culture plus the 
number of days in culture equalled, or exceeded, 17^ days (Fig. 3.2)
In two instances, male genital tracts were unilaterally 
castrated before culture. After 3 days in vitro Mullerian duct 
regression was evident in the genital tract in contact with the 
single testis, but not in the contralateral genital tract which 
had been castrated (Fig. 3.3).
c) Wolffian duct development in vitro
The Wolffian ducts were fully developed at the start of 
the culture in every case, even in the youngest [11^ days gesta­
tion) foetuses dissected. Therefore, no further development was 
detected in vitro.
d) Wolffian duct regression in vitro
In the absence of testes (female, or castrated male genital 
tracts) Wolffian duct regression in vitro occurred if the gesta­
tional age at the start of the culture plus the number of days in 
culture exceeded 17^ days. This was observed in 59 cultures, 
viz. 10 whole female genital tracts, 29 castrated female genital
tracts and 20 castrated male genital tracts (Fig. 3.41, The 
presence of a testis adjacent to the genital tract in culture

Fig. 3.2. Regression of the foetal rat Mullerian duct in vitro
in the presence of co-cultured rat foetal testes.
Fig. 3.2a. Genital tract removed from a 14% days gestation 
foetal rat and fixed in Bouin's immediately. This section, 
from the middle portion of the genital tract, shows both 
genital ducts to be present. The Mullerian duct is more 
lateral, towards the free border of the genital tract.
(H & E X 570 )
Fig. 3.2b. This is a similar genital tract explanted from 
a 14% days gestation male foetal rat and maintained for 3 
days in organ culture with the foetal testis remaining 
attached. The Wolffian duct persists, but the Mullerian 
duct has regressed completely because of testicular MIF,
(H & E X 570 )
Fig. 3.2a.
Fig. 3.2b.
Fig. 3.2. Regression of the foetal rat Mullerian duct 
in vitro in the presence of co-cultured rat 
foetal testes.
Fig. 3.2c. Lower magnification of Fig. 3.2b showing the 
adjacent foetal testis. The Wolffian duct is present at 
the left hand edge of the cultured genital tract, and the 
testis is present at the right hand border. Mesonephric 
tubules are seen in the central portion of the tract.
( H  &  E  X  2 0 0 )  .

Fig. 3.3. Unilateral regression of the Mullerian duct 
in vitro after unilateral castration.
Fig. 3.3a. Genital tract explanted from a 14% days gest­
ation male foetal rat and maintained for 3 days in organ 
culture. This side was not castrated, the testis being in 
contact with the genital tract throughout the culture 
period. The Wolffian duct (left hand duct) persists and 
is viable, but the Mullerian duct has regressed.
(H & E X 570)
Fig. 3.3b. This contralateral genital tract was castrated 
before culture, the testis being removed before explantation 
After 3 days in organ culture the absence of an adj acent 
testis allows persistence of the Mullerian duct (right hand 
duct) but the Wolffian duct is regressing,
(H & E X 570)
« hy.*:: -V
Fig. 3.3a
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Fig, 3.3b
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Fig.' 3.4. Regression of the Wolffian duct in vitro in 
the absence of a foetal testis.
Fig. 3.4a. Genital tract removed from a 14% days gestation 
foetal rat and fixed immediately in Bouin's. This section 
shows the presence of the Wolffian duct but the Mullerian 
duct has not yet fully developed. (H & E X 570 )
Fig. 3.4b. This foetal rat genital tract was explanted 
from a female sib of the above foetus and maintained in 
organ culture for 3 days. Although the ovary is intact, 
the absence of a testis has resulted in persistence of the 
Mullerian duct, but the Wolffian duct (left hand duct) is 
regressing. (H & E X 570 )
Fig. 3.4a
C l
%
Fig. 3.4b
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prevented Wolffian duct regression in vitro,
e) Gonadal differentiation in vitro
One pregnant rat was killed at 11^ days gestation. The 
genital tracts of the foetuses could be identified, but there 
was no evidence of gonadal tissue under the dissecting microscope, 
nor histologically. Six of these genital tracts were cultured 
for 6 days after which time histologically identifiable indifferent 
gonads had developed in vitro in two.
In 11 cultures, genital tracts from 13)g day foetuses had 
indifferent gonads at the start of the culture , but after 3 days 
in vitro, recognisable testes with primary testicular sex cords 
had developed. In another 20 cultures, indifferent gonads at 
the start developed into ovaries identified by the presence of 
meiotic figures in the germ cells of the secondary sex cords 
in the cortex (Fig. 3.5).
The above series of experiments confirm that normal 
development of gonads, and normal development and regression of 
genital ducts can be reproduced in vitro in organ culture, and 
the time scale in vitro closely approximates to the time scale 
in vivo. They also confirm that the foetal testis is responsible 
for Mullerian duct regression and Wolffian duct stabilisation, 
and that the influence of the foetal testis is, unilateral. Further 
confirmation of this can be achieved by transplanting foetal testes, 
as in the following experiments:-
a) Transplanted foetal rat testes
Castrated female genital tracts explanted from 2 foetal 
rats of days gestation were cultured with foetal testes

Fig. 3.5. Differentiation of rat foetal gonads in vitro.
Fig. 3.5a. Genital tract removed from a 13% days gest­
ation foetal rat and fixed immediately in Bouin's. The 
gonad could not be sexed under the dissecting microscope. 
This histological section shows the ill-defined primary 
sex cords of the indifferent gonad. At this stage, 
the forerunner of the testis is identical to that of the 
ovary, (H & E X 5 70 )
Fig. 3.5a

Fig. 3.5b. Genital tract explanted from a 13% days gest­
ation foetal rat (sib of Fig, 3.5a.) and maintained in organ 
culture for 4 days. The primary sex cords have expanded 
and differentiated into primitive seminiferous tubules 
with germ cells and Sertoli cells. This is a recognisable 
foetal testis. (H & E X 570 )
Fig. 3.5c. Genital tract explanted from a 13% days gest­
ation foetal rat (sib of Fig, 3.5a.) and maintained in organ 
culture for 4 days. The primary sex cords of the gonadal 
medulla have regressed, and the germ cells are recognised 
by their meiotic activity causing expansion of the cortex 
of the ovary. (H & E X 570 )
— J . X
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Fig. 3.5b
Fig. 3.5c
removed from, male litter mates. The testes were placed 
adjacent to the genital tracts from whence the female gonad 
had been removed. After 3 days in culture, the Mullerian 
ducts had regressed and the Wolffian ducts were present,whereas 
castrated female genital tracts without transplanted testes 
showed Wolffian duct regression and Mullerian duct persistence 
after the same culture period.
b) Transplanted foetal human testes
Testes from 7 human foetuses ranging from 12 to 24 weeks 
gestation, were cut into small portions - approximately 1mm 
diameter - and maintained in organ culture. These were placed 
adjacent to castrated rat foetal genital tracts explanted from 
17 rat foetuses ranging from 12i^  to 16^ days gestation. The 
rat foetal genital tracts and adjacent human foetal testes were 
cultured for a few days, after which time the human foetal testes 
were shown to have caused stabilisation of the Wolffian ducts, 
and inhibition of the Mullerian ducts in 11 different cultures.
This shows that in the absence of rat foetal testes, normal genital 
duct stabilisation and regression in the rat foetal genital tract 
can be affected by human foetal testes. Therefore, the humoral 
factors involved are not species specific.
c) Transplanted pregnant rat ovary
Portions of pregnant rat ovary were cultured adjacent to 19 
foetal rat genital tracts on the assumption that the pregnant 
ovary was a source of progesterone. After 3 days in organ culture, 
all the pregnant rat ovaries were completely necrotic and there 
was no evidence of Mullerian duct inhibition. The presence of HCG 
in the culture medium had no effect on the genital ducts and did
not prevent degeneration and necrosis of the pregnant rat 
ovary.
3. Effect of exogenous steroid hormones on genital ducts in vitro
The steroid hormones testosterone and progesterone were 
added to some culture media. Concentrations of up to 10“^M were 
used in order to observe a definite effect, although this 
concentration is pharmacological, and grossly in excess of the 
normal physiological concentration in the circulation. Testo­
sterone and progesterone are not soluble in aqueous solution at 
such high concentrations, but are taken up by the proteins of the 
foetal calf serum in the culture media. The steroids were 
dissolved in analytical grade ethanol and added to the culture 
media.
a) Effect of ethanol in culture medium
Because steroid hormones were added to the culture medium 
in ethanol, a similar concentration of ethanol was used in the 
control cultures. Culture media containing 1% analytical grade 
ethanol caused non-specific cytotoxic effects in 18 genital tracts 
maintained in organ culture for 3 days. However, in another 8 
genital tracts this concentration of ethanol had no apparent 
deleterious effects. Because 1% ethanol may be toxic, a maximum 
concentration of 0.2% ethanol, which had no demonstrable toxic 
effects, was used in subsequent cultures.
b) Non-toxicity of testosterone
Testosterone at a concentration of 10 was used in 37
cultures of foetal genital tracts.
No toxic effect attributable to testosterone was observed 
indicating that a steroid at 10 M concentration need not be 
toxic. Testosterone did not affect the Mullerian ducts, nor 
gonadal differentiation in vitro. The presence of testosterone 
in the culture medium was shown to stabilise the Wolffian duct 
in the absence of a foetal testis (Fig. 3.6Ï.
c) Effect of progesterone in culture medium
Progesterone was included in the culture medium on 75
— 5 —5
occasions, the final concentration being 10 M  CXSI, 5X10 M
(X17) or lO ~'*M ( X53) .
(i) Effect of progesterone on the Mullerian duct [Table 3.Ill) 
10 “‘^ M progesterone had no noticeable effect on the 
Mullerian duct in organ culture, but 5 x 10"^M on 6 
occasions, and 10 ^M on 21 occasions, had specific 
Mullerian duct inhibitory effects without inhibition of 
the Wolffian duct. These Mullerian inhibitory effects 
were seen in cultures of genital tracts explanted from 
days (X3) , 13^ days (X9), 14^ days (X121, 15^ days 
(XI) and 161  ^days (X2) foetuses. In the younger tracts, 
progesterone prevented the development of the Mullerian 
ducts in vitro and in the older tracts the pre-existing 
Mullerian ducts regressed in vitro [Fig. 3.7). However, 
in some cultures progesterone failed to inhibit the 
Mullerian ducts (Table 3.111}, and in other cultures, 
generalised cytotoxicity of the cultured tissue was 
observed indicating a non-specific deleterious effect of 
progesterone.

Fig. 3,6. Stabilisation of the Wolffian duct in vitro by 
exogenous testosterone in the culture medium.
Fig. 3.6a. Genital tract castrated and explanted from a 
14% days gestation foetal rat and maintained for 3 days in 
organ culture in the presence of 0.1% ethanol, but no 
exogenous steroid hormone. The Mullerian duct(right hand 
duct) persists and remains viable, but the Wolffian duct 
is regressing because of lack of stabilising androgens,
(H & E X 570 )
Fig. 3.6b. A similar castrated foetal rat genital tract
explanted at 14% days gestation. This tract was maintained 
in organ culture for 3 days in the presence of 0.1% ethanol
_ 4
and 10 M testosterone. The Mullerian duct is unaffected 
by the testosterone and remains viable. However, the 
Wolffian duct (loft hand duct) has been stabilised and 
testosterone has prevented its regression in vitro.
(H & E X 570)
*Fig. 3.6a
Fig. 3.6h
Table 3. III. Effect of progesterone on the Mullerian ducts in rat 
foetal testes in vitro.
Concentration of 
progesterone in 
culture medium
Effect of progesterone on genital tracts: > 
Number of cultures showing
Mullerian duct 
inhibition
Lack of Mullerian 
duct inhibition
10"® M 0 5
5X  10"^ M 6 10
-4 10 M 21 2

Fig. 3.7. Inhibitory effect of exogenous progesterone in 
the culture medium on the foetal Mullerian duct in organ 
culture.
Fig. 3.7a. Genital tract removed from a 15% days gest­
ation foetal rat, and fixed immediately in Bouin's,
Sections from the anterior and posterior portions of the 
genital tract show that the Wolffian duct is fully developed 
and has not regressed. The Mullerian duct is present 
posteriorly and has reached the urogenital sinus, but 
anterior regression has commenced. (H & E X 570 )
—  J . Z  J  —
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Fig. 3.7a.
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Fig. 3.7b. This is a male genital tract and a sib of 
Pig. 3.7a. It was castrated and explanted at 15% days 
gestation,and maintained in organ culture for 2 days in 
the presence of 0.1% ethanol but no added steroid hormone. 
The Wolffian duct remains intact, and castration has 
prevented further Mullerian duct regression, it still 
being present posteriorly. (H & E X 570)
yy
m
Fig. 3.7b
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Fig. 3.7c. This male genital tract, also a sib of
Fig. 3.7a, was castrated and explanted into organ culture
at 15^ days gestation, at the same time as Fig. 3,7b.
After 2 days in culture in the presence of 0.1% ethanol 
and 10 progesterone, the Wolffian duct has not altered, 
but Mullerian duct regression is now complete. Progesterone 
has simulated the inhibitory effect of the foetal 
testis, (H & E X 570 )
—  / —
4
Fig. 3.7c.
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Ciil Effect of pxogeatexone on the Wolffian duct; In the 
cultures showing generalised cytotoxicity due to 
progesterone, the Wolffian ducts as well as the 
Mullerian ducts showed some regressive changes, but 
tended to be more resistant than the Mullerian ducts 
to the toxic effects of progesterone. Normally, 
progesterone did not inhibit the Wolffian ducts, and 
in 18 cultures the presence of progesterone in the 
culture medium caused Wolffian duct stabilisation 
(Fig. 3.6) compared to the control cultures which did 
not have added progesterone. Progesterone concentrations 
lO ”^M (X3) , 5 X 10 ”^M (X3) and 10 ““"^ M (X12) showed 
Wolffian duct stabilisation activity.
-ivy-
Fig. 3.8. Stabilisation of the Wolffian duct in vitro by
exogenous progesterone in the culture medium.
Fig. 3.8a. Genital tract castrated and explanted from a
14h days gestation foetal rat and maintained for 3 days 
in organ culture in the presence of 0.1% ethanol, but no 
exogenous steroid hormone. Mullerian duct development 
has progressed normally to completion in vitro and it has 
not regressed. The Wolffian duct has almost completely 
regressed because of lack of stabilising androgens,
(H & E X 570)
Fig. 3.8b. A similar castrated foetal rat genital tract
explanted at lAh days gestation at the same time as its
sib (above) and maintained for 3 days in organ culture in
-4the presence of 0.1% ethanol and 10 M progesterone. In 
this case, the Mullerian duct has regressed and the 
Wolffian duct has been stabilised by the added progesterone
(H & E X 570)
- l J U -
Fig. 3.8a
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Fig. 3.8b
B. DISCUSSION
The organ culture of foetal rat genital tracts is a good 
model for studying the development of foetal gonads and genital 
ducts. Gonadal tissue may develop in vitro when there is no 
evidence of gonadal tissue at the start of the culture and 
explanted indifferent gonads may differentiate into testes or 
ovaries in culture (Fig, 3.5). This development and differentiation 
occurs in the absence of added hormonal factors.
The presence of foetal testis adjacent to a genital tract 
causes Mullerian duct inhibition and Wolffian duct stabilisation 
demonstrable at 17i^  days gestation in the foetal rat in vivo or 
in vitro (Figs. 3.2&3.3). The foetal testis producing these 
effects may be autologous, homologous (from a sib) or heterologous 
(from a human foetus). These effects have been described by many 
workers (see introduction) and are verified by the experiments in 
the present series.
Testosterone causes Wolffian duct stabilisation in culture 
(Josso, 1970a; Price & Pannabecker, 1959) and in vivo (Elgar,
1966; Jost, 1953,1967). The present experiments clearly demonstrate 
that concentrations of testosterone up to 10 are non-toxic
to explanted foetal rat genital tracts and gonads in organ culture. 
However, progesterone at a concentration of 10 ^M may have non­
specific cytotoxic effects in such cultures. The Mullerian duct 
is more sensitive to progesterone than the Wolffian duct, and in 
many cases progesterone results in Wolffian duct stabilisation and 
specific Mullerian duct inhibition.
The androgenicity of progesterone has been known for a long 
time (Green et al,, 1939; Hill, 1937; Lamar,1940) which probably
explains its ability to stabilise the Wolffian duct. However, 
the direct stimulatory effect of progesterone on the Wolffian 
duct in vivo or in vitro has not been previously published, and 
this is the first report of its stabilising effect in organ 
culture.
An in vitro bioassay for androgens using rat ventral 
prostate in organ culture has been described (Zaaijer et al.,
1966). Using this system, it has been claimed that foetal testes 
in organ culture produce androgens (Ortiz et al., 1966). However, 
in view of the known androgenic effect of progesterone on the 
prostate (Clausen, 1942; Green et al., 1939) and the stimulatory 
effect of progesterone on the Wolffian duct described in this 
thesis, doubt must be cast on the conclusion that this bioassay 
system specifically detects secretion of conventional androgens 
by the foetal testis in culture. It is also possible that the 
bioassay was responding to progesterone secretion.
The stimulatory effect of progesterone on the Wolffian duct 
in organ culture can be explained by its androgenic activity, 
but does not necessarily imply that progesterone is produced by 
the foetal testis at the time of Wolffian stabilisation. Testo­
sterone is produced at this time and is probably the active 
principle involved in vivo. However, the inhibitory effect 
of progesterone on the Mullerian duct cannot be as readily 
explained unless it is postulated that progesterone is involved 
in Mullerian inhibition in vivo.
Josso (Josso, 1972a, 1974b; Josso et al.,1975 ; Picard & Josso, 
1976) has indicated that MIF is not a steroid in free form, but 
is probably a polypeptide or protein. However, it is also possible 
that MIF is a protein - steroid complex. The adult testis is
known to. produce an androgen binding protein CABPÏ which is 
synthesised by Sertoli cells under the influence of FSH, and 
which passes into the rete testis and epididymis but not the 
blood stream (Means et al., 1976). It is a carrier protein for 
testosterone and dihydrotestosterone, and is taken up by the 
epithelial cells of the epididymis being concentrated by the 
head of the epididymis. Only very small amounts reach the tail 
of the epididymis (Hanssen et al., 1973). Its exact function is 
unclear, but it is thought to stimulate spermatogenesis and 
spermatid maturation by maintaining a high concentration of 
androgen in the seminiferous tubules and epididymis (Hanssen 
et al.,1974-
It has been claimed that ABP is a specific marker for 
Sertoli cell function in adult rats (Weddington et al., 1975) and 
that MIF is a specific marker for Sertoli cell function in foetal 
rats (Tran et a l ., 1977). Tran et al. (1977)postulate that the 
two substances may be the same molecule. Naftolin (1976) also 
suggests that ABP might be MIF, but Ritzep (1976) has not been 
able to detect ABP in foetal testes. Bardin (1976) concludes 
that MIF is not ABP because MIF disappears after birth. However, 
ABP is only a carrier protein and the active principle is the 
androgen present in the complex. It may also be true that MIF 
is a carrier protein for a Mullerian inhibitory steroid, for 
example progesterone. If so, MIF may be closely related to - 
or identical with - ABP, and the lack of Mullerian inhibitory 
properties of ABP may be because the correct steroid has not been 
attached.
The binding of progesterone to ABP has not been described. 
If MIF is analogous to ABP, requiring a bound steroid for its 
action on the Mullerian duct, this would explain the localised
- 1 J 4 -
action of MIF because the protein-steroid complex would pass 
directly to the genital ducts without entering the foetal 
circulation.
The inhibitory effect of progesterone on the Mullerian 
duct in organ culture has not been previously described, and 
the possibility that progesterone is involved in Mullerian 
inhibition in vivo is a new postulate. The results of the 
experiments described in this section may possibly add credence 
to the postulate that progesterone is the active principle, in 
an MIF-steroid complex required for Mullerian duct inhibition, 
further substantiation of this postulate may be obtained if it 
can be shown that foetal testes produce and release progesterone 
at the time of Mullerian inhibition. Experiments using rat 
foetal testes in monolayer culture were performed in an attempt 
to demonstrate progesterone secretion by foetal testes, and these 
experiments are described in the next chapter.
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CHAPTER 4
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RESULTS AND DISCUSSION
CHAPTER 4 
RESULTS AND DISCUSSION 
MONOLAYER CULTURE OF FOETAL TESTES
A. RESULTS
Of eighteen monolayer cultures of foetal rat testes which 
were prepared, twelve cultures were able to be maintained for 
at least 20 days, these being prepared from foetal rats of 
14^ (XI), 15^ (X2) , 16h (X2), 17H (X2) , 18i^  (X2) and 20î^  (XI) 
days gestation. Each of these 12 cultures was examined 
daily by phase-contrast microscopy and was seen to be viable 
throughout the course of the experiment (Figs. 4.1 a-h). The 
cultures were maintained for approximately 10 days in hormone- 
free medium, followed by 5 days in medium containing 10 iu 
HCG/ml and a further 5 days in medium containing 0,5 mM cAMP.
Each day, the cultures medium was collected and replaced 
by 5 ml of fresh culture medium. The monolayers were not washed 
between daily medium changes as this was considered not to be 
necessary. No attempt was made to assay'the concentration of 
HCG or cAMP at the end of each 24 hour culture period in these 
experiments, El-Khatlm(1976) and Tashjian et al. (1973) have 
shown that HCG is not broken down in tissue culture.
1. Cell morphology in monolayer culture
After 1 day in monolayer culture (Fig.4.1 a-dl many of the 
cells had become attached to the floor of the tissue culture

Fig. 4.1. Phase-contrast photomicrographs of foetal rat
testes in monolayer culture maintained at 37^C in 5ml of
tissue culture medium in Falcon tissue culture flasks.
Fig. 4.la&b. This culture was prepared from 24 foetal 
rat testes at 19^ days gestation and photographed after 
1 day in tissue culture. Large angular cells have become 
attached and have spread out along the base of the culture 
flask. The small dark rounded cells have settled to the 
bottom of the culture medium but are not attached. Non- 
viable cells and less dense germ cells remain in suspen­
sion, and are seen as round white retractile blobs.
The two photographs indicate the varying plating 
density of cells within a single culture. (RFT 22/1/76),
(Phase-contrast X 100)
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Fig. 4.1. Phase-contrast photomicrographs of foetal rat
testes in monolayer culture maintained at 37°C in 5ml of
tissue culture medium in Falcon tissue culture flasks.
Fig. 4.1c. Culture prepared from 20 foetal rat testes at
18% days gestation and photographed after 1 day in culture
Cells are spreading out along the floor of the flask from
a multilayered retractile clump of cells forming an almost
confluent monolayer. (RFT 21/1/76).
(Phase-contrast X 90)
Fig. 4.Id. Different region of the same culture photo­
graphed at the same time. This area is very sparsely 
populated with cells. (RFT 21/1/76),
(Phase-contrast X 85)
Fig. 4.1.C
Fig. 4.1.d

Fig. 4.1. Phase-contrast photomicrographs of foetal rat
testes in monolayer culture maintained at 37^C in 5ml of
tissue culture medium in Falcon tissue culture flasks.
Fig. 4.le. Culture prepared from 25 foetal rat testes at 
19% days gestation photographed after 5 days in culture. 
Most of the cells are adherent and have spread out to form 
a confluent monolayer. (RFT 24/6/77 : same as Fig. 2.2).
(Phase-contrast X 150)
Fig. 4.If. Culture prepared from 28 foetal rat testes at 
16% days gestation photographed after 10 days in culture 
in medium with no hormone added, and a further 5 days in 
medium containing HCG. The cell morphology has not 
changed appreciably by the addition of HCG. (RFT 3/5/76A)
(Phase-contrast X 140)
Fig. 4.l e
V
I
Fig. 4.1.f
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Fig. 4.1. Phase-contrast photomicrographs of foetal rat
testes in monolayer culture maintained at 37°C in 5ml of
tissue culture medium in Falcon tissue culture flasks.
Fig. 4.1g. Culture prepared from 28 foetal rat testes at 
16% days gestation (same culture as Fig. 4.If) photographed 
after 6 days in medium containing cAMP following 10 days 
in non-hormonal medium and 5 days in HCG medium. Again, 
there is no appreciable change due to trophic stimulation. 
(RFT 3/5/76A). (Phase-contrast X 150)
Fig. 4.Ih. Different region of the same culture photo- 
grophed at the same time as Fig, 4.1g. Cell proliferation 
has been incompletely suppressed and in this field, the 
cells have heaped up into a retractile mass at the lower 
right hand corner. (RFT 3/5/76A),
(Phase-contrast X 140)
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flask and had spread out as flattened squames with many 
sharp cytoplasmic projections. Some cells remained in clumps 
(Fig. 4.1c), some were rounded in suspension .(Fig. 4.1c), and 
others had become attached but remained rounded (Fig. 4.b).
It is assumed that non-viable cells, and low density primitive 
germ cells remain in suspension and are removed when the 
culture medium is poured off: the interstitial cells and
Sertoli cells are left attached to the flask.
The plating density of the cells in culture varied greatly 
from cultux'e to culture, and in different parts of the same 
culture (Fig. 4.1 a-d). Different types of cells could not be 
identified by phase-contrast microscopy in particular inter­
stitial cells and Sertoli cells could not be differentiated.
Germ cells and fibroblasts were assumed to form only a small 
proportion of the total number of cells.
After several days in culture, most of the attached cells 
became flattened, and the cells in the clumps migrated out, 
along the floor of the flask to become a monolayer (Fig, 4.1 e ) .
At this stage, the morphology of the cultures remained relatively 
static and was not appreciably altered by the addition of either 
HCG (Fig,4.If) or cAMP (Fig. 4.1g) to the culture media. In 
some cultures however, suppression of cell division was not 
complete and proliferative activity resulted in piling up and 
stratification of cells, some of which became detached (Fig. 4.1h)
2. Endogenous steroid production
The daily endogenous production of progesterone and 
testosterone by foetal rat testes in monolayer culture was 
measured by radioimmunoassay (RIAl and is shown in Fig,4.2a-g.
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Fig. 4.2. Daily endogenous secretion of progesterone and 
testosterone by monolayer cultures prepared from foetal 
rat testes of different gestational ages, and measured by 
radioimmunoassay.
HCG ; Human chorionic gonadotrophin
cAMP : Monobutyryl cyclic adenosine monophosphate.
Fig. 4.2a. 14% days gestation
Minimal amounts of progesterone and testosterone are 
produced by the unstimulated culture, or the culture 
after stimulation with HCG. Subsequent cAMP stim­
ulation results in secretion of progesterone, but not 
testosterone.
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Fig. 4.2. Daily endogenous secretion of progesterone and
testosterone by monolayer cultures of foetal rat testes.
Fig. 4.2b^ & ^^2* days gestation
Testosterone is secreted in excess of progesterone 
in the first day of culture, but progesterone is the 
predominant steroid during the next few days. There­
after, secretion of both falls to almost undetectable 
levels. Stimulation with cAMP, but not with HCG, 
causes increased progesterone output while testo­
sterone secretion remains at baseline levels.
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Fig. 4 .2. Daily endogenous secretion of progesterone and
testosterone by monolayer cultures of foetal rat testes.
Fig. 4.2c^ & '^ 2^ ' days gestation
Testosterone is the main steroid secreted on day 1, 
but subsequently testosterone levels fall and prog­
esterone output increases temporarily. By day 9, 
steroid output is at baseline levels and does not 
increase with HCG stimulation. Further stimulation 
with cAMP may cause resumption of progesterone 
secretion (2c^^ but this is not consistently seen.
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Fig. 4.2. Daily endogenous secretion of progesterone and
testosterone by monolayer cultures of foetal rat testes.
Pig. 4,2d^. 17% days gestation
•Production of testosterone, the major steroid at the 
start of the culture, falls rapidly and progesterone 
secretion increases temporarily. Then both fall to 
baseline levels. In this culture, there is no 
steroidogenic response to either HCG or cAMP.
Fig. 4.23^. 17% days gestation
This culture has a similar pattern of steroid 
production in medium without trophic stimulants. 
However, there is a small steroidogenic response to 
HCG stimulation, progesterone output being greater 
initially, but this is converted to testosterone in 
subsequent days. Stimulation with cAMP causes a much 
larger steroidogenic response, progesterone being 
the major secretory product.
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Fig. 4.2. Daily endogenous secretion of progesterone and
testosterone by monolayer cultures of foetal rat testes.
Fig. 4.2e^ & 26^. 18% days gestation
The initial pattern of steroid secretion is similar 
to that of the 15%, 16% and 17% days gestation 
cultures. Trophic stimulation has negligible effect 
in one of these cultures (2e^). In the other (2 6 2 ), 
HCG has no measurable stimulating action, but cAMP 
results in a marked increase in progesterone output.
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Fig. 4.2. Daily endogenous secretion of progesterone and
testosterone by monolayer cultures of foetal rat testes.
Fig. 4.2f^ & 2f2* 19^ days gestation
Testosterone is initially the major steroid hormone 
produced; but this rapidly falls to below the 
progesterone levels, then output of both diminishes 
to baseline. HCG stimulation causes an increase in 
progesterone secretion but this falls as testosterone 
production resumes and increases. Stimulation by 
cA>îP results in increased output of both steroids, 
the progesterone response being more pronounced.
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Fig, 4.2. Daily endogenous secretion of progesterone and
testosterone by monolayer cultures of foetal rat testes.
20h days gestation 
Initial testosterone excess (lasting 1 day) is super- 
ceded by progesterone excess lasting for the next 
■ few days before both fall to baseline levels. HCG 
stimulation causes resumption of secretion of both 
steroids, progesterone reappearing first and remaining 
the predominant steroid. Cyclic AMP is a more potent 
stimulant causing increased output of both, the prog-, 
esterone response being particularly marked.
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In many instances, when RIA showed substantial steroid 
production, the identity of the steroids was. checked by 
HPLC. The correlation between RIA and HPLC is shown in 
Table 4.1, and the steroids detected by HPLC are shown in 
Table 4.II.
In my hands, HPLC gave good separation of steroids and 
was good for identifying individual steroids. However, the 
precision of the method was not good and at best it could 
only be considered semi-quantitative. On the other hand,
RIA was more sensitive and. gave better quantitation but was. 
less specific. Table 4.1 shows that for most of the media there 
was good correlation between the results given by RIA and HPLC, 
but for other media marked discrepancies occurred. For example, 
in the monolayer culture, prepared from 2Qi^  day foetal rat testes, 
the culture media collected on days 2 and 16 contained appreciable 
amounts of progesterone as measured by RIA. However, progesterone 
was not detected in these media by HPLC. Table 4.II shows that 
these 2 culture media contained 20®:—dihydroprogesterone which may 
conceivably have cross-reacted with the progesterone antibody.
Such a cross-reaction,however, is unlikely since it has already 
been shown (Table 2.Ill) that 20«-dihydroprogesterone does not 
appreciably interfere in the progesterone RIA.
The graphs of steroid output (Fig. 4.2 a-g) show that in 
cultures prepared from testes of 15^ day and older foetal rats, 
testosterone is initially produced in greater amounts than 
progesterone: but, thereafter, testosterone output falls while 
progesterone output increases. After a few days, production of 
both steroids falls to very low baseline levels. Steroidogenesis 
can be reactivated by stimulation with cAMP and cultures prepared 
from older foetuses may also respond to HCG to a lesser degree.
± b ± -
Table 4 .1. Daily endogenous production of testosterone and progesterone 
by foetal rat testes in monolayer culture as measured by radioimmuno­
assay * (RIA) and high pressure liquid chromatography (HPLC).
Gestational age of 
rat foetal testes  
from which mono­
layer cultures 
were prepared
Day of 
culture
Additive 
to culture 
medium
Endogenous steroid 
production (ng/ml) 
in vitro
Progesterone Testosf:erone ,
RIA HPLC RIA HPLC
18 cA M P 74 19 0. 5 10. 5
14 | days 19 cA M P 65 108 ND 19
20 cA M P 132 23 a 2 14.
1 145 ND 335 47
2 190 ND 30 ND
18i days 3 102 38 2. 6 ND
4 67 38 0. 7 ND
5 60 19 0. 9 ND
1 50 355 240 109
2 94 43 40 16
19& days 1819
cA M P
cA M P
312
300
186
23
57
38
17
8 .4
20 cA M P 740 450 117 132
21 cA M P 533 345 75 78
1 28 96 186 90
2 80 ND 37 14
16 cA M P 75 ND 5 ND
20| days 17 cA M P 139 105 6 ND18 cA M P 272 184 12 42
19 cA M P 586 414 32 63
20 c A MP 1170 539 39 47
21 c A M P 1420 1390 60 101
c AM P : monobutyryl cyclic adenosine monophosphate
ND : not detected
* In the RIA,  dextran coated charcoal was used to separate the 
free and bound steroid
Table 4. II. Daily endogenous steroid production by foetal rat testes in 
monolayer culture as measured by high pressure liquid chromatography 
(HPLC).
Gestational age of 
ra t foetal testes 
from which mono­
layer cultures 
were prepared
Day of 
culture
Additive 
to culture 
medium
Endogenous steroid production in vitro (ng/ml)
Prog Testo iGaOHP 17o!OHP 20aDHP
18 cAM P 19 10.5 ND ND 33
14i days 19 cAM P 1GB 19 ND 42 64
20 cAM P 23 14 33 ND . 100
1 ND 47 ND ND 29
2 ND ND 89. ND 71
18| days 3 38 ND ND ND 19
4 . 38 ND ND ND 19
5 19 ND ND ND 19
1 355 109 19 121 ND
2 43 16 ND ND 109
1D& days 18 cAM P 186 17 23 80 168
19 cAM P 23 8.4 ND 32 202
20 cAM P 450 132 57 195 1020
21 cAM P 345 78 28 131 694
1 96 90 ND 61 46
2 ND 14 ND ND 207
16 cAM P ND ND ND ND 74
20|  days 17 cAM P 105 ND ND ND 86
18 cAM P 184 42 23 73 289
19 cAM P . 414 63 3Ù 145 689
20 cAM P 539 47 45 79 1210
21 cAM P 1390 101 68 184 2000
c A M P  : monobutyryl cyclic adenosine monophosphate
ND : not detected
16o!OHP ; 16of-hydroxyprogesterone
17û!OHP : 17o!-hydroxyprogesterone
20o!DHP : 20Œ-dihydroprogesterone
* Full systematic nomenclature of steroids is given in Appendix I
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When steroidogenesis is reactivated, progesterone 
production is detected several days Before testosterone output 
is identified- In the culture prepared from 14i^  day rat foetal 
testes (Fig. 4.2a). endogenous steroid output was not detected 
in the unstimulated, or liCG-stimulated, cultures. However, 
stimulation with cAMP resulted in progesterone biosynthesis.
The results from the HPLC [Table 4.II) show that cultures 
also produced 20a-dihydroprogesterone, and a marked increase 
in production of this steroid was noticed after cAMP stimulation. 
Small amounts of 16«:-hydroxyprogesterone and 17=-hydroxyprogesterone 
were also detected, but trophic hormonal stimulation of the 
cultures showed a less marked effect on the production rates 
of these steroids.
3. Monolayer cultures from testicular féminisation
Monolayer cultures of interstitial cells from testes 
from patients with testicular féminisation were prepared and 
maintained. The culture media were assayed for testosterone 
and progesterone. The daily endogenous production and output 
of these steroids are shown in Figs. 4.3 & 4.4 which also show 
the effect of stimulation with HCG and cAMP.
Cultures prepared from one patient (Fig. 4.3) initially 
produced very low levels of testosterone, but synthesis of this 
steroid increased over the next 9 days before falling off slightly. 
Progesterone was initially produced in greater quantities, and 
although output of this steroid also increased with the age of 
the culture, by the 6th day testosterone output exceeded that 
of progesterone and thereafter remained the major product 
detected.
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Fig. 4.3. Daily endogenous secretion of progesterone and 
testosterone from monolayer cultures prepared from human 
testicular féminisation testes.
Seminiferous tubules were drawn out leaving inter­
stitial cells which were used to prepare two identical 
monolayer cultures, each in Falcon tissue culture flasks 
with 5ml of tissue culture medium. The medium was 
changed daily and endogenous progesterone and testo­
sterone production determined by radioimmunoassay.
Fig. 4.3a. Monolayer culture maintained for 10 days in 
HCG-medium, then 10 days in hormone-free 
medium. [h t  10(F) l] .
Fig, 4.3b. Monolayer culture maintained for 10 days in 
hormone-free medium, then 10 days in HCG- 
medium. [h t 10(f ) i i] .
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Fig. 4.4. Daily endogenous secretion of progesterone and 
testosterone from a monolayer culture prepared from human 
testicular féminisation testes.
A monolayer culture of interstitial cells was 
prepared as in Fig. 4.3. The culture was maintained for 
10 days in hormone-free medium, then 5 days in HCG-medium 
followed by a further 6 days in cAMP-medium. [h t  2 6 (M)],
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HCG had little effect on steroidogenesis.
Monolayer cultare of the other patient produced 
progesterone in greater quantities than testosterone at all 
stages measured (Fig. 4.41. Testosterone production, in this 
case, started high and fell to very low levels whereas 
progesterone secretion continued at a much higher rate. HCG 
had negligable stimulatory effect. On the other hand, cAMP 
caused significant increase in testosterone output, and increased 
the secretion rate of progesterone by a factor of 10 to 20.
B. DISCUSSION
In discussing the physiological significance of the 
above results, it must be assumed that the in vitro function 
of the cells resembles the in vivo situation, but this can 
only be valid if the effects of tissue culture variables on 
cell function are known, and the degree of maturation of cells 
in vitro can be assessed.
1. Tissue culture variables
Neville & O'Hare (O'Hare et a l . , 1978). have examined the 
effects of cell density, and the presence or absence of trophic 
hormone (ACTH), on the steroidogenic function of adreno-cortical 
cells in monolayer culture. The pattern of endogenous steroid 
production is affected by both these parameters. In the present 
series, difficulties precluded an accurate control of cell 
density of monolayer foetal testicular cells; and the proportion 
of steroid-producing cells (probably mainly interstitial cells 
of Leydig) to other types of cells was not known and could not be 
assessed or controlled.
The cell density of culture is affected by the rate of cell 
death and cell proliferation, and the steroidogenic function of 
cells may differ in various parts of the cell cycle. For this 
reason, an attempt was made tp produce non-proliferative cell 
cultures by restricting the glutamine available to the cells. 
Unfortunately, too meticulous restriction of glutamine proved 
damaging to the cells, and a small amount had to be added to 
maintain cell viability. This resulted in some proliferative 
activity, more marked in some cultures than in others.
The lack of proper control of tissue culture variables 
may explain why cultures prepared from foetal testes of the 
same gestational age do not always respond identically.
2. Cell maturation in vitro
The organ culture experiments Cvide supra1 clearly 
demonstrate that foetal gonads and foetal genital tracts continue 
to mature and differentiate in vitro. It is not possible in 
the present monolayer culture experiments, to state that cells 
explanted from foetal testes at a given gestational age did - 
or did not - maintain the function of cells at that gestational 
age throughout the course of the culture. Therefore, the 
steroidogenic function of cells after several days in culture 
may - or may not - represent the function of cells at the 
gestational age of explantation-
3. Similarities between in vitro- and in vivo function
There is abundant evidence to show that foetal testes 
produce androgenic steroids which masculinise the male genitalia 
in utero. Freshly explanted monolayer cultures of foetal rat 
testes from 15% or more days gestation foetuses also produce 
androgens (testosterone), but androgenic production ceases in 
a non-hormonal environment (Fig. 4.2). Steroidogenesis can be 
re-stimulated by trophic hormones (HCG) or cyclic AMP. This 
is similar to the in vivo situation where trophic hormones from 
the' foetal pituitary and placenta act on the foetal testes. 
Therefore, at least in certain respects, the cells in vitro mimic 
the function of cells in vivo.
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O'Haxe and Kie co-workera Caee review by O'Hare et al. , 
1978) demonstrated that adrenocortical cells in monolayer 
culture are very similar in function to their activity in vivo, 
especially with respect to their response to trophic hormone. 
However, testicular interstitial cells in monolayer culture 
lose many of their in vivo characteristics. Cultures prepared 
from adult rat testes, and adult prepubertal and foetal human 
testes lose their responsiveness to HCG and LH CKhatim & O'Hare 
1976; O'Hare et al., 1976). Adult rat and human testicular cells 
in monolayer culture lose their ability to secrete testosterone 
because of a decline in 17«-hydroxylase and C 1^~20 desmolase 
activities (Khatim & O'Hare, 1976; O'Hare et al ., 1976),; 
stimulation by cAMP subsequently increases steroid output but 
does not reactivate these enzymes. Therefore, large quantities 
of progesterone and its metabolites are formed.
Cultures prepared from testicular féminisation testes 
continue to produce testosterone, but these cultures also lose 
their responsiveness to HCG (Figs.4.3 & 4.4). Stimulation with 
cAMP increases testosterone output, but progesterone secretion 
is stimulated to a much greater extent.
The experiments described in this thesis demonstrate that
monolayer cultures prepared from foetal rat testes in some
respects behave like cultures prepared from other types of 
testes, but in other respects, the rat testes in culture have 
certain properties peculiar
to themselves. They are the only cultures to retain some 
responsiveness to HCG. Also, some of the cultures of foetal 
rat testes retain the ability to secrete testosterone in quanti­
ties in the same order of magnitude as progesterone [Fig.4.2 
d2 , fy , f2/ï when stimulated by cAMP, and this property has not 
been observed in cultures of other types of testes.
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It can therefore be claimed that foetal rat testes 
in monolayer culture retain their in vivo properties and 
function better than other types of testes in culture.
4. Physiological significance of steroidogenesis by monolayer 
cultures
The biosynthesis of testosterone by the foetal testes 
can be considered as occurring in 2 stages: firstly, conversion 
of acetate to cholesterol and subsequent cholesterol metabolism 
by the enzymes C20:22 desmolase and 3g-HSD-I to produce 
pregnenolone and progesterone; and secondly, conversion of 
progesterone by the enzymes 17«-hydroxylase, 17 desmolase, and 
17|3-hydroxysteroid dehydrogenase forming respectively 17«-hydroxy-
progesterone, androstenedione and testosterone (Fig. 1.3).
5
This second stage may utilise the A - pathway (pregnenolone, 
17«“hydroxypregnenolone, dehydroepiandrosterone) thus by-passing 
progesterone, and requiring a 33-HSD-I isoenzyme system acting 
preferentially on DHA (dehydroepiandrosterone) rather than 
pregnenolone.
If the full complement of enzymes is present, testosterone 
is produced; but if only the first stage enzymes are functioning, 
progesterone is produced. It would appear that foetal rat 
testicular cells in monolayer culture rapidly lose the ability 
to convert progesterone to testosterone. Therefore, in the 
first few days in culture there is a diminution of testosterone 
output and an increase in progesterone output. This is similar
1 '7_9n
to the decline in activity of 17«-hydroxylase and C 
desmolase described by Khatim & O'Hare (1976) in monolayer 
cultures of adult rat testicular interstitial cells.
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The present experiments show that shortly after the foetal 
testicular cells lose their ability to convert progesterone 
to testosterone, the enzymes required for progesterone 
biosynthesis also become deactivated and steroid secretion 
falls below detectable levels.
Restimulation of steroidogenesis can be produced by 
the addition of HCG or cAMP to the culture medium, and in such 
instances, reactivation of progesterone biosynthesising enzymes 
occurs before the enzymes required for testosterone are 
active. Therefore, increase in progesterone output is detected 
initially, followed by an increase in testosterone production. 
This sequence of events may also occur in vivo. If so, when 
the foetal testis first secretes steroid hormones, progesterone 
will be released, and later, progesterone will be converted 
to testosterone before being released. The histochemical studies 
of Baillie and his co-workers (vide supra) support this sequence 
of events, and suggest that progesterone is synthesised at 
the time of Mullerian duct inhibition, and testosterone is 
released at the time of Wolffian duct stabilisation.
Steroidogenesis by steroid-producing cells in monolayer 
culture has been examined extensively over the last few years 
by members of our department (O'Hare et al.,1978) using adreno­
cortical cells, and more recently testicular cells. Monolayer 
cultures are used in preference to organ cultures because the 
exact cellular environment can be more readily controlled, 
therefore the exact requirements for normal cellular function 
can be assessed- However,the stringent requirements needed for 
normal function makes it more difficult to reproduce the 
in vivo situation in monolayer culture.
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The steroidogenic activity of monolayer cultures 
prepared from human adult, prepubertal, neonatal or foetal 
testes, and from rat adult and prepubertal testes have been 
examined (O'Hare et al., 1978). Monolayers of rat foetal 
testes have not been previously described. There are many 
problems involved in preparing monolayer cultures from foetal 
rat testes, mainly because of (a) the difficulty in producing 
rat foetuses of an exact gestational age on a certain date; 
and because of (b) the small size of individual rat foetal 
testes necessitating a large number of testes being used in the 
preparation of one culture. Quantitation of tissue and control 
of cell density in culture is therefore very difficult, and it 
is not possible to determine the proportion of steroid-producing 
cells to non-steroidogenic cells in individual cultures.
However, monolayer cultures were prepared and the cells remained 
viable for the duration of the culture periods used (3 weeks, 
or longer), and during this time endogenous steroidogenic 
activity was demonstrated.
The experiments described in this thesis demonstrate that 
foetal testicular cells from rats differ from human foetal testes 
with respect to steroidogenesis in monolayer culture. Rat foetal 
testicular cells rapidly cease producing testosterone, and shortly 
after, synthesis of progesterone also diminishes. In some 
cases, steroidogenesis recommences after HCG stimulation in vitro, 
but this effect is inconsistent. Stimulation with cAMP produces 
a much greater and more consistent steroidogenic response.
Cyclic AMP acts as a "second messenger" for trophic 
hormones. The trophic hormone binds to specific receptors on 
the target cell membrane and this stimulates cAMP production
■-L/2-
which in turn activates intracellular activity. Testicular 
cells in monolayer culture lose their responsiveness to HCG, 
but cAMP is still active in stimulating cell metabolism and 
steroid output. This indicates that although testicular cells 
in monolayer culture are still capable of synthesising steroids 
if the intracellular environment is suitable, the cells lose 
their capacity to respond to a specific trophic hormone. This 
result is rather surprising because adrenocortical cells in 
monolayer culture retain their responsiveness to ACTH, a trophic 
hormone which also acts through cAMP as the second messenger.
Rat foetal testes are unlike other types of testes examined because 
in some cultures they do show a small response to HCG.
It is clear, therefore, that the rat foetal testicular cells 
in monolayer culture in the present series of experiments retain 
steroidogenic activity in vitro, but there are differences between 
the in vitro and in vivo pattern of steroid hormone output.
For this reason, in vivo activity cannot be elucidated with 
■certainty from these results. However, some changes in the in 
vitro activity may reflect particular aspects of in vivo properties 
For example, in the culture prepared from the 14% day foetal rat 
testes (at a time when MIF is produced but androgens are not 
required for Wolffian duct stabilisation: see Fig.1.2) stimulation 
of the monolayer culture resulted in synthesis of progesterone 
but conversion of progesterone to testosterone was not evident 
(Fig 4.2a). This may imply that at 14% days gestation, the foetal 
rat testis is capable of producing progesterone but not testo­
sterone .
These results support the hypothesis that progesterone may 
be involved in Mullerian duct inhibition, and as the testis 
matures in the foetus, output of this Mullerian inhibitory factor
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falls because of conversion to androgenic steroids which 
are required at a later date for Wolffian duct stabilisation,
The results of Picon (1976b) indicate that cAMP does 
not have Mullerian duct inhibitory activity. On the 
contrary, it prevents the Mullerian inhibitory action of 
the foetal testis in organ culture. Picon concludes that 
cAMP probably has a direct stabilising effect on the 
Mullerian duct causing its maturation, and therefore 
interferes with testicular MIF at the target organ level. 
However, it is also possible that cAMP stimulates the 
testicular cells to metabolise MIF into a product devoid 
of Mullerian inhibitory activity. Perhaps the cAMP 
stimulates conversion of progesterone into testosterone.
If progesterone is required for Mullerian duct 
inhibition, then this postulate must not conflict with 
known facts concerning sexual development in various 
syndromes which result in intersexuality.
In the syndrome of testicular féminisation (Morris, 
1953; Morris & Mahesh, 1963) which is due to androgen 
insensitivity (Southren, 1965; Strickland & French, 1969; 
Wilkins, 1957), the patient is a 46,XY genotypic male 
with normally functioning testes.
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Testosterone is produced (Tremblay et al., 1972) but there 
is end-organ insensitivity to testosterone and dihydrotestosterone; 
therefore the Wolffian duct is not stabilised and hence it 
regresses. The urogenital sinus does not respond to androgens, 
therefore lack of male development results in female external 
genitalia. Externally an almost normal phenotypic female 
results. The Mullerian inhibitory factor is produced normally 
by the foetal testis, and because this is not an androgen 
(Jost, 1953) the end-organ (Mullerian duct) responds normally 
by regressing. This results in a blind-ending vagina: the 
uterus and fallopian tubes are not present. The descent of 
the testes is also controlled by androgens, therefore in 
testicular féminisation, intra abdominal or inguinal testes are 
found. This syndrome accentuates the fact that androgens are 
required for the development of male external genitalia and 
internal genital ducts, and also demonstrates that MIF is not 
an androgen. However, it gives no clue to the nature of MIF, and 
does not disprove the postulate that progesterone is involved 
in Mullerian inhibition. In fact, sex steroids other than 
androgens are still effective in these patients as evidenced 
by breast development in response to testicular oestrogens.
In the rare condition hernia uteri inguinalis in the male 
(Young, 1951) genotypic males only have a single testis* This 
solitary testis functions normally as an endocrine gland and a 
generative organ. There is unilateral (ipsilateral) inhibition 
of the Mullerian duct and stimulation of the Wolffian duct.
The external genitalia, which develop under the influence of 
systemic dihydrotestosterone and not to locally-acting testo­
sterone, develop as normal male organs. The contralateral sex 
ducts,however, follow female developmental lines with formation
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of a uterus and fallopian tube. This syndrome illustrates 
the local, ipsilateral, action of foetal testicular secretions 
on the genital ducts, but does not indicate the nature of MIF 
nor does it disprove the progesterone postulate.
The most common cause of intersexuality is pseudoherma­
phroditism due to congenital adrenal hyperplasia (Bongiovanni 
& Root, 1963a,b & c). Steroidogenic enzymes in the adrenal 
cortex and testis are lacking with resultant deficiency of 
glucocorticoid secretion. The negative feedback inhibition 
of tlie hypothalamus and pituitary is therefore reduced resulting 
in over-secretion of corticotrophin. Adrenal androgens, which 
are usually produced in relatively small amounts, become a major 
secretory product causing virilisation.
The most common defects in congenital adrenal hyperplasia 
are deficiencies of 21 hydroxylase and 1 1 3 -hydroxylase, neither 
of which are required for androgen biosynthesis (Fig. 1.3).
These deficiencies, therefore, do not affect testicular steroido­
genesis ,
More serious forms of congenital adrenal hyperplasia involve 
deficiencies of cholesterol 20:22 desmolase (Prader & Liebenmann, 
1957) and 33-HSD-I (Bongiovanni & Kellenbenz,1962), the former 
causing impaired synthesis of all active steroid hormones. Total 
lack of cholesterol 20:22 desmolase is incompatible with life 
(Bongiovanni et al., 1957); and partial deficiency which requires 
compensatory hyperactivity of steroid-producing organs does not 
preclude the secretion of progesterone by the foetal testis.
Deficiency of 33-HSD poses an interesting problem. Not 
only are glucocorticoids lacking but testosterone synthesis is 
also affected. Excessive stimulation of the adrenal cortex 
results in secretion of large amounts of DHA, a steroid with
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androgenic properties,, but not as androgenically active as 
testosterone. Therefore, in males there is androgen deficiency 
whereas in females there is excessive androgen secretion.
As a result, male foetuses are feminised because of lack of 
androgens, and female foetuses are virilised due to over 
production of androgens (Goldman et al., 1964). If Mullerian 
inhibition requires progesterone, deficiency of 33-HSD should 
results in persistence of the Mullerian ducts. Not many patients 
with this rare form of congenital adrenal hyperplasia have been 
described. If the defect is incomplete, some progesterone may be 
secreted. Complete deficiency of 3 3-HSD is rapidly fatal 
(Bongiovanni & Kellenbenz, 1962), and in such cases a complete 
description of the internal genitalia in association with karyotype 
has not been published.
The condition of congenital adrenal hyperplasia, therefore, 
does not give any indication as to the nature of MIF nor does 
it discount the postulate that progesterone is involved. Of 
interest, though, is the presence of varying degrees of Mullerian 
duct development in male patients with 33-HSD deficiency (Goldman 
et al., 1964; Bongiovanni & Kellenbenz, 1962): this suggests 
that steroidogenesis is involved to some extent in Mullerian 
inhibition.
Congenital adrenal hyperplasia due to deficiency of
17- 2017«-hydroxylase (New, 1970) of C desmolase (Zachmann et a l .,
1972} cause féminisation of male foetuses because of lack of 
testosterone secretion. In both of these syndromes, MIF is 
produced normally, but as neither enzyme is required for 
progesterone synthesis it is possible that progesterone is 
involved.
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Intexaexuality due to true hermaphroditism is rare and 
complex, and does not help in the determination of the nature 
of MIF.
On theoretical grounds it was postulated that progesterone 
may be required for inhibition of the foetal Mullerian duct. 
Progesterone has an inhibitory effect on the Mullerian duct 
in organ culture, and although it shows some cytoxic effects, 
it appears to inhibit the Mullerian duct specifically, and is 
capable of stabilising the Wolffian duct in vitro. Foetal 
testicular cells in monolayer culture produce and release 
progesterone and in the process of maturation, progesterone is 
secreted before testosterone biosynthesis is demonstrable.
Clinical syndromes characterised by abnormal sexual development 
do not contradict the progesterone hypothesis.
The evidence presented in this thesis is circumstantial and 
inconclusive. However, I believe there are grounds to pursue 
the possibility that progesterone and MIF are related. Genital 
tracts complete with testes attached should be cultured with a 
progesterone antagonist (for example anti-progesterone seruml, 
or with an inhibitory of progesterone biosynthesis (eg. cyanoketone) 
The binding of progesterone to androgen binding protein should 
be examined, and the effect of an ABP-progesterone complex on 
the Mullerian duet should be studied. Foetal calf testes in 
organ culture produce MIF which can be concentrated: further 
characterisation of this preparation is required.
Since the pioneer work of Jost in 1947, many workers 
have attempted to characterise MIF. Much work has been done, 
but we have progressed little. Mullerian inhibition is funda­
mental to sexual differentiation, and the elucidation of its 
nature warrants further study.
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A. ALPHA^-FETOPROTEIN AND TESTICULAR TUMOURS
Bergstrand and Czar (1956) first described an «g-globulin 
in the serum of human foetuses. This globulin is now known as 
alphaq-fetoprotein (AFP) and is one of the main serum proteins 
in early embryonic life in many animal species (Gitlin and 
Boesman, 1966,1967). It is produced mainly by the yolk sac and 
the foetal liver (Gitlin et al., 1967) but small quantities 
are also produced by the gastrointestinal tract, kidney and 
placenta (Gitlin et al., 1972). The foetal shark stomach is 
a major site of AFP production (Gitlin, 1971,1974). In the 
human foetus, a peak serum AFP level of 3mg/ml occurs at 13 
weeks gestation (Gitlin & Boesman, 1966) and this value falls 
to 10“150pg/ml at delivery (Norgaard-Pedersen, 19 76), the final 
value depending on gestational age at delivery (Sananes et al., 
1973). The normal adult range of 4-10.5ng/ml (Ruoslahti &
Seppala, 1972) is reached by the age of 2 years (Masseyeff et al.,
1975) and this value normally remains consistent till after the 
age of 60 years when a further slight fall in serum value occurs 
(Masseyeff et al., 1974).
Abelev et al. (1963) demonstrated that an «-globulin present
in the serum of foetal mice reappears in the serum of adult 
mice bearing a transplantable hepatoma which was originally 
induced by a chemical carcinogen. Non-neoplastic liver 
regeneration following partial hepatectomy also results in 
reappearance of the foetal «^ -globulin in the serum of adult
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mice. Tatarinov et a l . (1964,1965) were the first to
demonstrate a foetal globulin in the serum of humans with 
primary hepatomas; but cholangiocarcinomas and metastatic 
carcinomas in the liver did not apparently produce this 
globulin (Tartarinov et a l ., 1967), The foetal globulin 
appearing in the serum of hepatoma-bearing mice and humans 
is AFP. Abelev et a l . (1967) confirmed the presence of AFP
in the serum of hepatoma patients, and also noted its presence 
in the serum of some patients with testicular tumours; in 
Abelev's series, patients with pure testicular seminoma or 
pure testicular choriocarcinoma did not have elevated serum 
AFP, nor did patients with sarcoma arising from the non-germinal 
stromal elements of the testis (Abelev, 1968; Abelev et a l .,
1967). Since then. I, (Grigor et a l ., 1977) and many other 
workers, have demonstrated AFP production by testicular teratomas 
(Table.5.1).
AFP levels are now known to be elevated in body fluids in 
association with many neoplastic and non-neoplastic conditions 
(see review by Neville & Cooper, 1976). Measurement of AFP 
levels in amniotic fluid is used extensively in obstetric practice 
for the prenatal diagnosis of neural tube defects, anencephaly, 
hydrocephalus, congenital oesophageal atresia, congenital 
nephrosis, exomphalos, tetralogy of Fallot, foetal sacrococcygeal 
tumour and intra-uterine death (Norgaard-Pedersen, 1976; Chaube 
and Swinyard, 1975) . Maternal serum AFP is elevated during 
pregnancy, but higher than normal values are associated with 
foetal distress, intrauterine death, twin pregnancy, toxaemia, 
rhesus isoimmunisation, and various foetal congenital abnorm­
alities (Norgaard-Pedersen, 1976). Ferguson-Smith et al .(1978) 
have shown that the vast majority of anencephalic and spina
Table 5.1. Incidence of raised serum AFP associated with testicular 
tumours and male germ cell tumours reported by various authors.
Author
Number
of
patients
Type of tumour
Number of 
patients 
with raised 
serum AFP
Raised
serum
AFP
Abelev (1968) 32 teratoblastomas 13 41 %
Abelev et al. (1971) 32 teratoblastomas 15 68 %
Balias (1974) 6 embryonalcarcinoma 3 50 %
Bracken et al. (1975) 50
active teratocar- 
cinoma or 
embryonal 
carcinoma
15 50 %
Buffe (1973) 37 active teratomas of children 27 72 %
Elgorfcetal. (1973) 21 testicularterotoblastomas 19 91 %
Grigor et al. (1977) 88 active teratomas 56 67 %
Lange et al. (1976) 30 preoperativeteratomas 23 77 %
Ma was et al. (1971) 27
active malignant 
teratomas in 
children
15 71 %
Merrin et al. (1971) 14 active teratomas 3 21 %
Newlands (1976) 44 teratomas 38 86 %
Norgaard-
Petersen et al. (1975) 19
germ cell 
tumours with 
yolk sac tumour
19 100%
Perlin et al. (1976) 9 male germinal tumours 5 56%
Talerman et al. (1974) 30 active germ cell tumours 8 27 %
Talerman et al. (1977) 7
male germ cell 
tumours with 
yolk sac tumour
7 100 %
Tsuchida et al. (1973) 3 yolk sac tumours 3 100 %
—1Ü3 —
bifida births can be avoided by screening maternal serum for 
AFP at 16-20 weeks gestation. Raised serum AFP may be 
associated with malignant diseases other than tumours of the 
liver or germ cell tumours, especially tumours of the gastro­
intestinal tract, particularly if liver métastasés are present 
(Mclntire et al., 1975), but in such cases, serum CEA is a 
better tumour marker (Grigor et al., 19 75). Serum AFP may be 
elevated in patients with acute and chronic liver disease and 
this is probably a reflection of hepatic regeneration (Eleftherion 
et a l ., 1977; Silver et al., 1974a&b), Patients with ataxia 
telangiectasia ( Waldmann & Mclntire, 1972) or cystic fibrosis 
(Chadra et a l ., 1975) have moderately raised serum AFP levels.
The present study is concerned with male patients with 
gonadal or extragonadal germ cell tumours, and the correlation 
between serum levels of AFP, histological features of the 
tumours and the clinical course of the disease. In some patients, 
serum or urinary human chorionicgonadotrophin was also measured.
Many previous attempts at correlating serum AFP with 
the histological patterns of testicular tumours have been 
hampered by the fact that two major classifications of testi­
cular tumours (Mostofi & Price, 1973; Pugh, 1976) fail to 
stress the importance of recognising within teratomas areas of 
yolk sac (endodermal sinus) differentiation as described by 
Teilum (1959). In this thesis, germ cell tumours are classi­
fied according to the British Testicular Tumour Panel and 
Registry (Pugh, 1976) with minor modifications so that the 
significance of extraembryonic elements can be assessed (Fig.5.1). 
The criteria used in this thesis for diagnosing yolk sac 
(endodermal sinus ) tumour are those of Teilum (1976), and
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Fig. 5.1. Classification of germ cell tumours of the testis and extra­
gonadal sites.
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the histological features of yolk sac tumour CYST) are shown 
in Fig. 6.4, Yolk sac elements are found in patients of all 
ages although Pugh (1976) maintains that YST only occurs in 
infant testicular tumours.
In 1967 Abelev suggested that AFP production by testi­
cular "teratoblastomas" may be due to cells destined to become 
hepatoblasts. Gitlin et al ./1967) and Gitlin and Boesman (19 66) 
demonstrated that the yolk sac is an important source of AFP 
in the foetal circulation. Teilum (1959) previously suggested 
that certain histological patterns in testicular and ovarian 
germ cell tumours should be regarded as yolk sac (endodermal 
sinus) differentiation because of similarities with the rat 
placenta. Abelev (1971) therefore suggested that AFP pro­
duction by testicular tumours is a result of yolk sac differen­
tiation. Laurence & Neville (1972) stated that if the endodermal 
sinus tumour is of vitelline origin, as proposed by Teilum (1971), 
then it should produce AFP. Talerman & Haije (19 74) supported 
this contention, and many reports since then have shown a 
strong correlation between AFP production and the presence of 
yolk sac elements in testicular tumours [Balias, 1974; Grigor 
etal./ 1977; Norgaard-Pedersen, 1976; Norgaard-Pedersen et al., 
1975,1976; Sell et al., 1976; Talerman et al., 1977; Teilum 
et al., 1975; Tsuchida et al., 1973). There are also many 
studies demonstrating AFP in yolk sac structure by immuno- 
cytochemical techniques (Ito et a l ., 1976; Palmer et a l .,
1976; Shirai et a l ., 1976; Teilum et a l ., 1974; Yoshiki et a l .,
1976) .
It has been claimed that AFP is a specific marker for 
yolk sac elements in testicular tumours (Norgaard-Pedersen 
et a l ., 1975; Teilum et al,, 1975;- Sell et a l .. 19?6a;
Talerman et al., 1 9 7 7 b) but the correlation
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is not always absolute (Balias, 1974;
Grigor et a l ., 1977). Abelev (1974%, basing his conclusions 
on iramunofluorescence studies in mouse teratomas (Englehardt 
et a l ., 1973), has suggested that other endodermally derived 
epithelial elements may produce AFP.
Human chorionicgonadotrophin (HCG) is a glycoprotein 
hormone produced by the syncytiotrophoblasts of the placenta 
throughout pregnancy, being first detectable at 9-10 days after 
conception (Keller, 1976). It consists of « and B subunits.
The oc subunit of HCG is similar to the « subunits of luteini- 
sing hormone (LH) follicle stimulating hormone (FSH) and thyroid 
stimulating hormone (TSH); but the 3 subunit is specific for 
HCG (Vaitukaitis & Ross, 1974). Antiserum to 3 HCG specifi­
cally detects HCG even in the presence of other glycoprotein 
trophic hormones (Vaitukaitis et a l ., 1972%. Serial HCG deter­
mination is of proven value in the monitoring of gestational 
choriocarcinomas (Bagshawe, 1974). Using specific antisera to 
the 3 subunit, it has been shown that testicular tumours also 
produce HCG (Vaitukaitis, 1974). However, many other non-tropho- 
blastic tumours are also associated with HCG synthesis and release 
(Braunstein, 1973b; Goldstein et al., 1974; McManus et a l ., 1976).
Pugh states that the presence of syncytiotrophoblasts and 
cytotrophoblasts arranged in a papillary or villous pattern is 
essential for the diagnosis of malignant teratoma trophoblastic 
(MTT). In such tumours, other teratomatous elements are of minor 
prognostic significance and need not be mentioned in the classi­
fication (Pugh, 1976). Mostofi & Price (1973) and Teilum (1976) 
do not insist on the papillary arrangement of the syncytio- and 
cytotrophoblasts in order to make a diagnosis of choriocarcinoma
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of the testis, and these authors differentiate between pure 
choriocarcinoma and choriocarcinoma associated with other germ 
cell derivatives. In the present series, MTT indicates the 
presence of syncytiotrophoblasts and cytotrophoblasts arranged 
together, but not necessarily forming a papillary pattern: the 
presence of any other associated tumour elements was also 
recorded. In addition, isolated tumour giant cells which con­
tained 3HCG as demonstrated by immunocytochemical techniques 
(Heyderman & Neville, 1976a&b) were classified as isolated 
syncytiotrophoblasts.
In the present study, male patients with testicular and 
extragonadal germ cell tumours were examined serologically for 
evidence of AFP production, and the histological features of 
the tumours were re-assessed. The prognostic significance of 
elevated serum AFP and the presence of various histological 
patterns will be presented (Chapter 6). Details of 153 of these 
patients have already been published (Grigor et a l ., 1977% and 
this is,at present, the largest published series correlating 
serum AFP with histology of testicular tumours and clinical 
course. The strong correlation between AFP production and the 
presence of yolk sac elements is substantiated in this paper, 
in agreement with many other authors. However, the lack of 
absolute correlation between these two features was mentioned 
and this is an aspect of AFP production that is not well 
recognised. I have now examined a much larger series of 
patients, and this thesis presents data which is not available 
from other centres because of lack of numbers of patients.
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B. NON-HORMONAL ADRENOCORTICAL CARCINOMAS
Adrenocortical carcinomas are rare tumours which may 
be classified as "functioning" or"non-hormonal" according to 
the clinical syndromes with which they are associated. 
Hypercorticalism takes the form of the adrenogenital syndrome 
(virilation or féminisation), Conn's syndrome (hyperaldroste- 
ronism with low plasma renin), or Cushing's syndrome (Neville 
and MacKay, 1972; Neville and Symington, 1966, 1967; Symington, 
1969). Adrenocortical tumours are considered to be "non—hormonal" 
if there is no clinical evidence of endocrine upset. They are 
very rare; wide experience is difficult to obtain at one 
institution, as is exemplified by the large number of single 
case reports in the literature over the last 30 years.
An analysis of these cases along with 20 additional new 
cases seen at the Royal Marsden Hospital, London, Royal Infirmary, 
Glasgow, and the Institute of Cancer Research, London, was under­
taken in order to trace some aspects of their behaviour and 
response to treatment- The findingsof this survey have already 
been published (Lewinsky et al. , 1974). and will be presented 
as part of the present thesis in Chapter 7 as a further example 
of correlation - or lack of correlation - between morphology 
and function.
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CHAPTER 6
TESTICULAR TUMOURS
The aim of this part of the thesis is to attempt to 
explain why patients with teratomas sometimes have elevated 
serum AFP levels. In particular, I have tried to ascertain 
which cell type is responsible for AFP production. It is well 
known that endodermal sinus tumours of the ovary carry a very 
bad prognosis (Beilby & Parkinson, 1975; Beilby & Todd, 1974):
I have examined similar tumours in male patients to determine 
if such tumours have the same grave prognosis in both sexes.
A. MATERIALS AND. METHODS
1. Patients
All patients were referred to the Royal Marsden Hospital 
(RMH),Sutton and London branches,for treatment of testicular 
or extragonadal germ cell tumours. There were 322 patients 
all of whom had histological material of their tumour available 
for review, and had serum assayed for AFP. Of these, 153 patients 
have already been described (Grigor et al., 19 77) and have now 
been followed for at least 2^ years in order to study features 
of prognostic significance. A further 169 patients have been 
added to this group in order to increase the number available for 
morphological and functional correlation, but this latter group 
have not been followed for a sufficient length of time to make 
prognostic assessments.
2. Histological material
Twenty-four patients had inguinal orchidectomy with high 
ligation of the spermatic cord performed at RMH.
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Several blocks of tumour, adjacent testis, and cord were 
examined histologically. However, the majority of patients 
had initial surgery at other hospitals before referral to 
RMH, and surgical and pathological practices often differed.
In many instances, a limited number of histological sections 
were avilable for review, therefore some histological features 
of relevance may have been missed because of incomplete . 
sampling.
In this seris, 316 patients had testicular or extragonadal 
germ cell tumours, and 6 patients had non-germ cell tumours of 
the testis.
3. Age distribution
The age distribution of first diagnosis of 316 male patients 
with testicular or extragonadal germ cell tumours is shown in 
Fig. 6.1. The peak incidence of teratoma is in the 3rd decade, 
and that of seminomas extends over the 3rd, 4th and 5th decades. 
Yolk sac elements, and trophoblastic elements (including isolated 
syncytiotrophoblasts) are present in germ cell tumours of all 
ages (Figs. 6.2 and 6.3) and the proportion of teratomas con­
taining extraembryonic elements is relatively constant through­
out the age spectrum. Figure 6.2 shows that the proportion of 
teratomas containing yolk sac elements appears to be greater 
at both extremes of the age spectrum. However, such a conclusion 
cannot be made with certainty because of the small number of 
patients in these age groups.
4. Site
The distribution of primary site of 316 germ cell tumours 
in males is shown in Table 6.1.
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Fig. 6.1. Age distribution at first diagnosis of 316 
male patients with testicular and extragonadal germ cell 
tumours.
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Fig, 6.2. Age distribution of 232 patients with teratomas 
( - seminoma) and the proportion of teratomas containing 
yolk sac elements either alone, or in combination with 
other teratomatous elements.
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Fig. 6.3. Age distribution of 232 patients with teratomas 
( 1' seminoma) and the proportion of teratomas containing 
trophoblastic elements in the form of MTT or isolated 
syncytiotrophoblasts.
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Table 6.1. Primary site of 316 germ cell tumours in male patients.
TESTICULAR
left testis 137
right testis 143
bilateral 13
not stated 9
subtotal 302
EXTRAGONADAL
retroperitoneal 8
mediastinal 5
unknown 1
subtotal 14
T O T A L  316
5. Clinical staging of disease
All patients admitted to the Royal Marsden Hospital 
were examined thoroughly for the extent of tumour spread at 
presentation (Table 6.II). Lymphangiography (LG) and chest 
X-ray (CXR) were standard procedures, and intravenous pyelo­
graphy (IVP), lung tomography and ultrasonography [US) were 
used when indicated. Towards the end of the survey, computerised 
axial tomography (CAT) using an EMI scanner was available. 
Retroperitoneal lymphadenectomy as a staging procedure was not 
routine. On this basis, patients were staged as follows 
Stage 1 : Tumour confined to one, or both, testes
Stage 11 : Métastasés to lymph nodes below the diaphragm
Stage 111 : Métastasés to lymph nodes above the diaphragm
Stage IV : Extranodal métastasés
The clinical staging of 232 patients with teratoma or 
combined tumour is shown in Table 6.III. Of these, 60 patients 
(26%) presented with tumour confined to the testis and 172 [74%) 
had metastatic disease.
6. Serum samples
Ten ml of venous blood was collected and the serum 
separated by centrifugation within 3 hours and stored at — 70^C. 
Only 5 preorchidectomy serum samples were available for study 
because of the referral system used, but a sample was taken when 
the patient first attended RMH before commencement of post­
operative therapy, and at each subsequent follow-up visit.
7. Alpha-fetoprotein (AFP) assay
Serum AFP was measured by radioimmunoassay. Anti-AFP 
serum was raised in rabbits, and the free and bound fractions 
separated by precipitation with ammonium sulphate or ethylene 
glycol.
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Table 6. II. Ancillary staging procedures used in addition to full 
clinical examination for patients with testicular and extragonadal 
germ cell tumours.
Investigation Site of m étastasés examined
chest X « ray 
tomography
lung
mediastinal lymph nodes 
chest wall
lymphangiography abdominal (para-aortic) lymph nodes
(standard procedure) mediastinal lymph nodes
lymphangiography 
(specialised procedure)
renal hilar lymph nodes
ultrasound liver
abdominal
scanning
bones
liver
(isotope scintillography) brain
lung
computerised axial brain
tomography (CAT) abdomen
(EMI scan) any other site
2 0 3 -
Table 6. III. Clinical staging of 232 male patients with teratoma 
( + seminoma ) according to main histological type.
Main histological type
Clinical stage
Total
I n IE IV
malignant teratoma undifferentiated (MTU) 14 9 3 66 92
malignant teratoma intermediate (MTÏ ) 34 21 9 29 93
teratoma differentiated (TD ) 4 0 2 2 8
malignant teratoma trophoblastic (MTT) 0 0 0 4 4
yolk sac tumour (YST ) 8 2 3 22 35
Total 60 32 17 123 232
The sensitivity of this method is 2 ng AFP per ml of 
undiluted serum. Serum samples from 32 adult males (aged 20-40 
years) with no evidence of hepatic or malignant disease had 
AFP levels between 2 and 16 ng/ml serum [mean: 4.6^ 2.6 ng/ml). 
Values in excess of 25 ng/ml were considered in this study 
to be elevated, and values between 16 and 25 ng/ml were equi­
vocal but not definitely raised. The prime purpose of the
assay was to detect and quantitate elevated serum AFP rather
than to study fluctuations in the normal range. Therefore, 
for many of the samples, the lower limit of sensitivity of the 
assay was set at 25 ng/ml so that the working range of the
assay was extended at the upper level.
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B. RESULTS
1. Serum AFP levels as a function of type and activity of 
the tumour
The 322 patients in this survey were classified accord­
ing to their main histological type, viz. teratoma; seminoma; 
combined teratoma and seminoma; and non-germ cell testicular 
tumour. All had serum AFP measured while attended the Royal 
Marsden Hospital but 125 patients had no evidence of residual 
tumour by the time they were first seen at RMH, and no evidence 
of recurrence was seen in the follow-up period. These 125 
patients were considered to have "non-active" disease. All 
other patients had "active disease" at some time in the course 
of serum AFP determination although the tumour was not always 
clinically apparent. The incidence of raised serum AFP 
(>25 ng/ml) is shown in Table 6.1V.
A total of 120 patients had raised levels, and 110 of 
these had active teratoma (—  seminoma) at the time of serum 
sampling. Ten patients had elevated serum AFP.at a time when 
there was apparently no active teratoma present, and details 
of these patients are shown in Table 6.V. Four of these 
patients (1,2,6 & 10) had only a slight transient elevation 
of serum AFP and this was seen in only one serum sample: 
previous and subsequent samples were normal. These isolated 
elevations may have been caused by non-specific ailments, for 
example mild liver dysfunction. Another 4 patients (3,4,7 & 8) 
had serum samples taken shortly after orchidectomy and AFP in 
the serum may not have had time to fall to normal levels. In 
such cases, a preoperative sample would have been very useful.
- Z U D -
Table 6. IV. Serum AFP in 322 patients with germ cell tumours and 
non-germ cell testicular tumours according to main histological 
classes and clinical activity of the tumour.
Pathology Total number of patients
Activity of 
disease *
Serum AF P **
Normal Raised
Active 32 1
Seminoma 84
Non active 51 0
Seminoma Active 13 17
+ 51
Teratoma Non active 19 2
Active 39 93
T eratoma 181
Non active 43 6
Non-germ Active 1 1
cell tumour 6
of testis Non active 4 0
Total 322 202 120
* Active 
Non active
Serum sample taken at a time when viable tumour 
was present in the body
No clinical evidence of active tumour during period 
of serum sampling and no evidence of tumour 
recurrence throughout the follow-up period
** Normal range of serum AFP less than 25 n g/m l
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Table 6. V. Clinical details of patients who had raised serum AFP 
levels without apparent active teratoma : none of these patients 
developed evidence of recurrent or residual teratoma in the remainder 
of the period of investigation.
Patient Serum A F P  (ng/ml)
Clinical status 
at sampling Comments
1 (B.B.)
32
(on a single 
occa Sion)
active seminoma in 
para-aortic nodes
only 1 slide of 
original tumour 
available. Serum 
sample taken 3 days 
after laparotomy
2 (G.W.)
29
(on a single 
occasion)
active paratesticular 
rhabdomyosarcoma, 
lung métastasés
3 (D.M.) 100
9 days after orchid­
ectomy for stage I 
tumour
tumour contained 
MTI + YST + 
seminoma
4 (J.V.) 340
11 days after orchid­
ectomy for stage I 
tumour
tumour contained 
YST + seminoma
5 (M.S.) 52
no evidence of 
residual tumour : 
infant aged l |  yrs
pure YST stage I 
removed 6 months 
previously
6 (C.B.)
36
(on a single 
occasion)
no evidence of 
residual tumour
MTU stage I 
removed 6 weeks 
previously
7 (J.F.) 96
12 days after orchid­
ectomy for stage I 
tumour
tumour contained 
MTI + YST
8 (M.M.) 160
3 days after orchid­
ectomy for stage I 
tumour
tumour contained 
MTI + YST
9 (S.W.) 49
13 days after orchid­
ectomy for stage I 
tumour
11 month old infant 
tumour was TD
10 (R.L.)
28
(on a single 
occasion)
10 weeks after orchid­
ectomy for stage I 
tumour
tumour contained 
MTI
Patienta 5 & 9 were infants and the mildly elevated serum 
AFP levels may have been physiological.
If we exclude (a) small elevations seen in infants,
(b) small transient elevations in adults which cannot be 
verified by a repeat serum sample; and (cl postoperative 
samples before sufficient time has elapsed for high pre- 
operative levels to fall to normal, then in the present series, 
a confirmed elevated serum AFP always indicated the presence 
of active teratoma.
2. Histological sub-types and serum AFP levels
Fifty-four patients had active teratomas consisting 
of purely embryonic elements (TD,MTI, MTU) or purely one type 
of extra embryonic component (YST or MTT): some of these tumours 
also contained seminomatous elements but such elements were 
considered non-contributory to serum AFP. Table 6.VI. shows 
the correlation between teratomas of pure sub-type and serum 
AFP levels. The patient with TD was an infant with a single 
minimal elevation of serum AFP (Table 6.V: patient No.9) which 
may not have been related to the tumour (vide supra)- Pure 
trophoblastic tumours are not associated with raised serum AFP, 
and pure YST is most consistently accompanied by raised levels.
3- Incidence of yolk sac tumour (YST) in teratomas
The presence or absence of YST, as described by Teilum 
(1976) and illustrated in Fig. 6.4., in 232 teratomas is shown 
in Table 6.VII. Yolk sac elements appeared in teratomas in all 
age groups (Fig. 6.2), and the percentage of teratomas con­
taining YST in different age groups remains fairly constant 
(61-75%). YST may occur in pure extra-embryonic teratomas, or 
in combination with embryonic elements (Table 6.VIII).
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Table 6. VI. Relationship of specific histological features to serum 
levels of A F P  in 54 patients who had active teratoma of a single 
histological sub-type.
Serum Teratomas consisting entirely of
AF P * TD MTI MTU MTT YST
normal 0 5 8 4 2
elevated 1 1 17 0 16
Normal range of serum A F P  : le ss  than 25 n g/m l
Table G. Vli. Incidence of yollc sac elements in teratomas.
Yolk sac elements Number of teratomas Incidence
present 153 66 %
absent 79 34%
Total 232 100%
—  zl JLU —
Fig. 6.4. Histological patterns seen in yolk sac tumours
Fig. 6.4a. Microcystic pattern. Flattened endothelial 
cells form a reticular microcystic network having a 
honeycomb appearance. Intracellular and extracellular 
eosinophilic hyaline globules are present; this material 
stains with periodic acid schiff (PAS) and is diastase- 
resistant, Immunocytochemical staining has located AFP 
in these globules. This pattern of YST is common in the 
infantile testes. (H & E X 180 )
Testicular tumour in male aged 3% months. Pure YST.
Fig. 6.4b. Macrocystic pattern. In some areas, the cystic 
spaces are much larger, but the lining cells have a 
similar morphology to those of Fig. 6.4b. (H & E X 108 ) 
Testicular tumour in male aged 38 yrs. YST + MTI,
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Fig. 6 . 4 a .
Fig. 6.4b.
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Fig. 6.4. Histological patterns seen in yolk sac tumours.
Fig, 6.4c. Endodermal sinus body. This structure, alsoI "HI* i^iL m , I 'I.# *
known as a "Schiller Duval" body, is pathognomonic of YST. 
It consists of a mantle of cuboidal endothelial cells 
surrounding a fibrovascular core, and the central structure 
is surrounded by an outer layer of similar cuboidal cells.
(H & E X 450 ) 
Testicular tumour in male aged 34 yrs. YST + MTU.
Fig. 6.4d. Polyvesicular vitelline component. This
pattern is frequently present in ovarian YST, but is also 
noted in some testicular tumours. It consists of blasto­
cyst-like vesicles lined by flattened or cuboidal méso­
thélial cells in a cellular compact stroma. (H & E X 180) 
Ovarian tumour: this slide was kindly donated by Prof.
G. Teilum.
6.  4c .
Fig. 6.4d.
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Fig. 6.4. Histological patterns seen in yolk sac tumours.
Fig. 6.4e. Anaplastic YST, In some areas of YST, the 
tumour has a' much more pleomorphic appearance with 
numerous mitotic figures. It consists of solid sheets of 
cells, but cytoplasmic vacuolation is a prominent feature 
and the nuclei are fairly regular and vesicular. This 
pattern is similar to some MTU's, but MTU is more irregular 
and the cytoplasm is less vacuolated. Anaplastic YST can 
only be diagnosed with certainty if it merges with areas 
of better differentiated YST. (H & E X 720 )
Extragonadal germ cell tumour in male aged 21 yrs. Pure YST
fFig. 6.4e
Table 6. VHI. Incidence of yolk sac elements in association with 
other teratomatous elements.
Histology Total number of teratomas
Number of 
teratomas 
with YST
Incidence
M TU 92 48 52 %
M TI 88 66 75 %
TD 13 5 * 38 %
extra
embryonic 39 35 90 %
Total 232 153 66 %
* T D h Y S T would be classified as M TI in the British  
classification (Pugh, 1976).
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4. Incidence of trophoblastic elements In teratomas
In the present group of 232 teratomas, 4 patients 
(2%) had pure MTT and a further 13 patients (6%) had teratomas 
containing MTT in association with other teratomatous elements. 
In addition, 80 teratomas (34%) contained isolated syncytio- 
trophoblasts which could be detected by imraunoperôxidase 
staining for 3HCG (Heyderman & Neville, 1976a). Therefore,
42% of teratomas contained trophoblastic elements and these 
were present in all age groups (Fig. 6,3).
5. Incidence of pure extra-embryonic teratomas
Of the 232 patients with teratoma, 39 contained only 
extra-embryonic elements without associated embryonic 
components, although 10 of these also contained seminoraatous 
elements (Table 6.IX.)
6. Incidence of raised serum AFP in teratomas: 
association with YST
One hundred and sixty-eight (168) patients with teratomas 
had active disease at the time of serum sampling for AFP. Of 
these, 114 patients (68%) had evidence of YST and 119 patients 
(69%) had raised serum AFP at some stage in the course of 
the disease. However, as can be seen from Table 6.X., there is 
not an absolute and exclusive correlation between the two.
In 53% of cases, YST was present and serum AFP was elevated, 
and in 16% of cases there was evidence of neither. However,
15% of patients had YST identified histologically although 
elevated serum AFP was never detected in the serum samples 
assayed, and 16% had raised serum AFP without histological 
evidence of yolk sac elements in the sections available-for 
examination.
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Table 6. IX. Details of germ cell tumours consisting entirely of 
extra-embryonic teratomas.
Age and site
infantile testis  
adult testis 
adult extragonadal
total
3
32
4
39
(all pure yolk sac tumours)
Histopathology
Y ST 16
Y S T + trophoblasts 9
YST + trophoblasts + seminoma 4
YST + seminoma 6
MTT 4
total 39
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Table 6.X. Incidence of yolk sac tumour and elevated serum AF P in 
168 patients with active teratoma.
Yolk sac tumour * Serum A F P
Present 114 (68 %)
elevated 89 (53 %) 
normal 25 (15 %)
Absent 54 (32 %)
elevated 27 (16 %) 
normal 27 (16 %)
Total 168 (100 %) 168 (100 %)
* Alone or in combination with other germ cell elements
— 2 20—
7. Serum AFP in follow-up studies and therapeutic monitoring
All 32 2 patients with testicular tumours and extragonadal 
germ cell tumours had serum AFP measured, and most had 
sequential measurement at each hospital visit thus enabling 
the course of the disease and the effect of therapy to be 
monitored serologically. A normal serum AFP could indicate 
one of the following possibilities
(a) The patient was tumour free
(b) Seminoma was present
(c) MTT was present
(d) The patient had active non-AFP-producing teratoma
(e) The patient had a small AFP-producing teratoma but
insufficient to result in elevation of serum levels above 
the accepted upper level of normal (25ng/ml).
(f) AFP production had been suppressed by therapy although
the tumour was still growing.
Therefore a negative serum AFP had little clinical 
significance, but a confirmed elevated serum AFP in the present 
series always indicated the presence of active teratoma.
In some cases, the level of serum AFP was an accurate monitor 
of the extent of the disease in the body (Fig. 6.51.
A preoperative serum level is a very useful baseline 
measurement for the serological monitoring of the effect of 
surgery and subsequent therapy. Complete surgical eradication 
of tumour always resulted in serum AFP returning to normal, 
whereas failure to return to normal always indicated residual 
disease (Fig. 6.6). Unfortunately only 5 preoperative samples 
were available because of the referral system used, but the 
rate of fall of postoperative serum AFP could be used as an

Fig. 6.5. Serum AFP levels in an infant who had a left 
orchidectomy (0-) for a pure yolk sac tumour at the age 
of 3^ months. His AFP level was high postoperatively in 
spite of negative clinical examination, chest X-ray (CXR), 
lymphogram (.LG) and intravenous pyelogram (IVP) . It fell 
almost to normal and increased again to 40,000 ng/ml 
although LG remained negative. Examination under anaes­
thesia (EUA) revealed a left loin recurrence which largely 
regressed with chemotherapy using Vincristine (V), Actino- 
mycin D (A), Cyclophosphamide (C) and Adriamycin (AD), and 
this was accompanied by a fall in serum AFP. At subsequent 
laparotomy, residual tumour in the left renal hilar lymph 
node, together with the adjacent adherent kidney, Were 
removed. No other intra-abdominal métastasés were detected. 
Serum AFP fell to normal after the laparotomy and further 
AD therapy, and he remains tumour-free and in good health.
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Fig. 6.6. Serum AFP in a male aged 31 years presenting 
with a right testicular tumour and left iliac nodes, left 
supra-clavicular node, lung and liver métastasés. Chemo­
therapy with Vinblastine (V), Actinomycin D (A) and Metho­
trexate (M) caused tumour regression and a fall in serum 
AFP, but normal values were not reached even after orchid­
ectomy (0-) which revealed a pure yolk sac tumour. Serum 
values rose to 3,300 ng/ml but following chemotherapy and 
radiotherapy (RT) with additional Actinomycin D (Act.D) he 
went into complete clinical remission including regression 
of para-aortic and right eye métastasés. A subsequent 
rise in serum AFP preceded by several months clinical 
evidence of recurrent tumour when a liver scan showed 
hepatic involvement. Chemotherapy again resulted in a 
fall in AFP level to normal, but his metastatic disease 
progressed causing his death. Autopsy showed widespread 
undifferentiated teratoma with no evidence of yolk sac 
tumour.
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assessment of surgical completeness. In our laboratory 
(J. Kohn, personal communication) the half life of AFP in the 
serum was found to be 5 days, and if serum levels fell more 
slowly than expected then residual tumour was always present 
(Fig. 6.7). However, false negatives also occurred. In some 
cases, postoperative serum AFP fell to normal values with a 
half life of 5 days, but residual tumour was present and the 
tumour recurred at a later date.
Serum AFP fell to normal as a result of therapy (surgery, 
chemotherapy, radiotherapy) in 50 patients: in 31 of these, the 
tumour was completely eradicated, but in 19 cases incomplete 
regression occurred and the tumour recurred in spite of the 
period of normal serum values. In a further group of 19 patients 
under treatment, falling serum AFP coincided with clinical 
evidence of progression,
A secondary rise in serum AFP always indicated tumour 
recurrence: this was noted in 31 patients of whom 13 had raised 
serum AFP detected before the recurrence was evident by clinical 
and radiological examination (lead time: 1-30 weeks). In 14 
patients clinical evidence of recurrence ■ occurred
before the serum AFP was elevated (lag time: 4— 40 weeks), and 
in 4 patients clinical and serological evidence of recurrence 
occurred simultaneously. Six patients with AFP-producing tumours 
went into complete clinical remission as a result of therapy and 
serum AFP fell to normal, but tumour recurred at a later date 
without a secondary rise in AFP level.
It is clear that in many instances there is discordance 
between the changing levels of serum AFP and the progression or

Fig. 6.7. Graph of AFP levels in the serum of two hypo­
thetical patients showing the significance of rate of fall 
of serum AFP postoperatively. The half life of AFP in 
the serum is' 5 days. After complete excision of an AFP- 
producing tumour, serum levels fall exponentially with a 
half life of 5 days till normal baseline levels are 
reached (lower curve), A secondary rise does not occur.
If the postoperative rate of fall of serum AFP has a 
greater half life than 5 days (e.g. 8.6 days: upper curve) 
then there is a residual source of AFP production in the 
body, i.e. incomplete removal of tumour. Serum levels may 
fall into the normal range, but increasing bulk of tumour 
will cause a secondary rise in serum AFP indicating 
tumour recurrence.
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regreaaion of tumoxir in the body. However, in the majority 
of cases, rising or falling serum AFP positively reflected 
changes in tumour bulk. On 63 occasions tumour regression 
was accompanied by falling serum AFP, and in 37 cases, rising 
serum AFP coincided with tumour progression.
Four patients with raised serum AFP levels had an 
initial diagnosis of pure seminoma made on available histological 
material. Two of these patients had clinical evidence of 
active tumour at a time when a serum sample indicated elevated 
AFP levels: review of the histology of the primary tumour 
revealed teratomatous elements. The other 2 patients had 
normal serum AFP values initially, but raised levels developed 
later in the course of the disease: review of the histology 
of primary tumour confirmed that only seminomatous elements could 
be identified, but biopsies of recurrent tumours showed 
teratomatous elements (Fig. 6.8).
8. Prognostic features of teratomas
a) Effect of clinical stage
The significance of clinical stage at presentation on the 
mortality of 119 patients with teratoma followed prospectively 
for a minimum of 2î^  years is shown in Table 6.XI. Sixty-five 
(55%) of these patients died of malignant disease, the vast 
majority of deaths occurring in patients with stage IV • 
teratoma.
b) Effect of histological evidence of YST
The prognostic significance of YST in these 119 teratoma 
patients is shown in Table 6.X11. Pure YST carries a poor 
prognosis, worse than teratoma without yolk sac elements.
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Fig. 6.8. Serum AFP levels in a male patient aged 31 
years presenting with a testicular tumour diagnosed as a 
stage I pure seminoma by orchidectomy (0-) and lymphangio­
graphy (LG). He had postoperative radiotherapy (RT). A 
second pure seminoma in the contralateral testis was 
removed 6 months after the initial operation. Within 
3 months', chest X-ray (CXR) revealed lung hilar lymph- 
adenopathy which was treated with Vinblastine (V), Actino- 
mycin D (A) and Methotrexate (M), but he developed inferior 
vena caval compression (JVC comp) with lower limb oedema. 
Serum AFP was first measured at this stage and was found 
to be in the normal range. In spite of radiotherapy, the 
mediastinal tumour mass increased in size and serum AFP 
increased to very high levels (6,600 ng/ml). Chemotherapy 
with Cyclophosphamide (Cyclo), Adriamycin (Adria) and 
Dimethyl triazeno imidazole carboxamide (DIC) did not 
prevent tumour growth, and encroachment on the oesophagus 
caused dysphagia. A preterminal thoracotomy revealed an 
inoperable tumour which was biopsied and found to be 
teratomatous (MTI + YST).
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Table 6. XI. Correlation between clinical stage at presentation and 
mortality in 119 teratoma patients followed for at least 2i years.
Clinical stage at 
presentation
Number of patients
dead alive total
I 1 25 26
II 0 12 12
i n 1 4 5
IV 63 13 76
Total 65 54 119
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Table 6.xn. Correlation between histological evidence of YST and 
mortality in 119 patients with teratoma followed for at least 2 | years.
Histology Dead Alive Total
pure YST 14 (70%) 6 (30%) 20
YST + other 
teratomatous 
elements
28 (53 %) 25 (47 %) 53
teratomas with no 
evidence of YST 23 (50 %) 23 (50 %) 46
Total 65 (55 %) 54 (45 %) 119
-■233-
and worse than YST combined with other teratomatous 
elements. Table 6.X111 indicates that the presence of 
YST in MTU has little effect on prognosis of MTU, but 
yolk sac elements adversely effect the prognosis of MTI. 
However, MTI + YST has a better prognosis than MTU with 
or without YST.
c) Effect of raised serum AFP
In this group of 119 patients followed for at least years,
85 had serum AFP measured at a time when the tumour was active. 
The survival of these patients and the prognostic significance 
of raised serum AFP is shown in Table 6.XIV. Evidence of 
AFP production has a marginally adverse effect on the prognosis 
of teratoma taken as a whole. Although numbers are small, a 
raised serum AFP associated with MTU or MTI is probably 
an adverse sign (Table 6.XV).
9. Other tumour index substances
Human chorionic gonadotrophin (HCG) was measured in the 
urine or serum of some patients with testicular and germ cell 
tumours. Both AFP and HCG were measured in 102 patients with 
active teratoma and 18 patients with active seminoma (Table 6.XVI). 
Both markers were elevated in 54% of the teratoma patients, and 
only 6% of teratoma patients had neither elevated. Seminomas were 
not associated with raised serum AFP, but 44% of patients with 
active seminoma had raised HCG levels in the urine or serum.
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Table 6.XII1. Relative significance of YST, M TI and M TU with 
respect to mortality in 112 patients with teratoma followed for at 
least 2i years.
Histology Dead Alive Total
M TU 16 (64%) 9 (36%) 25
MTU + YST 15 (65 %) 8 (35%) 23
MTI 3 (21 %) 11 (79%) 14
M TI + YST 13 (43%) 17 (57%) 30
pure YST 14 (70%) 6 (30%) 20
Total 61 51 112
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Table 6 .XIV. Correlation between serological evidence of AF P 
production and mortality in 85 teratoma patients followed for at 
least years.
Serum A F P Number of patients
Dead Alive Total
elevated * 45 (78 %) 13 (22%) 58
normal ** 19 (70%) 8 (30%) 27
Total 64 (75 %) 21 (25%) 85
Serum AF P greater than 25 ng/m l at some time in the course 
of the disease
Seinim A F P  never greater than 25 ng/m l although disease was 
active at some stage in the course of serum sampling
— 23 6 —
Table 6 .XV. Significance of A F P  Production with respect to mortality 
in 80 patients with active MTI, MTU or YST followed for at 
least 2 | years.
Histology Serum AF P
Number of patients
Dead Alive Total
elevated 18 (82%) 4 (18%) 22
M T U
normal 13 (68%) 6 (32%) 19
elevated 14 (70%) 6 (30%) 20
M TI *
normal 1 (33%) 2 (67%) 3
elevated 12 (86%) 2 (14%) 14
YST
normal 2 (100 %) 0 2
Total 60 20 80
* Some of these teratomas contained extra-embryonic elements 
in addition to M TI or M TU
** Pure extra-embryonic teratomas
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Table 6. XVI. Tumour markers in 120 patients with active germ cell 
tumour at a time when both A F P  and HCG were measured.
Tumour markers 
. in serum (or urine)
Number of patients
Active teratoma 
( + seminoma)
Active seminoma
Neither A F P  nor 
HCG elevated
A F P  only elevated *
HCG only elevated * *
Both A F P  and HCG 
elevated
6 (6%)
19 (19%) 
22 (22 %)
55 (54 %)
10 (56%) 
0
8 (44%) 
0
Total 102 18
Serum A F P  greater than 25 ng/m l
Serum /3HCG greater than 2 ng/m l by RIA  
or Urinary HCG greater than 100 iU per 24 hours by 
pregnancy test
.23b'
c. DISCUSSION
There are many authoritative classifications of testi­
cular tumours (Mostofi & Price, 1973; Mostofi & Sobin, 1977;
Pugh, 1976; Teilum, 1976). The classification of the British 
Testicular Tumour Panel and Registry [Pugh, 19761 is straight­
forward for the histopathologist, readily understood by the 
clinician (Peckham & McElwain, 19751 and correlates well with 
the clinical behaviour of the tumour (Bar & Hedinger, 19761. 
However, it is mainly a prognostic classification rather than 
a histogenic or functional classification and is therefore limited 
in its ability to indicate the possible tumour markers which 
may be elevated in the serum. This deficiency can be partially 
overcome by incorporating the criteria for diagnosing extra- 
embryonic components as proposed by Teilum (1976), and by 
identifying isolated syncytiotrophoblasts by immunocytochemical 
staining methods.
In the present series of 316 germ cell tumours, 56% were 
teratomas (non-seminomatous germ cell tumours), 27% seminomas 
and 18'% combined tumours. In the teratoma (— seminoma)" group 
74% had metastatic disease at the time of referral to the Royal 
Marsden Hospital, and histologically 3.4% had TD. Comparing 
these figures with the results of Pugh (1976), the present series 
contains a low porportion of seminomas and TD, and a high 
proportion of tumours of high grade malignancy. Also, the present 
series contains a higher proportion of tumours which have 
metastasised beyond the testis. This suggests that there was 
a certain degree of patient selection in the present series, 
tumours with a poor prognosis being more prevalent, a feature
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which must be borne in mind when the significance of the 
results is discussed.
The results may also be biased because of sampling 
error. As a result of the referral system used, preoperative 
serum samples were seldom available, and the limited number 
of histological sections available may not have been fully 
representative of the complete range of structures present in 
any one tumour. In addition, any temporal changes in morpho­
logical patterns could not be monitored because tumours could 
only be sampled at a single instance in time.
1. The use of serum AFP as a tumour index substance
Serum AFP is elevated in association with many neoplastic 
and non-neoplastic conditions (see introduction) and is there­
fore not a specific marker for testicular tumours. However, in 
the preserAt series  ^ a confirmed raised serum AFP in an adult 
always indicated the presence of active teratoma and could rule 
out pure seminoma, pure trophoblastic tumour, and non-germ cell 
testicular tumour. Successful therapy always resulted in a fall 
of serum AFP levels with a half-life in the serum of 5 days; and 
a subsequent rise always indicated recurrent disease. If the 
rate of fall of serum AFP after surgery had a greater half-life 
than 5 days, then residual tumour was present. The lack of false 
positives in this series suggests that serial measurements of 
serum AFP is a very good adjunct to clinical examination in the 
follow-up of patients with germ cell tumour. However, its 
usefulness is limited by the large number of false negatives 
which may occur.
One third of teratomas are not associated with raised 
serum AFP, and of those that do produce AFP, serum levels give 
no absolute indication of tumour bulk, and often fluctuations 
of tumour size and activity are not reflected in the level of 
AFP in the serum (Fig. 5.5). However, in the cases where serum 
AFP accurately reflects the extent of the tumour in the body 
(Fig. 6.5), its serial determination is a valuable aid to the 
monitoring of the disease . Serum AFP often detects recurrent 
disease before it is clinically apparent (Figs. 6.5 & 6.6), but 
in other patients, clinical and radiological methods are more 
sensitive. Therefore serum AFP is not a substitute for 
meticulous clinical examination on the follow-up period.
2. Other tumour index substances
The measurement of more than one serum marker increases 
the usefulness of serological monitoring of teratomas. In the 
present series,94% of teratoma patients had elevation of at 
least one of serum AFP, serum gHCG, or urinary HCG. The levels 
of these markers may fluctuate discordantly with therapy 
(Braunstein et al., 1976), therefore serial estimation of both 
is desirable.
In a recent review of secretory products released by 
germ cell tumours (Grigor et al., in press) the importance of 
serial serum measurements of both AFP and gHCG in patients 'with 
testicular tumours was stressed. These two substances are the 
most specific and the most consistently elevated germ cell tumour 
markers, and they give the most accurate assessment of tumour 
progression and regression. Other tumour markers may be elevated 
in the serum, but none has yet been found to be better than AFP 
and 3HCG.
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Carcinoembryonic antigen CCEAl may show slight transient 
elevations in the serum of teratoma patients, but these levels 
are unrelated to AFP levels and do not give an accurate indi­
cation of tumour bulk nor tumour progression (Wahren & Edsmyr, 
1974). Talerraan et a l ., (1977) state that serum measurement
6fÇEA is of no value in the monitoring of germ cell tumours; 
however, elevated CEA levels may indicate differentiation towards 
gastrointestinal structures within teratomas.
An iron-containing oncofetal antigen called =2 -H globulin 
has been detected in the serum of some patients with malignant 
disease (Buffe et a l ., 1968). This globulin was later found to 
be ferritin, and is elevated in the serum of some patients 
with teratomas (Laurence & Neville, 1972). Pedersen et al.
(1976) confirmed that some germ cell tumours are associated with 
raised serum ferritin levels, but these levels are not related 
to AFP levels, and do not reflect tumour activity.
Human placental lactogen (HPL),, also known as human 
chorionic somatomammotrophin (HCS),is another placental hormone 
produced by the syncytiotrophoblasts and is elevated in maternal 
serum during pregnancy. Some germ cell tumours, especially if 
chorionic elements are present, are associated with raised serum 
levels, and it is postulated that HPL in conjunction with elevated 
oestrogen levels are responsible for gynaecomastia in patients 
with testicular tumours (Frantz et al., 1965; Greenwood et al., 
1971). However, HPL is less consistently produced by chorionic 
elements than gHCG (Frantz et al., 1965; Stepanas et a l ., 1978), 
and as with gHCG, HPL is not specific for trophoblastic tissues 
(Weintraub & Rosen, 19 71).
‘ 2 4.2 —
Bohn (1972 4 described a pregnancy specific -^glycoprotein 
(PSgj^G) which Horne et al. (1976,19771 have demonstrated in 
the syncytiotrophoblasts of normal placentae, and also in 
gestational choriocarcinomas and trophoblastic elements in 
malignant testicular teratomas. Searle et al. (1978) have shown 
that, in addition to choriocarcinomas and teratomas, this 
glycoprotein may be elevated in the serum of patients with 
tumour .of the breast, colon and ovary, as well as in the serum 
of some healthy males and non-pregnant females. Therefore,
PSg^G is not a specific marker for trophoblastic tumours. In 
choriocarcinomas, gHCG levels in the serum are greater than 
PSg^G levels, and gHCG is a more useful tumour marker in the 
monitoring of the tumour. However, in some cases of malignant 
teratoma, PSg^G levels may excede gHCG levels, and may be more 
useful in the detection of residual minimal disease (Searle 
et al.,1978).
Many patients with malignant disease have elevated serum 
acute phase reactive proteins which are produced by the liver in 
times of stress or injury (Koj, 1975). These serum markers are 
not specific for tumours, but may give an indication of the extent 
of tumour spread. Alpha^-antitrypsin (AAT) is an acute phase 
reactive protein which is elevated in the serum of some patients 
with testicular tumours, and which has been demonstrated within 
teratoma cells (Palmer et al., 19 76). However, this does not 
necessarily indicate production by tumour cells, and AFP is a 
more specific and more sensitive marker.
Kadish et al. (1976) described a case of primary retro­
peritoneal germinoma (seminoma) with elevated serum levels of 
lactic dehydrogenase (LDH). Radiotherapy resulted in complete
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tumour regression, and serum LDE levels, returned to normal.
This suggests that in some cases, serum LDH levels inay 
accurately monitor the course of a germ cell tumour, but LDH 
is not a specific marker for tumour activity.
Patients with testicular tumours often have gynaecomastia, 
and this is considered to be a poor prognostic sign, especially 
if galactorrhoea is also evident. Stepanas et al. (1978) studied 
45 patients with testicular tumours, 27 of whom had gynaecomastia. 
Serum levels of 6 hormones were measured, v i z . prolactin (PRL), 
human placental lactogen (HPL), gHCG, testosterone, oestrone 
(E^) and oestradiol(E^). Levels of testosterone tended to be 
low, but the other hormones were often present in the serum in 
elevated amounts. Tumour HCG was thought to stimulate aroma­
tisation of steroid precursors within tumour cells with resultant 
oestrogen production. The oestrogens subsequently stimulated 
pituitary secretion of prolactin. Gynaecomastia formation in 
these patients tended to be suppressed by high circulating 
testosterone levels. Stepanas et a l . (1078) suggested that these
hormones, especially oestrone, should be measured in the serum 
of all patients with testicular tumours as tumour markers in 
the monitoring of the course of the disease.
It is evident that testicular tumours may be associated 
with abnormal levels of many substances in the serum. The 
complete assessment of patients with testicular tumours should 
involve serial serum monitoring of all substances which may be 
affected, but such a comprehensive follow-up protocol is im­
practical for routine monitoring of all testicular tumour patients 
Frequent thorough clinical examination is mandatory; and accurate
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clinical staging using all available technology (Table 6.II) 
is the most important index of prognosis. Serological 
monitoring is a very important and useful adjunct to clinical 
examination and should be considered as a necessary part of 
routine follow-up. At present, serum AFP and BHCG levels are the 
most useful known markers for monitoring the progress of 
testicular tumours, and both should be measured at frequent 
intervals. However, in a few patients, other markers may have 
more to offer, and these should be considered in cases where 
AFP and 3HCG levels are found to be unrepresentative of the 
activity and extent of the tumour.
3. Correlation between serum AFP levels and tumour morphology
There is a strong correlatiion between raised serum AFP 
and the presence of yolk sac elements in teratomas, and some 
authors claim that AFP is a specific marker for YST (see 
introduction). However, the results presented in this thesis 
indicate that there is not an absolute and exclusive correlation 
between the two, 15% of patients having raised serum AFP 
without YST being recognised in the available histological sections, 
and 16% of patients having yolk sac elements but serum AFP within 
the normal range (<25ng/ml). This discrepancy may be explained 
by sampling error. It is possible that patients with raised 
serum AFP levels but no histological evidence of YST had yolk 
sac elements present in parts of the tumour which were not 
examined histologically. Also, it is possible that patients 
with YST identified in their tumour but no evidence of raised 
serum AFP levels had raised levels at a time when the serum was 
not sampled: and when their serum was tested they may have had
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active teratoma without residual yolk sac elements. However, 
it is more likely that some yolk sac tumours do not produce 
AFP, and that elements other than YST are capable of its 
production. The discrepancy between AFP production and the 
presence of YST is also evident when considering the prognosis 
of testicular tumours (vide infral.
AFP in teratomas had been demonstrated in yolk sac 
structures by immunocytochemical staining (see introduction) 
but this technique is not always reliable for AFP localisation 
(Heyderman & Neville, 19 76b). AFP is soluble in formol saline 
fixative (Grigor & Kohn, unpublished observational therefore 
diffusion may have occurred in formalin fixed tissue. Also 
formaldehyde inhibits the binding of anti-AFP antibodies to 
AFP, therefore routine formaldehyde fixed paraffin sections 
must be washed meticulously in order to remove all traces of 
fixative.
AFP is produced in the embryo and foetus by the yolk sac, 
liver and gastrointestinal tract, therefore hepatoblastic or 
gastrointestinal differentiation in teratomas may account for 
AFP production. Engelhardt et al. (1973) demonstrated AFP in
mouse teratomas in regions showing differentiation towards 
endodermally derived endothelium, and Kurman et a l . (1977) have 
shown that large mononuclear cells in embryonal carcinomas (MTU) 
contain AFP. Abelev (1967) suggested that AFP production in 
teratomas may be due to hepatoblastic cell, and the cells 
described by Kurman et al. (1977) are possibly hepatoblasts. The
anterior mediastinum is a common site for extragonadal germ 
cell tumours (Luna et al., 19761 . Wepsic et al . (1976) described
an anterior mediastinal "anaplastic carcinoma with hepatoblastic" 
appearance
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associated with high serum AFP; this tumour may have been a 
teratoma with differentiation towards hepatoblasts thus 
accounting for the AFP production.
A female patient with an ovarian teratoma containing 
neural elements had a raised serum AFP (Esterhay et al., 19 73). 
If the foetal neural tube is exposed to the amniotic fluid 
in utero due to neural tube defects, amniotic fluid AFP is 
higher than normal indicating that perhaps neural tissue 
produces AFP. Breborowitz & Mackiewicz (19 77) demonstrated 
that embryonic brain in tissue culture produces AFP, Therefore, 
neural elements within a teratoma may account for AFP production
Since a variety of elements in teratomas are theoretically 
capable of producing AFP, it is difficult to argue that AFP 
is a specific marker for yolk sac elements. Parkinson &
Beilby (1977) state that many cases of embryonal carcinoma 
or MTU of the testis should be reclassified as YST because 
of AFP production, but such a conclusion is unwarranted 
because of lack of specificity of AFP production.
4. Incidence of yolk sac elements in teratomas
Very few published figures are available which indicate 
the incidence of YST in teratomas because there is confusion 
and disagreement about the diagnostic criteria for its recog­
nition, and because very few standard text books describe fully 
the histological features, Teilum (1976) has recently described 
the morphological features which he accepts as YST differentia­
tion, and these criteria have been accepted by many authors 
and by the WHO classification of testicular tumours (Mostofi 
& Sobin, 1977). However, Pugh (1976) denies the existance of 
YST in germ cell tumours of adults, and Parkinson & Beilby 
(19 77) at the opposite extreme suggest that all non-organoid
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Cnon-somatic). structures ±n non-seminomatous germ cell tumours 
should be regarded as extraembryonic elements.
Teilum (19 76) studied a selected group of teratomas 
with a definite bias towards those with yolk sac elements and 
therefore his series does not indicate the true overall incidence 
of YST in teratomas.
Pugh (1976) states that the incidence of YST in germ cell 
tumours of adults is nil. Parkinson & Beilby (1977) claim that 
89% of 92 teratomas contained YST but this figure must be 
regarded with caution because of their broad acceptance of yolk 
sac differentiation. Talerman (1975) used Teilum's classifi­
cation and found YST in 38% of 68 teratomas of adult testes, but 
stated that pure YST does not occur in adult testicular tumours. 
Wurster et al. (1972) found YST in 37% of 122 teratomas of adult 
testes.
In the present series there was probably some degree of 
patient selection towards those with more aggressive tumours.
In our group, 66% of 2 32 teratomas in males contained yolk sac 
elements, and YST was found in all age groups: the porportion of 
teratomas containing YST remained fairly constant in all the age 
groups. Pure YST was found in adults as well as in tumours of the 
infantile testes.
The exact incidence of YST will not be known until the 
criteria for its diagnosis is standardised and examined in many 
large series of unselected teratomas.
5. Features of prognostic significance in teratomas
The most important prognostic indicator of the outcome of 
testicular tumours is the clinical staging (Table 6.XI).
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The best hlatological classification of germ cell tumours 
giving an indication of prognosis is that of Pugh (1976) 
as discussed by Bar & Hedinger (1976), Seminomas and TD's 
have a good prognosis whereas MTT is usually rapidly fatal and 
is the most sinister histological feature. The prognosis 
of MTI and MTU lie between these two extremes, MTI having 
a better prognosis than MTU (Pugh, 1976). The present series 
vindicates these conclusions. Parkinson & Beilby (1977) find no 
difference in prognosis between MTI ("Mixed germ cell tumours") 
and MTU ("Yolk sac tumours") but our series agrees with Pugh 
(19 76) that MTI carries a better prognosis than MTU.
Many authors claim that the presence of YST (Parkinson 
& Beilby, 1977? Roth & Panganiban, 1976; Sell et a l ., 1976; 
Talerman, 19 75) or a raised serum AFP (Abelev, 1971; Balias,
1974? Bourgeaux, et al., 1976? Norgaard-Pederson et al., 1975) 
adversely affect the prognosis of germ cell tumours. In the 
present series, the presence of YST in MTI had an adverse 
prognostic effect, but MTI + YST had a better prognosis than MTU, 
and the presence of YST had little or no effect on the prognosis 
of MTU (Table 6. Xlll). Pure YST in adults carries a poor 
prognosis. Evidence of AFP production probably has a marginally 
adverse effect on the prognosis of teratomas (Tables 6.XIV & 6,XV) 
but numbers are still too few to make a definite conclusion.
These results indicate a further discrepancy between the presence 
of YST and AFP production. A raised serum AFP adversely affects 
the prognosis of MTU (Table 6.XV) whereas the prognosis of MTU 
is unaffected by the presence of YST (Table 6.Xlll).
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SECTION II : HUMAN TUMOURS
CHAPTER 7
ADRENOCORTICAL TUMOURS
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CHAPTER 7 
ADRENOCORTICAL TUMOURS
This chapter is a continuation of the general theme 
of the thesis: the correlation of morphology and function 
in tissues, using steroid-producing glands and human 
neoplasms as examples. The normal foetal testis is a 
steroid-secreting organ whose functions were described and 
discussed in Section I. In the first part of Section II,
I gave’ an account of germ cell tumours of the testis in 
man, and the association between morphological patterns 
and secretory products was considered. However, in such 
tumours, steroid production is not a major feature and 
therefore steroidogenesis was not discussed in depth.
Adrenocortical tumours, like foetal testes, have the 
capacity to synthesise and secrete steroid hormones and/or 
precursors. Testicular germ cell tumours are usually 
malignant neoplasms, but in some cases the actual degree of 
malignancy cannot be assessed on histological grounds alone. 
Although the malignant potential of adrenocortical tumours 
may also be difficult to determine histologically, those 
studied by me were all clinically malignant. In this chapter 
I attempt to correlate the morphology of these adrenocortical 
tumours with their steroidogenic capacity and their degree 
of malignancy.
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CHAPTER 7
NON-HORMONAL ADRENOCORTICAL CARCINOMAS
A. MATERIALS AND METHODS
1. Patients
Thirteen cases of "non-hormonal" adrenocortical tumours 
were seen at the Royal Marsden Hospital in London from 19 48 to 
1972. One case was excluded because the histological material 
was not available. The cases were referred primarily to the 
hospital for treatment rather than diagnosis. Some of the 
clinical and all of the histological data are available in a 
further 8 cases referred for pathological diagnosis to the 
University Department of Pathology, Glasgow Royal Infirmary, 
from 1960 to 1970. Their inclusion brings the total number of
new cases to 20.
Histological examination was made on paraffin-embedded 
material sectioned at 6ii and stained with haematoxylin and eosin. 
Some specimens were received as paraffin-embedded blocks or 
previously stained sections. Surgical material was fixed in 
10 per cent neutral formalin and trimmed prior to embedding.
The present series (Table 7.1) consists of 11 males and 
9 females ranging in age from to 66 years; 10 of the patients 
were between 50 and 70 years of age. The right adrenal gland
was affected in 9 patients and the left in 10. In one (Case 13),
the site was not stated.
2. Signs and Symptoms
The commonest presenting features were a palpable mass 
(11/20) and pain (11/20)(Table 7.1). Anorexia was present
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Table 7.1. Clinical details of 20 patients with non-hormonal
adrenocortical carcinoma.
C ase Sex Age Signs, symptoms and radiographic studies
1 M 2^ • 5 days history of m alaise, drowsiness, backache, right facial w eakness and fever. IV P  : ill-defined m ass in right kidney. M étastasés to right 8th and 10th rib s .
2 M 38
W eakness and tiredness fo r 5 years. 5 months p r io r  to adm ission, h ea rt fa ilu re  and 
hepatomegaly. Pain right upper quadrant, palpable m ass, weight lo ss, ankle oedema. L iver 
palpable 6 cm. I V P  : p tosis  of right klÂiey. A rteriogram  : vascu la r component identified.
3 F 35 8 y ea rs  left loin pain. 2 y ea rs  hepatosplenomegaly of unknown aetiology, m ass in left loin, shortness of breath . I V P  : tum our of left adrenal gland.
4 M 38 Swelling of abdomen fo r 2 years . P y rosis fo r 2 years . M ass righ t upper quadrant. I V P  : la rge  right renal m ass. Mass above and la rg e r than the kidney. '
5 F 61 abdominal discom fort and increasing g irth  fo r  1 month.
6 F 56 Dragging sensation in epigastrium  fo r 1 month, m ass palpable, increasing  nausea and vomiting, anaemia, weight loss and pain. Barium m eal : carcinom a of stom ach.
7 M 64 Pain righ t side and back. Haematuria. IV  P  ; enlarged righ t kidney.
8 F 53
5 weeks pain in left flank, increasing girth , palpable m ass, anorexia. I V P  : downward 
displacem ent of left kidney. P re -sa c ra l a ir  insufflation : adrenal m ass. A ortagram  : tum our 
vesse ls seen originating from  aorta .
9 F 48 Backache, abdominal discom fort, anorexia, palpable m ass fo r  1 month. I V P  : m ass left kidney
10 F 42
July '69 admitted with pain in left hypochondrium radiating to the left iliac  fossa , shortness of 
breath. Neurofibrom atosis. October '71 tiredness, anorexia, loin pain, nausea and vomiting, 
pain over 9th and 10th rib s , IV  P  : renal pelves enlarged, m ass in  le ft upper quadrant. 
Barium m eal : m ass in left hypochondrium. Spine : lo ss of pedicle of T 9 . Pelvis : right 
acetabular deposit.
11 F 65 1966 right adrenal tumour removed, 1972 nausea, vomiting and anorexia. M ass in right loin and a skin nodule found. I V P  : negative. Chest : m ultiple m étastasés in the lung.
12 M 66
Indigestion " fo r  many yea rs  ", 2 week history  of lower abdominal pain. 2 stone weight lo ss 
and palpable m ass in right upper quadrant. Barium m eal : large liv e r and displacem ent of 
stomach to left. I V P  : righ t kidney displaced downwards. Lymphogram : deposits in left 
external iliac  and left p a ra -ao rtic  nodes.
13 M - Urinary obstruction and paraplegia due to dorsal v e rteb ra l m étastasés. Radiography ; a ir  insufflation revealed adrenal tumour.
14 M 59 Abdominal swelling in  left upper quadrant fo r  1 year. Abdominal wall recu rren ce  3 |  y ea rs  postoperatively.
IB M 39 1 y ear " indigestion " and upper abdominal pain. Chest X -  Ray : lung m étastasés 2 years postoperatively.
16 F 45 Chest X - Ray : lung m étastasés seen M arch *66. Mild abdominal pain and backache. IV  P  : left kidney displaced downwards. Spleen displaced upwards.
17 F 57 Asymptomatic. Chest X -  Ray showed lung m étastasés.
18 M 50 Abdominal swelling, proptosis 3 vears postoperatively. Skull X -R a y  showed re tro -o rb ita l tumour confirmed by tomography and arteriography. C hest X -  Ray showed lung m étastasés.
19 M 14 Chest pain, m ass in right loin. Chest X - Ray : lung m étastasés. A rteriog ram  : blood supply of tum our from  aorta . . -
20 M 61 3 stone weight loss in 1 year. Left abdominal pain. Chest X -  Ray norm al.I V P  : left kidney displaced downwards. A rteriogram  ; adrenal tum our confirmed.
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in six patients, while fever was recorded only once (a child 
aged 2^ years). In each of four patients, backache and vague 
dyspepsia were also observed.
3. Radiological studies
These investigations were carried out in most but not all 
patients (Table 7.1). The intravenous pyelogram was abnormal 
in 12/13 cases and revealed either a renal deformity, a supra­
renal mass, or displacement of the kidney. The barium meal was 
abnormal in three patients and was interpreted as a primary 
gastric tumour in two cases (Cases 6 and 10). Presserai air 
insufflation and arteriography contributed to the diagnosis in . 
six cases (Cases 6,8,10,13,19 and 20). A postoperative lymphangio- 
gram (Case 12) revealed evidence suggesting left external iliac 
and para-aortic node involvement.
4. Steroid investigations
The principal investigations which were carried out are 
shown in Table 7.II. In a few instances, minimal aberration of 
cortisol metabolism may have existed but without causing overt 
clinical manifestations. In addition, increased excretion of 
the metabolites of pregnenolone, including pregn-5—ene—3°=, 16«, 
20«-triol were present in the urine of two patients (Cases 3 and 
20) .
5. Treatment
Complete excision of the tumour was achieved surgically, 
in 11 patients (Cases 1,5,10-12,14-16,18-20,). The tumours of 
3 (Cases 2,4 and 8) could only be partially removed, and in a
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Table 7. II. Therapeutic and laboratory aspects of 13 patients with
non-hormonal adrenocortical carcinoma.
C ase Postoperative radiotherapy* Postoperative chemotherapy* Laboratory te s ts
1 None M ethotrexate 10 m g /24 h rs None relevant
2 2700 r  in 35 days to tumour bed
o ,p ’-DDD 8 g /d ay  fo r  2 months. 
I^ednlsone 15 m g/day
Urinary ^ U rinary  * 
17-oxogenic^ 17-hydroxysteroids 
stero ids
135 m g/24  h rs  152 m g /2 4  h rs
60 m g /24  h rs  83 m g/24  h rs  (after
o,p'-DDD)
3 None None Blood and u rine  ste ro id s reported  slightly abnorm al
4 None None
f
Urinary 17-oxosteroids : 4 .3  m g/24  h r s
5 2740 r  in 35 days None
+
U rinary 17-oxosteroids : 7 .5  m g/24  h r s
6 P itu itary  gold rods None None relevant
7 2340 r  in 35 days ■ None None relevant
8 None None U rinary 17-oxosteroids : 40 m g /24  h rs
9 2050 r  in 21 days None
Plasm a cortiso l : (0900) 24 pg/lOO m l 
(2400) 22 pg/lOOm l 
Urinary 17-oxosteroids : 23 m g/24  h rs  
Urinary 17-hydroxysteroids : 12 m g /2 4  h rs
10
Bone m étastasés.
3900 r  in 21 days to T 9 
3500 r  In 30 days to fem ur
None
Plasm a co rtiso l : 33. 5 pg/lO O  m l 
VMA : norm al . 
U rinary 17-oxosteroids : 5 m g/24  h rs  ^ ^ 
U rinary 17-hydroxysteroids ; 5 m g/24  h rs
11
4890 r  in  52 days to the 
tum our with minimal 
cliange in its size
2nd June '71 to 11th Dec. '71 r cyclo - 
phosphamide and vincristine sulphate. 
3rd M arch '72 to 26th May '72 : 
m ethotrexate.
3rd June '72 to 4th June '72 : 5-fluoro- 
u rac il (2 doses only) and o,p'-DDD 
8 g /day .
July '72 onwards : dexamethasone 
2 m g/day .
P lasm a co rtiso l ; ^ . .
3 rd  June '71 ' 13th June '7 2 ' 
0900 47 p g /100m l 15 pg/lO O m l 
2100 37 pg/lOO m l 6 pg/lO O m l 
U rinary 17-hydroxysteroids : 16 m g /2 4  h rs
12 2808 r  in 15 days to sacro - . iliac  region. Good re lief 
of pain
None
Plasm a cortiso l : . .
25th May '72 ’ 5th June '72 ' 
am  25 pg/lO O m l 
pm  30 pg/lO O m l
U rinary 17-oxosteroids :
6 m g/24  h rs  3 .3  m g/24  h rs  
U rinary l'?-hydroxysteroids :
13 m g/24  h rs  5 m g /24  h rs
20 None None
Urinary 17-oxosteroids ; 18 m g/24  h rs  
Urinary 17-oxogenic stero ids ; 17 m g /24 h rs  
Plasm a co rtiso l : am 11 p g /1 0 0  ml 
pm 19 pg/lO O  ml 
U rinary f re e  co rtiso l : 220 p g /2 4  h rs .
• F o r  surg ical details see Table 7. IE. 
1 Postoperative resu lts
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further 3 patients (Cases 6,7 and 91 a diagnostic biopsy only 
was taken. The diagnosis was established at autopsy in 2 
patients (Cases 3 and 17), in 1 of whom a prior liver biopsy 
had revealed "metastatic tumour".
Adequate details of therapy are available only for 13 
patients (Table 7.II). Five of the patients received post­
operative radiotherapy to the tumour bed; the dose range 
utilizing megavoltage equipment was between 2040r and 4800r 
over 21 to 52 days (Table 7.II). There was no significant 
clinical change in these 5 patients with the exception of Case 
11 (vide infra). Two patients (Cases 10 and 12) received 
palliative radiotherapy for bone métastasés with relief of pain. 
One patient (Case 6) was treated by radioactive-gold pituitary 
ablation with no measurable tumour response. Four other patients 
received no radiotherapy (Table 7.II).
Four patients were treated with chemotherapeutic agents.
Two (Cases 2 and 12) .received in addition to radiotherapy, 
o,p-DDD (2-chlorophenyl)- 2 - (4-chlorophenyl)-1, Cl-dichloroethane1, 
8-lOg per day. Case 12 has shown good tumour regression in the 
positive nodes as judged by lymphangiography. Case 1 received 
methotrexate, lOrag per day, and the final patient (Case 11) was 
treated with cyclophosphamide (0.5-lmg intravenously) weekly, 
vincristine sulphate (O.Srag intravenously,) methotrexate (SOrag 
intravenously), and 5-fluorouracil (5-FU; 300mg intravenously) 
singly or in combination at various time intervals after 
completing a course of radiotherapy. After two doses of 5—FU 
she developed a duodenocolic fistula which was surgically 
repaired. No tumour remained in the treated area, and while 
recovering from surgery and without receiving further chemotherapy.
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her lung métastasés also completely disappeared radiologically.
This remission, however, was short-lived.
Three patients received neither radio-nor chemotherapy 
postoperatively and one of them (Case 4) was known to be alive 
18 years after operation,
B, RESULTS
1. Survival
Adequate data are available in 18 cases (Table 7.111) one 
of whom was an autopsy diagnosis. Six patients died within 6 
months of diagnosis. Two patients survived 7 months, one 13 
months and two, 7 years. At the end of the present survey, 
two patients were alive and well without evidence of recurrent 
disease (Case 4, 18 years; Case 20, 1 month). Four patients were 
alive but had evidence of remaining or recurrent tumour (Case 
12, 5 months; Case 14, 3% years ; Case 18, 4 years; Case 19,
6 months) .
2. Pathology
The details of the pathological features are shown in 
Table 7.III. All the tumours are large, lobular, and with cut 
surfaces which are reddish-brown in colour and show areas of recent 
and old haemorrhage and evidence of necrosis (Pig 7.1), The 
tumours have a thin capsule which may be adherent to the 
adjacent tissues. They weighed from 700-4500g and measured up 
to 40 X 33 X 25cm.
A variable histological pattern is seen not only between 
tumours but also in the same lesion. The tumour cells arranged 
in sheets, large alveoli, or cords which may radiate from the
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Table 7. ni. Pathological features of 20 patients with non-hormonal
adrenocortical carcinoma.
Case Macroscopic features
number
Size Surgery Autopsy ‘
1 lOX 7. 5 cm
Right adrenal tumour 
removed —
Cerebral haemorrhage 
Métastasés to brain 
and ribs
2 Not known
Right adrenal tumour 
infiltrating liver, aorta, 
surrounding tissues; 
partially removed
Not performed
3 16 cm diam
Needle biopsy of liver 
showed metastatic 
carcinoma. Inoperable 
left adrenal tumour seen 
at laparotomy
Invasion and obstruc­
tion of renal and 
adrenal veins and 
inferior vena cava. 
Métastasés to liver 
and kidney
4 25 X 20 cm
Partial removal of cystic 
tumour filling entire 
upper right quadrant dis­
placing stomach, duod­
enum, colon, kidney
5 "Foetalskull"
Right adrenal turn our 
removed from between 
liver and diaphragm: 
ruptured during removal
Métastasés to liver
6 "Large"
Tumour arising from left 
of liver and surrounding 
spleen: m étastasés to 
liver; inoperable
7 25X  19X  15 cm
Inoperable right adrenal 
tumour extending beyond 
capsule involving peri­
renal tissues, liver, 
lymph nodes
Métastasés to left 
kidney and 
peritoneum
1
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Histological features Histological Survival
(years)
Cell Pleomorphism degree of
Arrangement Type Cellular Nuclear malignancy
Lobulated
sheets
radiating cords
Compact Marked Marked High 2 /12
Lobulated 
sheets, cord. Compact Moderate Slight Moderate 13/12
Lobulated 
sheets, cords
Mixed 
compact 
and clear
Moderate Moderate Moderate 3 days
Lobulated 
sheets, radiat­
ing cords
Compact Slight Slight Low Alive 18
Lobulated 
sheets, few  
radiating . 
cords
Mainly 
compact; 
few clear 
cell nests
Moderate Moderate Moderate 7 /1 2
Sheets,
acini,
radiating
cords
Compact Slight Slight Low 3/12
Lobulated
sheets
\
Compact Slight Slight Moderate 3 /12
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Table 7.m .  (Continued).
Case Macroscopic features
number
Size Surgery Autopsy
8 Not loiown
Left adrenal tumour invol 
ving renal vein; removed 
except for renal vein 
extension
-Métastasés to lung, 
liver, vertebral 
bodies, and 
femur
9 11 cm diam
Inoperable tumour 
involving spleen, great 
vessels, vertebral bodies
10 20X  2ÔX 20 cm
Removal of tumour 
displacing stomach and 
pancreas
11 40X  33 X 25 cm
Right adrenal tumour 
removed
12 30 cm 4, 5 Kg
Removal of right 
adrenal tumour
13 Not known
14 27. 5X  22 X 12. 5 cm
Removal of left adrenal 
tumour adherent to 
adjacent organs. P eri­
pheral fleshy tissue: 
central necrosis
15 15X  15X  
9 cm
Left adrenal tumour 
removed with adherent 
spleen, kidney, tail of 
pancreas: capsule intact. 
Central haemorrhagic 
necrosis
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Histological features Histological Survival
(years)
Cell Pleomorphism degree of
' Arrangement Type Cellular Nuclear malignancy
Lobulated
sheets,
radiating
cords
Compact Marked Marked High 7/12
Lobulated
sheets
Mixed 
compact 
and clear
Marked Marked Moderatelyhigh 3/12
Lobulated 
sheets; few 
cords
Compact Marked Marked Moderatelyhigh 6/12
Sheets, few  
cords and 
acini
Compact Moderate Moderate Moderate 6
Sheets, radiat­
ing cords Compact Slight Slight Low Alive 5 /12
Lobulated
sheets,
radiating
cords
Spindle Marked Marked High Not known
Lobulated 
sheets, few 
cords
Compact Moderate Moderate Moderate Alive
Lobulated 
sheets, acini, 
radiating cords
Compact Slight Slight Low 6
-
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Table 7.m. (Concluded).
Case Macroscopic features
number
Size Surgery Autopsy
16 23 X 20 X 15 cm
Removal of left adrenal 
tumour. Smooth, 
encapsulated, fleshy with 
central necrosis
17 1100 g
Right adrenal tumour 
invading inferior 
vena cava: m étastasés 
to lung
18 19X  17X  9 cm
Removal of lobulated 
tumour of left adrenal: 
left lobectomy for lung 
métastasés
19 18 X 15X  13 cm 
1520 g
Removal of right, well- 
encapsulated adrenal 
tumour adherent to liver 
and invading adrenal vein
20 12 cm diam 700 g
Removal of left adrenal 
tumour with adherent 
kidney and spleen t
2 6 2
Histological features Histological Survival
(years) 1
Cell Pleomorphism degree of
Arrangement Type Cellular Nuclear
malignancy
Lobulated 
sheets, 
radiating 
cords, acini
Mainly 
compact: 
nests of 
clear cell
Slight
8
Slight Low Not known
Lobulated 
sheets, few  
radiating 
cords, acini
Mainly 
compact: 
few clear 
cells
Moder­
ately
severe
Moder­
ately
severe
Moderate Autopsydiagnosis
Trabeculated
sheets,
radiating
cords
Mixed 
compact 
and clear
Moderate Moderate Moderate Alive 4
Lobulated
sheets
radiating
cords
Compact Slight Slight Low Alive 6 /1 2
Lobulated 
, sheets
Mixed 
compact 
and clear
Marked Marked High Alive 1 /1 2
—  z  b  J —
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Fiq. 7.1. Colour photograph showing the cut surface of 
an adrenocortical carcinoma from case number 20. This 
12 cm. tumour weighed 700g. Areas of haemorrhage and 
necrosis can be seen clearly. (Magnification X 0.83)
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numerous thin-walled vascular sinusoids (Figs. 7.2 & 7.3) can 
vary in size from normal to large bizarre forms, but are 
generally polygonal with abundant eosinophilic lipid-poor 
cytoplasm,and resemble the cytoplasmic features of "compact 
cells" seen in the zona reticularis of the normal adrenal gland. 
Small groups of lipid-laden clear cells are also seen occasionally.
The nuclei are usually large, single, and vesicular with
one or more prominent nucleoli (Fig.7.3); giant bizarre or
multinucleate forms are not uncommon. Nuclear and cytoplasmic
pleomorphism may be marked in some tumours and slight in others.
Several tumours exhibit different degrees of pleomorphism in
adjacent parts (Fig. 7,4). Mitotic activity varies from 3 
HP
per field to less than 1 per 10 HP field.
We used those histological features - cellular and nuclear 
pleomorphism, nuclear vesicularity and mitotic activity — of 
proven value in assessing the malignant potential of endocrine 
tumours (Neville & Symington, 1967; Symington, 19691 and graded 
the present series of tumours into those of high, moderate or 
low malignancy. Those classified as highly malignant died within 
7 months, those of moderate malignancy between 1 month and 5 years, 
while those of low malignancy survived up to 18 years postoperat­
ively, although one died within 3 months (Table 7.111), Thus, 
as a general rule, using those criteria, the higher the grade 
of histological malignancy, the shorter the survival (but 
exceptions exist).
The adrenal cortex attached or contralateral to the tumour 
was available for study from only four patients (Cases 5,8,10 
and 17). The appearances were within normal limits (Fig. 7.5) 
in both cases (Cases ID and 17) where the gland was not compressed.
Zbb'
Fig. 7.2. Photomicrograph of adrenocortical carcinoma 
showing cords of tumour cells radiating out from a central 
vascular sinusoid. (H & E X 380)
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Fig. 7.3. Photomicrograph of adrenocortical carcinoma 
showing general arrangement of cells forming large alveolar 
structures. The nuclei are large and vesicular with a 
prominent nucleolus. (H & E X 380)
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Fig. 7.3.

Fig. 7.4. Photomicrograph of adrenocortical carcinoma 
showing different degrees of cellular and nuclear pleo­
morphism in adjacent fields. The upper right segment 
contains small, rounded, fairly uniform cells in contrast 
to the lower left field where the cells are variable, some 
being very large and bizarre. (H & E X 380)
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Fig. 7.5. Photomicrograph showing uninvolved adrenal 
cortex attached to the tumour in Case 10. The clear and 
compact zones, and the zona glomerulosa are present in the 
normal proportions, (H & E X 285)
— z  /  z  —
Fig. 7.5
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Evidence of tumour spread was noted in many cases.
Two of the tumours directly invaded local structures, and in 
six, there was extension along the central adrenal or renal 
veins, or involvement of the inferior vena cava or aorta 
(Table 7. Ill). The local lymph nodes were involved in only 
two cases (Table 7.Ill); distant métastasés were observed 
initially or developed in 14 patients, the commonest sites 
being liver (6 cases), bones (6 cases), lung (5 cases), and 
brain (2 cases).
C. DISCUSSION
One hundred and fifty-eight cases with non-hormonal adreno­
cortical carcinomas have been collected from the literature 
(See References; articles marked with "R") and are now reviewed 
together with the present series, making a total of 178 examples. 
This tumour, thus, is extremely rare, an observation which is 
further demonstrated by the fact that members of our department 
have personally seen and reviewed during the past 12 years the 
pathology of 112 adrenal tumours causing hypercorticalism 
(Neville & Mackay, 1972; Neville & Symington, 1966, 1967; Symington, 
1969).
1. Age, sex, incidence and location of tumours
In 133 of the 178 patients, age data are known and are 
shown in Fig. 7.6 and Table 7.IV. There appear to be two 
distributions, one between 0-10 years and the other between the 
5th and 7th decades (Fig. 7.6) (Craig & Landing, 19 51; Sherman, 
et a l . , 1 9 5  8).

Fig. 7.6. Age and sex distribution of 133 patients with 
non-hormonal adrenocortical carcinoma described in the 
literature and in the present series.
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Table 7, IV. Sex distribution and incidence of presenting signs and 
symptoms of 172 patients with non-hormonal adrenocortical 
carcinoma described in the literature.
— Literature
Present
series
Total
Male 100 11 111
Sex distribution Female 52 9 61
No information 6 6
Pain 49 11 60
Mass 68 11 79
Signs and symptoms
W eakness/anorexia 38 9 47
Fever 24 1 25
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Males are affected more often than females [Table 7 -IV),
In 89 of the cases in the literature in which the site is 
stated, the left adrenal was involved in 55 and right in 30.
In the remaining 4, tumour involved both adrenal glands. It is 
not known if these represent separate primary tumours or whether 
one is a metastasis of the other.
2. Signs and symptoms
Table 7.IV records the four commonest presenting signs
and symptoms. In their discussions; Wood et al. (1957), Lipsett
et al . (1963), and Heinbecker et al. (1957) stated that the
clinical onset was insidious and it may be months and sometimes
years before a diagnosis is made, by which time a mass is palpable
or the pain is severe, A left—sided tumour may mimic a gastric
ulcer or tumour; gastro-intestinal bleeding was a presented
symptom in six cases. The lack of early symptoms allows the
tumour to remain undetected. Therefore, patients may present
such
initially in bizarre fashions as simulating the Budd-Chiari syndrome 
(Dupuy et al., 1964) with a right adrenal tumour, acute perforated 
appendicitis resulting from a metastasis (Grendahl, 1958)^ visual 
problems due to a secondary deposit in the retinal choroid 
(Francios et al., 1952), or pelvic complaints due to vaginal 
métastasés (Hirsh-Hoffman, 19 28).
Fever was a feature in all cases described by Wood et al.
(19 57) but in only 16 other cases in the literature. In our 
series, only one case, a child of 2^ years, had a fever. Its 
significance is obscure; fever may decline immediately after 
surgical removal of the tumour (Weiss et al., 19 70) and has been 
related to the presence of marked tumour necrosis (Vandergrind et al 
1964; Weiss et al., 1970; Wood et al., 1957).
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3. Diagnostic radiological studies
The most valuable diagnostic radiological test is the 
intravenous pyelogram; 22 out of 24 carried out by other workers 
and 12 out of 13 in our series being positive, and therefore 
should be the first study performed if the diagnosis is suspected. 
Arteriography is helpful in outlining its vascular supply and may 
detect involvement of the contralateral gland. Presserai air 
insufflation can outline the mass more clearly but gives no 
further information as to its nature.
Due to the rarity of this type of tumour, the role of 
lymphangiography remains to be established. The adrenal gland 
is rich in lymphatics which drain to the para-aortic nodes 
(Ackerman & Del Regato, 19 70). Following adequate surgery a 
lymphangiogram may not only detect occult disease in the lymph 
node chains but may also provide a visual guideline for further 
radio- or chemotherapy.
4. Pathology
The tumours of the present series have macroscopic appear­
ances similar to those of most functioning adrenocortical carcinomas 
described in the literature (Mackay, 1969; Neville and Mackay,
19 72; Neville & Symington, 1966,1967; Symington, 1969) but are 
generally much larger, probably because they do not produce clinical 
symptoms at an early stage. The predominant cell is compact in 
type, a feature not emphasized by other authors. Indeed most 
tumours described in the literature have been purported to have 
had more clear than compact cells, a feature which is at variance 
with our experience of all other large adrenal tumours which cause 
hypercorticalism with the exception of those causing hyperaldo­
steronism. A possible reason for the cytoplasmic differences is
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discussed later.
Some authors (Heinbecker et al., 1957; Huvos et al., 1970; 
Birke et al., 1959) have suggested that non-hormonal tumours have 
peculiar features not shared by functioning tumours. We failed 
to detect any single histological feature, or group of features, 
which enabled definitive histological assessment of the 
functional capacity of those adrenocortical carcinomas, and their 
differentiation from other compact cell carcinomas causing 
hypercorticalism. However, examination of the attached or 
contralateral cortex will give some clue as to the secretory 
potential of a tumour causing Cushing's syndrome when it shows 
cortisol-induced atrophy (Neville & Symington, 1966) or Conn's 
syndrome when the zona glomerulosa is hyperplastic in association 
with a gland of normal width (Neville & Syminton 1967). While 
the presence of distinct tumour spread, e.g. to the lymph nodes 
or kidney, is pathognomonic of a malignant tumour, such criteria 
may not be present at the time of initial treatment. Consequently, 
reliance has to be placed upon the gross pathology and morphology.
It seems that the largest tumours in this series are 
associated with a better prognosis (Cases 4,11,14,15 and 18)
(Table 7,11). However, this criterion is not a reliable guide 
to management as is shown by Cases 7 and 10 (Table 7.Ill) who died 
within 6 months with large tumours. The histological features 
of capsular invasion or tumour cells in vascular spaces are also 
quite independent of the potential behaviour of the tumour and 
reaffirm previous conclusions that these criteria occur with 
benign and malignant tumours (Neville & Mackay, 19 72; Neville & 
Symington 1967; Symington, 1969). While other features, such as 
nuclear pleomorphism and vesicularity, which have proved of value
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in other studies of endocrine tumours, did give some indication 
of the "Malignant" potential, such criteria were by no means 
absolute. Consequently, all such tumours are best viewed as 
as carcinomas and the patient followed accordingly at frequent 
intervals when suitable steroids assays should be conducted 
(vide infra) .
5. Métastasés
Inadequate data with regard to sites of métastasés are 
recorded in the literature. In his series of 55 examples of 
"functioning" and "non-functioning" tumours, Macfarlane (1958) 
reported a 31 percent overall incidence of ' "
local invasion with local lymph node involvement in 44 percent 
and métastasés to the liver in 68 per cent, lungs in 47 per cent, 
and bones in 18 per cent. In our series, the local lymph nodes 
were involved in 10 per cent of patients, and osseous métastasés 
(30 per cent) were as frequent as those in liver. We found two 
cases (Cases 1 and 18) of verified brain lesions; five other cases 
were found in the literature (Ansari & Shafer, 1971; Demaret 
et al., 1968; Francios et al., 1952; Horn, 1956; Sherman et al., 
1958). Previous authors (Hotter & Kayhoe, 1966; Huvos et al., 1970; 
Lipsett et a 1., 1963) have stated that cerebral métastasés were 
extremely rare.
6. Steroid assays
Non-hormonal adrenocortical carcinomas are not without 
steroidogenic activity. Rather, they are incapable of forming 
excess active hormones, such as cortisol, aldosterone, androgens, 
or oestrogens.
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The work of F-ukushima and Gallagher (1963) has shown that 
so-called "non-functioning" tumours can form pregnenolone, and 
that its metabolites occur in the urine in the form of pregn-5- 
ene-33/ 20«:-diol and pregnane-3 = ,20=-diol. More recent work by 
Fantl et al. (19 73) has confirmed and extended this to show that
16=-hydroxylated metabolites of pregnenolone may also occur in 
the urine. The tumours of Cases 3 and 20 were found to have this 
secretory pattern. Thus, some of these tumours, appear to have 
enzymatic defects involving the 5A-33-hydroxysteroid dehydro- 
genase-isomerase systems and possibly the 17<=c-hydroxylase, which 
account for failure of pregnenolone utilization (Fig. 7.7). 
Enzymatic defects could also account for the presence of clear 
cells in some tumours (vide supra). If there is a deficiency of 
the C20:22 desmolase system, cholesterol utilization will be 
prevented and with its esters, it will accumulate in the cytoplasm 
and give the tumour cells a lipid-laden clear appearance. This 
is the cause-of the appearance of the adrenal in congenital lipoid 
hyperplasia, a rare form of the adrenogenital syndrome (Prader 
& Siebenmann, 1957).
Therefore in the follow-up of patients treated for adreno­
cortical carcinomas, without overt function, it is essential that 
the urinary metabolites of pregnenolone are studied and used 
as tumour index substances to gauge the clinical status of the 
patient rather than the typical adrenal steroid products.
7. Treatment
The primary role of treatment remains surgery, which was 
carried out on 57 out of 65 patients recorded in the liaterature.
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Fig. 7.7. Schematic representation of main steroidogenic 
pathways. Recommended systematic nomenclature of steroids 
and enzymes is given in Appendices I and II,
— 28 3—
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Fig. 7.7. Steroid biosynthetic pathways.
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While others [Lipsett et al.. 19631 claim that this tumour is 
radioresistant, we found that high doses of external irradia­
tion may be beneficial [Cases 10-12). In our hands, a response 
to radiotherapy indicates that the tumour may also respond to 
ch emo therapy.
Hutter and Kayhoe (1966a&b) and Bergenstal et al. [I960) 
have described the oral administration of o,ÿ-pDp for the treat­
ment of adrenocortical carcinomas with prednisone being given 
concomitantly if signs of adrenal insufficiency are suspected. 
Gastro-intestinal toxic manifestations (diarrhoea, nausea, and 
vomiting) develop in 83 per cent of patients, neurological 
symptoms (somnolence and lethargy) in 41 per cent and skin rashes 
in 14 per cent. Other effects such as dizziness, muscle tremor, 
headache, confusion, and weakness have also been noted. The 
control of these symptoms is achieved by reducing the total dose 
or by giving the drug intermittently.
Because responses to o,p--DDD occur slowly, treatment should 
be continued for at least 8 weeks provided the side effects are 
not too severe. The dramatic but short lasting response to 
combination chemotherapy in addition to radiotherapy in one 
patient (Case 11) suggests that this form of therapy may be more 
effective than o,p-DDD alone.
In view of these findings, it seems worthwhile to propose 
that treatment might be attempted in a manner similar to that 
employed for other highly malignant tumours, namely surgery, 
radiotherapy and combination chemotherapy.
8. Prognosis
This tumour carries a poor prognosis. Of 61 patients on 
whom sumrival data are available, 42 were dead within J year.
and of those 24 died within the first 2 months. No correlation 
was found between age at diagnosis or sex and the survival. The 
only long term (18 years), survivor in the literature is present­
ed in the series.
9. Conclusion
For non-hormonal adrenocortical tumours surgery remains 
the treatment of choice, with radical excision whenever feasible, 
even if this necessitates the removal of adjacent adherent organs, 
e.g. kidney, or spleen. Intravenous pyelography and arteriography 
are the best aids to diagnosis. The functional capacity of these 
tumours must be assessed before surgery, and we recommend that 
the following should be measured: (A) 24 hours urinary 17-hydroxy-
and 17-oxosteroids and steroid metabolites of pregnenolone;
(B) morning and evening plasma cortisol levels; (C) response to 
ACTH stimulation and (D) dexamethasone suppression.
Postoperatively, the presence of lymph node involvement 
may be assessed by lymphangiography. We have found radiotherapy 
to be useful in the treatment of residual tumour and métastasés. 
While chemotherapy with o,p^DDD is of limited value, a combination 
of other chemotherapeutic agents may give more beneficial results. 
The course of the disease should be monitored by serial urinary 
steroid metabolite studies.
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SECTION III : GENERAL DISCUSSION AND SUMMARY
CHAPTER 8
GENERAL CONCLUSIONS ON FUNCTIONAL AND
MORPHOLOGICAL CORRELATIONS
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CHAFTER 8
GENERAL CONCLUSIONS ON 
FUNCTIONAL AND MORPHOLOGICAL CORRELATIONS
The general theme of this thesis has been the correlation 
between function and morphology in normal and neoplastic tissues. 
Morphological changes have been examined at histological and 
cytological levels. These morphological changes are well known, 
and in most cases a functional interpretation has been made 
although not fully ratified by experimental proof-
Jost (1953) in his review of his pioneering work on the 
function of the mammalian foetal testis clearly demonstrated that 
this organ functions in utero, and is required for normal sexual 
development of the male foetus. This functional activity coincides 
with the morphological appearance of the interstitial cells of 
Leydig which are known to produce androgens in the adult testis.
The foetal testis also secretes androgens [Winter et al., 1977) 
which are required for normal-development of the male genital 
ducts (Jost, 1953). The Mullerian inhibitory factor (MIF) is 
also synthesised and released by the foetal testis, and production 
of this compound occurs at a time when Sertoli cells and Leydig 
cells are both present. The morphological basis of MIF production 
is not yet certain. la it produced by Sertoli cells. Leydig cells, 
both or neither? Morphological studies alone cannot answer 
this question.
The histochemical studies of Baillie and his co-workers 
(See Chapter 1) have shown that steroidogenic enzymes are present 
when MIF is produced.
-288-
However, the substrate specificity of these enzymes changes 
during the period of sex duct differentiation although this 
functional change is not reflected in definite morphological 
alterations in the steroid-producing cells of the testis. 
Therefore, the steroidogenic activity of Leydig cells cannot 
be assessed morphologically.
The Sertoli cells of adult testes produce an androgen 
binding protein (ABP) which binds testicular androgens before 
they reach the circulation. MIF is not a steroid in free form 
and at least part of it is a protein, probably produced by the 
foetal Sertoli cells (Josso et al., 1977), If this protein is 
similar (or identical) to ABP then it is logical to assume that 
MIF is a protein requiring the addition of a steroid molecule 
before it is biologically active. If so, is this steroid 
progesterone?
On theoretical grounds, progesterone seems to be a likely 
candidate (See Chapter 1). This thesis has demonstrated experi­
mentally that progesterone has a deleterious effect on the 
Mullerian duct in organ culture although this effect has not been 
proved to be specific. The in vitro assay system used for 
detecting MIF is a bioassay with a morphological end-point 
(PicOn, 1969). Jost (1953) has already described the pitfalls 
of such a system when he demonstrated that DOCA dissolved in olive 
oil containing benzyl alcohol caused regression of the Mullerian 
duct. The initial conclusion that DOCA was MIF had to be dis­
counted when the Mullerian inhibitory effect was found to be due 
to the olive oil/benzyl alcohol solvent system used.
The morphological end-point of this bioassay is therefore 
non-specific thus accentuating the difficulties of making a 
direct functional interpretation of morphological changes.
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Non-specific regression of the Mullerian duct also occurs in 
response to certain prostaglandins (Josso, 1974a), and the 
experiments presented in this thesis demonstrate that 1% ethanol 
also results in non-specific Mullerian duct inhibition as a 
result of generalised cytoxicity.
Progesterone causes Mullerian duct regression in organ 
culture, but how specific is this effect? Is this another 
example of non-specific cytoxicity; or an example of one bio­
logical substance mimicking the,effect of another; or is it a 
reflection of a physiological process indicating that progesterone 
acts on the Mullerian duct in vivo? Clearly, the bioassay system 
used is not sufficiently specific to answer those questions, and 
more evidence must be accumulated before a physiological role 
for progesterone in this context can be assumed.
Further evidence for a possible physiological role of 
progesterone came from the monolayer culture experiments described 
in this thesis. Foetal rat testes in monolayer culture produce and 
secrete progesterone, and this activity is stimulated by cAMP, 
Does this indicate a biological role of foetal testicular 
progesterone ?
Monolayer cultures of human adult and prepubertal testes 
produce progesterone (O'Hare et al., 1976a) as do monolayer cultures 
of adult rat testes (Khatim & O'Hare, 1976). Testes from patients 
with testicular féminisation also produce progesterone in mono­
layer culture (Grigor, Bullman & O'Hare, unpublished observation; 
vide supra). Shin (1967) demonstrated that a monolayer culture 
derived from an interstitial cell tumour produces progesterone 
in vitro, and Channing (Channing, 1969a&b; Channing & Grieves,1969) 
described "spontaneous luteinization" of ovarian granulosa cells 
in culture, a process whereby the cells in vitro lose the ability 
to secrete oestrogens and they secrete progesterone instead.
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Some steroid-producing cells continue to produce androgens 
in vitro as O'Hare et al■ (1976a) demonstrated using adult human 
adrenocortical cells, but there seems to be a general tendency 
for "spontaneous luteinization" of testicular and ovarian steroido­
genic cells in tissue culture (O'Hare et al., in press). This 
tendency casts doubts on the physiological significance of 
progesterone secretion by foetal rat testicular cells in the 
monolayer cultures described in this thesis. Do rat testes secrete 
progesterone in vivo, or is there a process of "spontaneous 
luteinization" of these cells once they are in tissue culture?
Monolayer cultures of endocrine glands are useful in the 
determination of the exact cellular environment required for 
normal synthetic activity. Adrenocortical cells in monolayer 
culture may function normally, but cell-to—cell relationships 
and the presence of ACTH are important factors in the maintainence 
of normal function [O'Hare et al., 19781. Testicular steroido­
genic cells are more demanding in their requirements, and culture 
methods employed at the present time predispose to a diminution in 
testosterone production and a loss in responsiveness to HCG.
Foetal rat testicular cells produce progesterone for a short 
time in non-stimulated monolayer cultures. Reactivation of 
steroidogenesis in vitro by cAMP results in progesterone secretion 
before testosterone output is detected. Foetal rat genital tracts 
in organ culture respond to progesterone which causes Mullerian 
duct regression. These three facts have been demonstrated 
emperimentally for the first time in this thesis, and point to a 
possible role of progesterone in ths physiological inhibition of 
the Mullerian ducts in the male foetal genital tracts. However, 
definite proof is still lacking.
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Progesterone may be involved in Mullerian inhibition 
in vivo, and if so, probably does not act alone. It is more 
likely to be transported from the foetal testis to the adjacent 
genital tract by a carrier protein similar to the androgen 
binding protein produced by the adult testicular Sertoli cells. 
Morphological studies alone cannot resolve this question, and 
further functional studies are required, before a stronger claim 
for the role of progesterone can be made,
O'Hare et al. (1978) stressed the importance of cell-to-cell
relationships and cellular contact in the control of steroido­
genesis in adrenocortical cells in monolayer culture. The cell 
density and the presence of ACTH in the culture medium are 
important: the presence of ACTH enhances steroid 17 hydroxylation 
whereas increasing cell density stimulates 11 g-hydroxylase 
acbivity. Having established the functional properties of normal 
adrenocortical cells in monolayer culture, O'Hare and his co­
workers examined cultures of neoplastic cells and determined their 
functional divergence from non-neoplastic cells. The functional 
differences between normal and neoplastic cells in culture were 
correlated with their morphological differences in histological 
sections. The importance of correlating morphology with function 
in the human adrenal cortex lies in the differentiation of 
neoplastic and non-neoplastic swellings, and in neoplastic 
conditions it is important to differentiate between benign and 
malignant growths.
Non-neoplastic discrete masses in the adrenal cortex are 
usually indicative of nodular hyperplasia, and this may be 
associated with Cushing's syndrome if there is excessive trophic 
stimulation causing increased glucocorticoid secretion.
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Hyperplastic nodules are usually multiple although their 
multiplicity is not always readily apparent. Macroscopically 
and histologically an apparently solitary hyperplastic nodule 
and an adrenocortical neoplasm may appear very similar (Neville 
& O'Hare, 1978; Neville & Symington, 1967). In Cushing's syndrome, 
therefore, a functional interpretation of the morphological 
features of the attached adrenal cortex is useful in the 
differential diagnosis. If the attached cortex is hyperplastic, 
the lump is a nodule (Neville, 1978). If the attached cortex is 
atrophic, the lump is a neoplasm (Neville, 1969). The difference 
is due to the autonomy of the neoplasm.
Neoplasms of the adrenal cortex show varying degrees of 
autonomy and responsiveness to trophic stimulation. Being 
autonomous, excessive steroid production occurs causing inhibition 
of the hypothalamus and pituitary, therefore there are low levels 
of circulating ACTH. This results in atrophy of the uninvolved 
adrenal cortex. The autonomous functional activity of adreno­
cortical neoplasms in vivo is reflected by their activity in 
monolayer culture, and it is found that in vitro activity closely 
resembles in vivo activity. There are differences between benign 
and malignant neoplasms in vivo, and these differences can also 
be examined in vitro.
Adrenocortical adenomas are diagnosed early when they are 
still small tumours because their autonomous production of active 
steroid hormones cause early clinical symptoms. In tissue 
culture, their autonomy is retained; however, they also respond 
to ACTH which stimulates increased steroid output (O'Hare et al., 
1978). Adrenocortical carcinomas differ from adenomas in mono­
layer culture in that an abnormal profile of steroids is produced, 
and steroid output per cell is reduced.
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In addition/ they show no response to ACTH stimulation 
(O'Hare et al., 1978). This has clinical significance because 
clinical symptoms are less severe resulting in delayed diagnosis. 
Therefore/ malignant neoplasms are usually larger and more 
advanced at the time of diagnosis.
The differences between benign and malignant neoplasms in 
tissue culture may have practical importance in the diagnosis 
of malignancy because the histological criteria of malignancy in 
adrenocortical neoplasms are ill-defined (Symington/ 1969).
It may be that all adrenocortical tumours should be examined 
in tissue culture in order to differentiate between benign and 
malignant growths.
The functional activity of adrenocortical neoplasms is 
reflected in the morphology of the adjacent uninvolved gland.
An atrophic gland, as already discussed, indicates autonomous 
production of glucocorticoids by the neoplasm and this may be 
associated with Cushing's syndrome. In Conn's syndrome (hyper- 
aldosteronism with a low plasma renin), a rather paradoxical 
situation occurs. The usual presentation is hypertension, and 
the majority of cases is due to an adrenocortical adenoma with 
characteristic macroscopic and histological appearances (Neville, 
1978; Neville & Symington, 1966). Rarely, malignant aldosterone- 
producing tumours of zona glomerulosa cells are encountered, and 
these have a definite histological appearance (Neville & Mackay, 
19 72; Neville & Symington, 1966) and are readily differentiated 
from their benign counterparts. The paradox is seen on examina­
tion of the adjacent adrenal cortex. These tumours - benign or 
malignant - have been shown to produce aldosterone (Brode et al., 
1962). Although in monolayer culture aldosterone output is not
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sustained (Neville & O'Hare, 19781, yet the adjacent cortex 
usually shows hyperplasia of the zona glomerulosa (Neville 
& Mackay, 19 72; Neville & Symington, 1965) the normal site of 
aldosterone production.
Hypersecretion of aldosterone should be expected to 
suppress the zona glomerulosa. Xs it possible that these tumours 
produce an adrenal glomerulosa trophic hormone (AGTH) in addition 
to aldosterone? Alternatively, the zona glomerulosa may be under 
constant stimulation due to abnormal production of an AGTH from 
another source, and after excessive stimulation part of the 
hyperplastic zone may have undergone neoplastic transformation. 
Such conjecture is outwith the scope of this thesis. Suffice it 
to say that aldosterone-producing tumours are usually associated 
with specific morphological changes in the adjacent adrenal 
cortex, and in many cases a preoperative distinction between 
neoplasia and hyperplasia may be made (Ferriss et al., 19701,
Some adrenocortical tumours are associated with a normal — 
looking adjacent adrenal cortex. This situation arises when the 
tumour produces sex steroids (Adreno-genital syndrome: Neville, 
1969; Symington, 1969) which do not suppress ACTH release; or 
when the tumour produces very little, or no, hormonally active 
steroids. The adrenocortical tumours described in this thesis are 
of the non-hormonal variety. Non-hormonal tumours deviate from 
normal to a greater extent than hormone-secreting tumours. 
Therefore, being more dedifferentiated, they would be expected 
to have a greater tendency to be malignant, and also would be 
expected to present late when the tumours have reached a large 
size. The tumours presented in this thesis verify these expect­
ations. The functional capacity of the tumour themselves cannot 
be assessed on tumour morphology alone, however, the large size
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of the tumours and the lack of trophic changes in the adjacent 
gland indicate a low secretion rate of active hormones.
"Non-hormonal" does not mean "Non-functional". Many tumours 
which cause no apparent hormonal imbalance have been shown 
in vivo and in vitro to be associated with production of abnormal 
steroids. Therefore, an assessment of function requires serum 
or urine steroid analysis in the tumour-bearing patient. Ideally, 
the excised tumour should be extracted for steroid content, and 
steroidogenic activity in tissue culture should be assessed if 
possible. These methods are required to make a diagnosis of a 
truly non-hormonal or non-functional tumour. These functional 
studies have a definite role to play in the management of the 
patient. Once the profile of steroid secretion has been established, 
the subsequent course of the tumour can be monitored serologically 
by measuring the steroids known to be produced by the tumour.
Functional studies are also important in the choice of 
chemotherapeutic agents. The drug o,p'-DDD has been used in the 
treatment of patients with adrenocortical carcinomas (Bergenstal 
et al., 1960; Hutter & Kayhoe, 1956; Molnar et a l .,1963) The 
cytotoxic action of this drug is not fully understood but it 
probably interferes with the conversion of cholesterol to 
pregnenolone, and with llg-hydroxylation of 11 deoxycortisol 
(Hoffman & Mattox, 1972). If its mode of action depends on 
steroidogenic activity in the target cells, a truly non-functioning 
tumour will be resistant to its cytotoxic effects. Since this 
drug is unpleasant to take (Hoffman & Mattox, 1972) an assessment 
of tumour steroidogenic activity should be made before subject­
ing the patient to unnecessary misery.
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Carcinomas of the adrenal cortex illustrate the difficulty 
in correlating morphology with function. The appearance of the 
adjacent gland gives a clue to the functional capacity of the 
tumour, but the morphology of the tumour alone gives no indi­
cation of its steroidogenic potential. Assessment of malignancy 
is difficult. Monolayer cultures of adrenocortical tumours 
give a good indication of in vivo activity and in this respect 
such cultures are more representative than the tissue culture 
of foetal testes and genital ducts. Functional studies are 
important in the examination of patients with adrenocortical 
tumours, and tissue culture studies are also of potential value 
in the assessment and management of these cases.
Patients with germ cell tumours may also benefit from 
functional studies. This is demonstrated by the functional aspects 
of germ cell tumours presented in this thesis paying particular 
attention to production of AFP by teratomas.
There is a strong correlation between morphology and 
function of teratomas in that AFP production is often associated 
with the appearance of yolk-sac elements in the tumour. The 
histogenetic basis for production of AFP by yolk sac tumours 
has been presented, and the lack of absolute and exclusive 
correlation between AFP and yolk sac elements has been discussed.
In this part of the thesis, the possible effect of AFP production 
on the clinical course of the disease will be considered.
Tumours producing AFP tend to run a more malignant course 
than non-AFP-producing tumours. Production of HCG also appears 
to be a poor prognostic sign. Are the tumour cells which produce 
AFP or HCG more malignant than the tumour cells without this 
synthetic capacity, or do these secretory products have properties
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which enhance tumour progression at the expense of the host?
Perhaps both these possibilities are true.
HCG is normally produced by the syncytiotrophoblast, a 
cell which has the capacity to invade blood vessels. If HCG 
production by a tumour indicates the presence of syncytio- 
trophoblasts, then early blood vessel invasion and haematogenous 
dissemination of tumour is to be expected. Similarly, if AFP 
production is an indication of yolk sac differentiation then 
the tumour will be expected to have a poor prognosis because of 
the known highly malignant nature of yolk sac tumours as described 
by Beilby (Beilby & Todd, 1974; Beilby & Parkinson, 1975) in 
ovarian tumours.
Many tumours produce HCG even when there is no histological 
evidence of trophoblastic differentiation (Braunstein et al., 1973b; 
Gailani et al., 1976), therefore HCG production by testicular 
tumours need not indicate trophoblastic elements. McManus et a l . 
(1976) also described HCG production by many different types of 
tumours and suggests that the synthesis of HCG enhanced tumour 
growth by inhibition of host immunological defence mechanisms.
They concluded that the normal presence of HCG in syncyttotropho- 
blasts may prevent immunological rejection of the foetus and 
placenta because in vitro studies have shown that HCG is immuno­
suppressive by preventing lymphocyte transformation [Adcock et al., 
1973; Beling & Weksler, 1974; Contractor & Davies, 1973; Han,
1974; Kaye & Jones, 1971). The cellular localisation of HCG 
may also be important. Hormones are usually stored within 
secretory granules in the cytoplasm of endocrine cells. However, 
HCG is exceptional in that it is not only stored in secretory 
granules, but is also present on the cell surface of syncytio- 
trophoblasts (Kawarai & Nakane, 1970; Mason et al., 1969; Nakane,
1971; Jenkins et a l ., 1 9 7 2 ),
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It may also be situated on the surface of malignant tumour 
cells (McManus et al., 19761. This surface localisation may 
protect the placenta and malignant tumours from immunological 
attack by the host. If so, the presence of HCG production will 
facilitate tumour progression.
The possible role of AFP in enhancing tumour growth may 
be considered in the light of the suspected biological properties 
of this glycoprotein. AFP has been shown to have immunosuppressive 
properties affecting cell-mediated responses and antibody form­
ation due primary to its interaction with T cells (Dattwyler 
et al., 1976; Goeben & Thompson, 1976; Tomasi, 1977; Zimmerman 
eb al., 1977). Rat and mouse AFP, and a small proportion of 
human AFP, bind oestrogens (Tomasi, 1977) and this results in 
inhibition of oestrogen metabolism (Aussel & Masseyeff, 1976).
AFP is also though to have a regulatory effect on cell prolifer­
ation and growth (Tomasi, 1977). The immunosuppressive effect 
of AFP and its regulatory effect on cell kinetics are related 
to its oestrogen binding (Keller et al., 1966; Tomasi, 19771 and 
its immunosuppressive properties are dependent on the presence 
of sialic acid residues (Zimmerman et al., 1977).
Does the immunosuppressive effect of AFP have physiological 
and biological importance? There is non-specific depression of 
immunological reactions in the foetus and newborn, during pregnancy, 
in some hepatic disorders, and in some malignant diseases.
Tomasi (1977) and Dattwyler et al.(1976) suggest that this effect 
is mediated by AFP. Tomasi (19,77) also states that in some 
cancer-prone families, circulating cells of the lymphoid series 
contain surface AFP although the serum AFP is not elevated.
Similar AFP-coated cells are found in some patients with lymphoma.
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The iramunosuppresaîve potential of AFP has not gained 
universal acceptance, and at present the exact biological role 
of AFP has not been fully established (Sell, 1976). Weller 
(1976), however, has demonstrated that AFP is required for the 
survival of chick embryos because antibody to chick AFP causes 
mortality in the great majority of cases. Sell et al. (1976) 
tried to demonstrate a similar toxic effect of anti-AFP anti­
bodies on AFP-producing rat tumours. Although some of the tumours 
showed slight suppression of growth, the majority of tumours 
were unaffected.
The biological properties of AFP may be important in the 
survival and progression of AFP-producing tumours. However, 
these biological properties are not yet fully elucidated and it 
has been shown in this thesis that the adverse prognostic effect 
of AFP production by teratomas is not great. It has also been 
shown that there is not a direct correlation between AFP 
production and the presence of yolk sac elements just as HCG 
production does not necessarily imply trophoblastic differentiation. 
The importance of AFP production lies in the fact that it can 
be measured readily in the serum of patients with germ cell 
tumours, and in many cases it serves as an excellent tumour 
marker. Morphological and functional studies are therefore 
complimentary in the management of germ cell tumours and both are 
important in the proper assessment of afflicted patients.
In every aspect of this thesis, it has been shown that 
morphological studies are incomplete by themselves-, and inter­
pretation requires adequate functional studies for verification.
All viable cells are functional. All normal somatic cells 
in an organism have the genetic capacity of performing all the 
cellular functions of that organism.
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Cells which produce substances for "export" may be exocrine, 
endocrine or paracrine and these produce effects on the host 
which may be localised or generalised. These effects are 
essential for the normal integrated existence of the organism 
as a whole. The particular function of a certain cell depends 
on differentiation due to gene inactivation, and this differen­
tiation is dependent on cellular environment and cell-to-cell 
contacts. Cellular organisation into specific tissues and organs 
results in morphologically identifiable structures with; known 
functional capacities.
In disease, normal morphological and functional correlations 
axe often defective. Tumours become dedifferentiated and genes 
become derepressed- Morphological appearances are abnormal 
and cellular functions are altered due to loss of some special­
ised properties, and reactivation of others. Adrenocortical 
tumours produce abnormal steroid products with varying mani­
festations. Paradoxically, the more abnormal the process of 
steroidogenesis, the longer the delay in diagnosis because of 
the prolonged period of latent growth without systemic upsets.
Germ cell tumours often regain the capacity to produce foetal or 
trophoblastic compounds and these compounds may give the tumour 
an advantage over the host cells resulting in tumour progression 
at the expense of normal tissue.
Function in relation to cellular contacts and cell-to-cell 
integration can be examined in tissue culture. In this respect, 
monolayer culture is the most exacting and informative system 
in general use. However, histological relationships are lost 
in monolayer culture, and morphological examination is confined 
to a cytological level as was seen in the monolayer cultures of 
the foetal testis.
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When histological relationships in vitro are important, organ 
culture techniques are used. Monolayer culture and organ 
culture were both used successfully in the experiments of this 
thesis, and in both cases functional studies were discussed 
in relation to possible physiological correlations.
Morphology and function must always be studied in relation 
to each other. Using this approach continuing studies of 
biological phenomena will lead to a better future understanding 
of natural processes in health and disease.
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SECTION III ; GENERAL DISCUSSION AND SUMMARY
CHAPTER 9
SUMMARY
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CHAPTER 9 
- ' SUMMARY
This thesis deals with experimental aspects of morph­
ological and functional correlations at the histological and 
biochemical levels in various normal and neoplastic tissues.
A physiological section examines functions and effects of 
the normal foetal testis, and a clinicopathological section 
is concerned with morphological and functional features of 
testicular and adrenocortical neoplasms.
The normal foetal testis.
The foetal testis is hormonally active, producing 
androgenic steroids which cause masculinisation of the sex 
ducts and urogenital sinus: and a separate Mullerian 
inhibitory factor (MIF) which actively suppresses the female 
sex duct. MIF is not a steroid molecule in free form, and 
at least part of it is a protein. I set up an organ culture 
bioassay system to study aspects of Mullerian duct inhibition
Foetal rat genital tracts, containing Mullerian and 
Wolffian ducts, were explanted from foetal rats and main­
tained in organ culture for 3 days. The development of 
gonads and sex ducts in vitro followed the normal in vivo 
pattern. The Wolffian ducts were stabilised by androgens, 
by autologous or homologous foetal rat testes, and by heter­
ologous human foetal testes. The Mullerian ducts regressed 
in the presence of autologous, homologous or heterologous 
foetal testes.
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On theoretical grounds, I wondered if foetal testic­
ular progesterone, probably attached to a carrier protein 
analogous to the androgen binding protein produced by the 
adult testicular Sertoli cells, may be involved in Mullerian 
duct inhibition. Addition of progesterone to the culture 
medium did cause Mullerian duct regression, but it was 
difficult to be certain that this was a specific physio­
logical effect rather than a non-specific cytotoxic effect. 
Progesterone vzas also found to stabilise the Wolffian duct 
in organ culture.
Substantiation of the possible physiological role of 
foetal testicular progesterone necessitated verification that 
the foetal testis is capable of progesterone production and 
secretion. This was attempted using monolayer cultures of 
rat foetal testes maintained with and without trophic 
hormonal stimulation. The endogenous steroid production and 
secretion was determined by radioimmunoassay (RIA) for 
progesterone and testosterone, and by high pressure liquid 
chromatography (HPLC) which could efficiently separate, 
identify and quantitate 47 different standard steroid mole­
cules. A testosterone RIA had been established in our 
laboratory, and I developed a similar assay for progesterone 
paying particular attention to precision, sensitivity, 
specificity and choice of method for separating free and 
bound labelled progesterone. HPLC was used to examine the 
profile of steroids secreted by the foetal testicular cells 
in monolayer culture.
Foetal testes secrete testosterone and progesterone 
in monolayer culture. Testes from 14^ day foetal rats
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initially failed to produce significant amounts of steroid 
hormone in vitro, but after cyclic AMP stimulation substan­
tial amounts of progesterone were identified. Testes from 
older foetal rats initially produced testosterone in greater 
amounts than progesterone in culture, but after a few days 
testosterone, then progesterone, output fell to baseline 
levels. Steroidogenesis was occasionally reactivated by 
human chorionic gonadotrophin stimulation, but a greater, 
more consistent reactivation was effected by cyclic AMP, 
progesterone production being evident before testosterone.
• The results indicate that the foetal testis may 
produce progesterone at a time when it is known to produce 
the Mullerian inhibitory factor. Later in gestation, 
secretion of MIF diminishes, and output of androgens increases 
I postulate that this may be due to conversion of prog­
esterone to testosterone. Definite proof of this hypothesis 
is still lacking.
I conclude from the section on experiments with normal 
animal tissues that the histological features of foetal 
testes give no indication of the pattern of steroidogenesis, 
and that the cytological appearances of foetal testicular 
cells in monolayer culture do not alter with changing 
functional activity. The histological regression of Mullerian 
ducts in organ culture is morphological evidence of the 
presence of MIF, but it is not truly specific.
The remainder of this thesis concerns neoplastic 
tissue with secretory potential, and the morphological
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patterns associated with various secretory products.
Testicular tumours.
I examined the clinical and histological features 
of 322 male patients with testicular tumours and extra- 
gonadal germ cell tumours, and in each case, the serum level 
of alpha-fetoprotein (AFP) was measured. Many teratomas 
contain extra-embryonic elements although their significance 
and identification are not always stressed in authoritative 
classifications of testicular tumours. About two thirds of 
teratomas.contain extra-embryonic yolk sac elements, and a 
similar proportion are associated with elevated serum AFP,
I found a strong correlation between the presence of yolk sac 
elements and AFP production, but many exceptions occurred.
I suggest, therefore, that the presence of one should arouse 
the suspicion of the other, but that an absolute and 
exclusive correlation does not exist.
Yolk sac elements occur in teratomas in patients of 
all age groups. Pure yolk sac tumours carry a poor prognosis, 
marginally worse than malignant teratoma undifferentiated 
(MTU). The presence of yolk sac elements does not adversely 
affect the prognosis of MTU, but malignant teratoma inter­
mediate (MTI) has a poorer prognosis if yolk sac elements are 
present, MTI, however, even when yolk sac elements are 
present, carries a better prognosis than MTU.
Serum levels of AFP may indicate tumour activity in 
teratoma patients. A persistently elevated serum AFP always 
indicated active teratoma, and was often a more sensitive 
index of tumour recurrence than full clinical examination.
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However many false negatives occurred and serology alone is 
insufficient in the monitoring of teratoma patients. Many 
tumour index substances•may be produced by teratomas, but 
the two most sensitive and reliable markers are the serum 
levels of AFP, and the beta subunit of HCG. Both should be 
measured serially in all patients with testicular tumours, 
and a preoperative sample is very important.
The data presented in this thesis suggest that 
evidence of AFP production by teratomas may be a poor 
prognostic sign, but the effect is, at best, marginal. 
Seminomas carry a better prognosis that teratomas, and the 
most important prognostic feature of teratomas is the 
clinical stage at presentation. The presence of extranodal 
métastasés has dire significance.
Adrenocortical tumours.
Adrenocortical tumours have features in common with 
normal foetal testes, and with testicular neoplasms. They 
are said to be hormonally active when they produce endocrine 
imbalance; however seme are not associated with endocrine 
upset. Such tumours are not truly "non-functional". They 
do not secrete excess active hormones, but are often assoc­
iated with production of hormonally inactive steroids 
detectable in the serum or urine. Twenty such "non-hormonal" 
adrenocortical tumours are presented in this thesis. They 
are usually large at presentation because of their lack of 
systemic upset and of their inaccessible position. Pain and 
abdominal mass are the most frequent presenting features.
They are usually malignant and prognosis is poor because of
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the prolonged latent period during which time local infil­
tration and distant metastasis are common.
Vv The histological features of these tumours were
examined in order to determine if there are any features 
associated with degree of malignancy, or steroidogenic 
potential. As with many other endocrine tumours, the usual 
criteria for histological grade of malignancy are poorly 
correlated with clinical behaviour of adrenocortical tumours. 
The most important pathological prognostic feature is size of 
tumour at presentation, the larger tumours having a shorter 
survival. They are histologically very similar to hormonally 
active adrenocortical carcinomas, therefore the secretory 
potential cannot be surmised on histological examination 
alone, and additional functional studies are required. The 
most important morphological index of tumour function is the 
appearance of the attached adrenal cortex. A non-hormonal 
tumour is not associated with trophic changes in the 
uninvolved gland which may, therefore, be distorted because 
of tumour bulk, but the normal elements are present in 
normal proportions. A hormonally active adrenocortical 
tumour producing active glucocorticoids will, by dint of its 
negative feedback, result in atrophy of the inner zones of 
the adjacent (and contralateral) adrenal cortex.
The morphologist has an essential role to play in the 
examination of normal and pathological tissue, but morphology 
alone is insufficient. The conclusion of this thesis is that 
the morphologist and the experimentalist must work together 
in order to achieve a functional pathological interpretation 
of disease.
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APPENDK I
STEROID NOMENCLATURE
Trivial name Abbreviation Chemical name
I ...........-..... — . . . .
adrenosterone G androst-4-ene-3,1 1 ,17-trione
aldosterone ALDO 11)8, 21-dihydroxy-18-al-pregn- 
4-ene-3, 20-dione
3 O' - andro stane die 1 5o'-androstane-3o!, 17)3-diol
3/3-androstanediol 5o!“androstane-3j3,17j3-diol
andro stanedione 5o!-androstan-3,16-dione
andro stenediol 5-androsten-3/3,17j3-diol
andro stenedione AD 4-androsten-3,17-dione
andro sterone 5 O'-an dros tan - 3 O'- 01-17 - on e
cholesterol CHOL 5-cholesten-3j3-ol
corticosterone B 4-pregnen-ll)8, 21-diol-3, 20- 
dione
cortisol
(hydrocortisone)
F 4-pregnen-llj8,170?, 21-triol- 
3, 20-dione
cortisone E 4-pregnen-17o!, 21-d iol-3 ,11, 20- 
trione
cyproterone acetate 1, 2o'-methylen-6-chlor-Zf ' 
pregnadien-17o'-ol“3, 20-dione 
acetate
cyanoketone 2o'-cyanO“4, 4 ,17o?-trimethyl- 
androst“5-ene-17j3-ol-3-one
11 - dehydroaldosterone DHALDO 21“hydroxy-18-al-pregn-4-ene- 
3,11, 20-trione
11-dehydro corticosterone A 4-pregnen-21-ol-3,11, 20-trione
dehydroepiandrosterone DBA 5-androsten-3)S-ol-17-one
ll-de(s)oxycorticosterone DOC 4-pregn-21-ol-3, 20-dione
11 ~de(s)oxy corticosterone 
acetate
DOGA 4-pregn-21-01-3, 20-dione 
acetate
11-de(s)oxy cortisol S 4-pregnen-17o', 21-diol-3, 20- 
dione
21-de(s)oxy cortisol 21-deoxy F 4-pregnen-ll/3,17o?-diol- 
3, 20-dione
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Trivial name Abbreviation Chemical name
dexamethasone 1, 4-pregnadien-9-fluoro-16a- 
methyl-11/3,17a, 21-triol- 
3, 20-dione
20o! “dihydroprogesterone DHP 20a-hydroxypregn-4-en-3-one
20/3-dihydroprogesterone 2 0/3-hy dr oxypr egn- 4 - en-3 - one
Sof -dihydrotestosterone 
(andro stanolone) 
(dihydrotestosterone)
DHT 5a-androstan-17/3-ol-3-one
5/3-dihydrotestosterone 
(aetiocholanolone)
5/3-androstan-17/3-ol-3-one
17 ethinyltestosterone 4-androsten-17a-ethinyl-17/3-
ol-3-one
llj3-hydroxyandrostene-
dione
11/30H-AD 11/3 -hydroxy andro st-4-ene - 
3 ,17-dione
19-hydroxyandrostene- 
dione
19-hydroxyandrost-4-ene- 
3 ,17-dione
18-hydroxycorticosterone 180H-B 11/3,18, 21 -trihydroxypregn- 
4-ene-3, 20-dione
6/3-hydroxycortisol 6/30H-F 4-pregn-6/3,11/3,17a, 21-tetrol- 
3, 20-dione
18-hydroxy-11-dehydro- 
corticosterone
180H-A 18, 21 -dihydroxypregn-4-ene- 
3,11, 20-trione
18-hydroxy-11 -deoxy­
corticosterone
180H-D0C 4-pregnen-18, 21-diol-3, 20-one
11 j3-hy droxy - 2 Oq! - dihydro 
progesterone
11/3, 20a-dihydropregn-4-en- 
3-one
17 cv - hy droxy-20a- 
dihy droprogesterone
17aOH-DHP 17a, 20a-dihydroxypregn-4- 
en-3-one
17a-hydroxy - 20/3- 
dihydrop rogesterone
17a, 2 0/3 - dihy d r oxyp r egn - 4 - 
en-3-one
17a -hydroxypregnenolone 17aOH-preg 5-pregnen-3/3,17a-diol-20-one
6a-hydroxyp rogesterone 4-pregnen-6a-ol-3, 20-dione
6/3-hydroxyp rogesterone 4-pregnen-6)3-o l-3, 20-dione
11/3-hydroxyprogesterone 4-pregnen-ll/3-ol-3, 20-dione
16a -hydroxyprogesterone 16aOH-P 4-pregnen-16a-ol-3, 20-dione
17a-hydroxyprogesterone 17aOH~P 4-pregnen-17a-ol-3, 20-dione
7 a -hydroxytestosterone 7aOH-T 4-androsten-7a, 17/3-diol- 
3-one
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Trivial name Abbreviation Chemical name
11/3 -hydroxytestosterone 4-androsten-ll/3,17/3-diol- 
3-one
16a -hydroxytestosterone 4-androsten-16a, 17/3-diol- 
3-one
19-hydroxytestosterone 4 - andro st en-17/3,19-diol- 
3-one
17-isoaldosterone 11/3, 21-dihydroxy-18-a l- (17/3)- 
pregn-4-ene-3, 20-dione
11 -ketoprogesterone 4-pregnen-3,11, 20-trione
17 methyltestosterone 1,4 -andro stadi en-17 a -m ethyl - 
17/3-ol-3-one
17a-oestradiol 1, 3, 5(10)-oestratrien-3,17a- 
diol
17/3-0 estradiol 1, 3, 5(10)-oestratrien-3,17/3- 
diol
oestx'iol ^3 1, 3, 5(10)-oestratrien-3,16a, 17/3- triol
0estrone 1, 3, 5(10)-oestrien-3-ol-17-one
prednisolone
(1 -dehydrocortisol)
1, 4-pregnadien-11 /3,17a, 21- 
triol-3, 20-dione
prednisone
(1 -dehydrocortisone)
1,4 -p r egnadi en -17 a , 21-diol- 
3,11, 20-trione
pregnanediol 5/3-pregnan-3a, 20a-dione
5a -pr egnanedione 5a-pregnan-3, 20-dione
5/3-pregnanedione 
(pr egnanedione)
5/3-pregnan-3, 20-dione
5a " pregnanolone 5a-pregnan-3a-ol-20-one
5/3-pregnanolone
(pregnanolone)
5/3-pregnan-3/3-ol-20-one
pregnenolone Preg 5-pregnen-3/3-ol-20-one
progesterone P 4-pregnen-3, 20-dione
testosterone T 4-androsten-17/3-01-3-one
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a p p e n d i x  II
STEROIDOGENIC ENZYME NOMENCLATURE
Abbreviated name Recommended name Systematic name
3/3-HSD-I -3/3-hydroxy steroid 
dehydrogenase-isomerase 
system
3^-hydroxysteroid
dehydrogenase
and
5-ene-3-ketosteroid
isom erase
3/3-hydroxysteroid:NAD^ 
oxidoreductase 
(E.G. 1 .1 .1 .51 )
3-ketosteroid-^-A ^ -
isom erase
(E.G. 5 .3 .3 .1 )
20 : 22 D 20- and 22- hydroxylase 
desmolase system
no systematic nanie yet 
recommended
17a K steroid 17a-hydroxylase 
or
steroid 17a mono- 
oxygenase
steroid, hydrogen donor: 
oxygen oxidoreductase 
(17a - hydroxylating) 
(E.G. 1 .14 .99 .9 )
17 D ^17-20 ,C desmolase no systematic name yet 
recommended
17/3 HSD 17/3-oxidoreductase
or
17/3-hydroxy steroid 
dehydrogenase
or
testosterone 17/3- 
dehydrogenase
17/3-hy droxy steroid:NAD^ 
17-oxidoreductase 
(E.G. 1.1.1.63)
Based on Enzyme Nomenclature : Recommendations (1972) of the 
Commission on Biochemical Nomenclature. l U P A C  and l U B  
Elsevier : Amsterdam (1973)
APPENDIX XXI
LABORATORY TECHNIQUES
(a) Glass redistilled water was used for the preparation of 
all aqueous solutions.
(b) Laboratory glassware
All glassware (except scintillation vials) was soaked in 
detergent (2% RES 25 in distilled water), rinsed several 
times in glass distilled water and finally glass redistilled 
water before drying in a hot oven.
Radioimmunoassays were performed in new 75 X lOmra glass 
assay tubes washed as above and discarded after using 
once.
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a p p e n d i x  IV
RADIOIMMUNOASSAY OF PROGESTERONE
The method is siinilar to that of Cameron & Scarisbrick (1973)
1. Reagents
Oxygen free nitrogen: British Oxygen Company.
Petroleum ether (boiling point 40°-60°C): BDH "analar" grade.
Ethanol: James Borroughs Ltd. analytical reagent.
Gelatin: Standard Laboratory reagent.
Dextran T-70: Pharmacia.
Washed activated Charcoal: "Norit-A", Sigma. Several grams 
agitated for 15 minutes in a 1 litre beaker containing 
approximately 800ml glass redistilled water. Allowed to 
settle for 5 minutes and supernatant decanted.
This procedure repeated 6 times to remove large (floating) 
charcoal particles. Residue dried in 140*^0 oven.
Tritiated progesterone: (1,2,6,7(n)-^H) progesterone,
Radiochemical Centre, Amersham, UK. Specific activity 
94 curies/mMole. 298 mCi/mg suppied in benzene (ImCi/ml), 
250pl of this diluted to 12.5ml in nanograde benzene 
(Mallinckrodt) to give a stock solution of 20pCi/ml.
Progesterone: Sigma. Recrystallised before use.
Scintillation fluid: Instagel, Packard.
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2. Working solutions
Stock phosphate solutions CBDH: Analar)
il 0.5M NaH2P0^: 7.80g of NaH^PO^ (MW 156.01) made
up to 100ml and stored at 4^C.
ii) 0.5M NagHPO^: 35.82g of Na^HPO^.lZH^O (MW 358.16) 
made up to 200ml and stored at 4^C.
Buffer solutions :
i) 0.9M phosphate buffered saline with azide pH 7.0 ("PBS"):-
7.78g NaCl (BDH Analar)
O. 89g Naisr^  (BDH reagent grade)
6.67ml of 0.5M NaH P O .
2 4
13.33ml of 0.5m  Na^HPO^
Made up to approximately 800ml and pH adjusted to 7.0 with 
NaH 2 P0 ^ or Na 2 HP0  ^ stock solutions.
Made up to 1 litre and stored at 4^C.
ii) PBS 0.5% gelatin solution:-
1.25g gelatin dissolved in approximately 2O0ml PBS using 
heated magnetic stirrer,.and made up to 250ml with PBS 
to give 5g gelatin per litre of phosphate buffered saline 
with azide. Stored at 4^0.
iii) PBS 0.1% gelatin solution ("assay buffer"):-
250mg gelatin dissolved in approximately 200ml of 
PBS using heated magnetic stirrer and made up to.250ml 
to give Ig gelatin per litre of phosphate buffered saline 
azide. Stored at 4°C.
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Dextran coated charcoal
500ml PBS 
500mg gelatin
dissolve with heated magnetic stirrer then cool to 4^C 
125mg Dextran T-70-
o
Dissolve with magnetic stirrer at 4 C 
1.25g washed charcoal
Suspend with magentic stirrer at 4°C for at least 30 min. 
Final concentration gelatin lg/1
Dextran T-70 250rag/l 
Charcoal 2.5g/l
Store at 4^C. Agitate for at least 15 minutes at 4°C 
with magnetic stirrer before use, and agitate with 
magnetic stirrer at constant speed throughout period 
of use.
Polyethylene glycol (PEG) 19,5% Cw/v);- 
39g of PEG made up to 200g with PBS 
1 ml of 19.5% PEG added to 0.3ml reaction mixture 
gives final PEG concentration of 15% (w /y I .
Standard progesterone solutions:-
15mg recrystallised progesterone made up to 10ml with 
ethanol to give 1.5mg/ml stock progesterone solution. 
Stored at -20°C.
Stock progesterone solution diluted with ethanol in glass
scintillation vials to give 10ml of each of 5ng/ml,
4ng/ml, 3ng/ral, 2ng/ral, Ing/ml (500, 400, 300, 200, 100 
pg/lOOpl respectively).
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Standard progesterone solutions used for standard 
curves.
Progesterone antiserum:-
O.Sitil of l-in-5 anti serum thawed and diluted to 10ml 
with assay buffer to give stock 1:100 antiserum.
Stored at 4^C.
Diluted to appropriate concentration [1:2000 to 1:60001 
with assay buffer and stored at 4^0 for up to 1 week.
Tritiated progesterone label:-
lOOpl of stock 20].iCi/ml in benzene evaporated to dryness 
under nitrogen at 4CPC so that lOOpl gives approximately 
22,000 distintegrations per minute (DPM).
3. Procedure
i) Pipette in duplicate or triplicate 100^1 of progesterone 
solution (standard, or unknown extractl in analytical 
grade ethanol at 4°c into cleaned assay tubes (75 X lOitim) 
lOOpl of ethanol is used for zero ("00"1 on the standard 
curve; for reagent blank ("RBI"); and for total counts 
added ("tot").
ii) Dry all tubes at 40^0 under a jet of nitrogen
iii) Chill tubes to 4 c and add lOOpl of antiserum diluted 
in assay buffer. lOOpl assay buffer used instead of 
antiserum in "tot". Mix tubes on a vortex and allow to 
stand for 20 mins at 4^C.
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ivl Add 100]] 1 tritiated progesterone in assay buffer
(approximately 22,000 DPMI. lOOpl assay buffer used 
instead of progesterone label in "RBI". Mix on vortex 
an incubate overnight at 4^0.
o
v) Add lOOpl PBS with 0.5% gelatin at 4 C, Mix on vortex, 
vi) Add 1 ml of dextran coated charcoal suspended in assay 
buffer at 4^C.
1 ml of assay buffer used instead of charcoal suspension 
in "tot". Mix on vortex and allow to stand for 5 minutes 
only. (The dextran charcoal suspension is agitated by a 
constant velocity Teflon coated magnetic stirrer at 4*^ 0 
for 2 minutes before use and throughout the time it is 
being pipetted into the assay tubesI. 
vii} Centrifuge at 4°C for 12^ minutes at 2400rpm in a Minstral 
6L centrifuge.
viii) Decant the supernatant containing the bound progesterone 
into scintillation vials, add lOmJ. Instagel and determine 
the radioactivity (in DPM) in a scintillation counter.
4. Separation of free and bound progesterone: comparison of 
dextran coated charcoal and polyethylene glycol (PEG)
In step (vi) of procedure, 1 ml of 19.5% PEG is added to 
the reaction mixture in place of dextran charcoal. This 
precipitates the bound progesterone leaving free progesterone 
in solution as opposed to charcoal separation which preci­
pitates free progesterone. The PEG supernatant is decanted
into scintillation vials, lOml Instagel added and the 
radioactivity determined.
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5. Progesterone RXA: Antibody dilution curve
In step CiI of the procedure add lOOpl of standard 
progesterone solution CSng/inl ethanol! to half of the 
assay tubes and lOOpl ethanol to the others.
In step (iii! add lOOpl of varying dilutions of 
antiserum in duplicate or triplicate to the tubes 
containing progesterone, and to those containing none.
In step (vi) use dextran coated charcoal or PEG to 
separate free and bound progesterone.
6. Progesterone RIA: standard curve
In step (i) of procedure pipette in triplicate 
lOOpl of each of the standard progesterone solutions 
in ethanol (5,4,3,2,1 ng/ml giving 500,400,300,200,100 pg 
of progesterone in lOOpl respectively) into cleaned assay 
tubes, Use 100]jl of ethanol in place of progesterone 
solution in "OO", "tot", and "RBl".
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APPENDIX V
RADIOIMMUNOASSAY OF TESTOSTERONE
The method is similar to that of Collins et al. C1972).
1. Reagents
Testosterone: Sigma. Recrystallised before use.
Toluene: Mallinckrodt. Nanograde reagent.
Gelatin: Standard laboratory reagent.
Dextran Ï-70: Pharmacia.
Washed activated charcoal: "Norit-A" Sigma.
Washed as for progesterone RIA.
Hydrochloric acid: BDH Analar concentrated HCl.
Tritiated testosterone: (1,2,6,7-^H) testosterone.
Radiochemical Centre, Amersham, UK. Specific activity
100 Ci/mMole supplied in benzene. This was evaporated
under a jet of oxygen-free nitrogen and taken up in
analytical grade ethanol (Borroughs) to give a final
concentration of lOOuCi/ml. Stored at 4^ C. 200ul of
this dried under nitrogen.and taken up in 2ml of nano­
grade toluene to give lOpCi/ml.
2. Working solutions
Tritiated testosterone label: lOOpl of lOpGi/ral testosterone 
in toluene dried under nitrogen and taken up in 10ml of 
Tris assay buffer (vide infra) . lOOpl of tritiated testo­
sterone in buffer contains approximately 22,000 DPM,
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O.IM Tria buffer pH 8.5:-
12.Ig Tris-CHydroxymethylï-methylamine ("tris buffer"
SLR, Fisons).
Dissolved in approximately 850 ml redistilled water. 
pH adjusted to 8.5 with approximately 2ml conc. HCl.
Made up to 1 litre with redistilled water.
O.IM Tris buffer pH 8.5 with 0.5% gelatin solution:
1.25g gelatin
Dissolved in approximately 200ml Tris buffer using heated 
magnetic stirrer.
Made up to 250ml with Tris buffer
O.lM Tris buffer pH 8.5 with 0.1% gelatin solution ("assay buffer") 
50ml Tris buffer 0.5% gelatin 
200 ml Tris buffer 
Dextran coated charcoal :
500ral O.IM Tris buffer
SOOrag gelatin. Dissolved using heated magnetic stirrer 
125mg dextran T-70. Dissolved using magnetic stirrer at 
4°C.
1.25g washed charcoal. Suspend with magnetic stirrer for 
Ihour at 4°C.
Store at 4°C.
Standard testosterone solution (stock):
24.2mg testosterone made up to 10ml in toluene to give 
2.4 2mg/ml.
Working standard testosterone solutions:
Stock testosterone solution diluted with toluene to 
give 2.5, 2.0, 1.5, 1.0, 0,5 mg/ml equivalent to 250,200,
150, 100, 50 pg testosterone in lOOpl standard solution.
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Testosterone antisenim:-
Diluted in assay buffer to a final concentration of 
1:4000 to 1:7000.
3. Procedure
i) Pipette lOOpl testosterone solution (standard or
unknown) in toluene at 4°C into cleaned assay tubes
(75 X lOirati) in duplicate or triplicate- lOOpl of toluene
is used for zero ("00") on the standard curve, for the
reagent blank ("RBl") and for the total counts added ("tot"),
ii) Dry all tubes at 45°C in a jet of nitrogen
iii) Chill assay tubes to 4°c and add lOOpl of anti testosterone
serum diluted in assay buffer. lOOpl of assay buffer used
instead of serum in "tot", 
iv) Add lOOpl tritiated testosterone in assay buffer
(approximately 22,000 DPM). lOOpl assay buffer used 
instead of testosterone label in "RBl". Mix on vortex and 
incubate overnight at 4°C. 
v) Add lOOpl Tris buffer 0.5% gelatin at 4°C to all tubes.
Mix on vortex.
vi) Add 1ml of dextran coated charcoal suspension in assay buffer 
at 4°c. 1ml of assay buffer used instead of charcoal 
suspension in "tot". Mix on vortex and allow to stand 
for 20 mins at 4°c. (The dextran charcoal suspension is 
constantly agitated by a Teflon coated magnetic stirrer 
at 4*^ C for 20 minutes before use and throughout the period 
of pipetting into the assay tubes).
vii) Centrifuge at 4^C for 12^ minutes at 2400 rpm in a 
Minstral 6L centrifuge.
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viii) Decant supernatant containing the bound testosterone 
into scintillation vials, add 10ml Instagel (Packard) 
and determine radioactivity in DPM in a scintillation 
counter.
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APPENDIX VI
EXTRACTION OF TISSUE CULTURE MEDIA FOR RIA
Five ml of tissue culture fluid was collected daily from 
each monolayer culture and stored at -20^C till required for 
extraction when it was thawed at room temperature and 1 ml 
pipetted into each of two Sovirel glass extraction tubes fitted 
with Teflon lined plastic screw caps. The tubes were chilled 
to 4^C. One tube was used for progesterone and the other for 
testosterone determination.
Procedure :
i a) Progesterone: Add lOOpl of tritiated progesterone
in PBS assay buffer (approx 22,000 DPM). as internal 
recovery standard to one tube containing 1 ml of culture 
medium. Mix on vortex and allow to stand for 15 minutes 
at 40°C and one hour at 4^C. The total amount of label 
added is determined by pipetting lOOpl of tritiated 
progesterone in PBS assay buffer into a scintillation vial 
with SOOtjI of ethanol and 10ml of Instagel. 
i b) Testosterone: Add SOpl of tritiated testosterone
in Tris assay buffer (approx 11,000 DPM) as internal 
recovery standard to other tube containing culture medium. 
Mix on vortex and allow to stand for 20 minutes at 4^C.
The total amount of label added is determined by pipetting 
50pl of tritiated testosterone in Tris assay buffer into a 
scintillation vial with 400]j1 of toluene and 10ml of Instagel
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ii al Progesterone: Add 3ml of petroleum ether (B.P.
40-60°C) at 4°C to extraction tube, firmly stopper and 
invert manually 120 times in cold room. Allow to settle 
for 10 minutes.
o
ii b) Testosterone: Add 2ml of nanograde toluene at 4 C
to extraction tube, firmly stopper and invert manually 
120 times in cold room. Allow to settle for 10 minutes,
iii a ) } Freeze lower aqueous layer by emersing glass tube
iii b ) )
in ethanol cooled by solid carbon dioxide, and decant 
upper solvent layer into clean glass scintillation vials.
iv a )I Repeat steps (ii) and (iii) pooling the solvent layers
iv b)j o
into scintillation vials to dryness at 40 C (petroleum
ether) or 45^c (toluene) under a jet of nitrogen.
v a) Progesterone; Dissolve the residue in the scintillation
vial with 2.5ml ethanol at 4^C. Transfer 500pl of this to a
fresh scintillation vial with lOOpl PBS assay buffer and
10ml of Instagel: this is 20% of total label recovered by
the extraction procedure.
V b) Testosterone: Dissolve the residue in the scintillation
o
vial with 2.0ml toluene at 4 C. Transfer 40Opl of this to 
a fresh scintillation vial with 50pl Tris assay buffer and 
lOml Instagel: this is 20% of the total label recovered
by the extraction procedure, 
vi a) Progesterone: ) Ranging assay: Pipette 20,50,100,
vi b) Testosterone; j 200pl of extracted steroid in solvent
to clean assay tubes at 4^C. Evaporate to dryness at 40°c
o
(Progesterone) or 45 c (Testosterone) under nitrogen and 
determine approximate amount of steroid by RIA.
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Preclse assay: Dilute extracted steroid with ethanol
(Progesterone) or toluene (Testosterone) to give a final 
concentration of approximately 2ng/ml (Progesterone) or 
ing/ml (Testosterone). Determine amount of steroid in 
lOOpl of diluted extract by RIA and calculate total amount 
of steroid in 5ml of culture medium.
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APPENDIX VII
PREPARATION OF TISSUE CULTURE MEDIA
A. CULTURE MEDIA FOR ORGAN CULTURE OF FOETAL GENITAL TRACTS
1. Preparation of solid Caqar) medium
Sralof medium 199 (X 2 concentration) [f I o w  laboratories] 
with Hank's balanced salt solution 
with 40mM HEPES buffer 
with glutamine 
without bicarbonate 
without phenol red 
4ml of foetal calf serum (Gibco)
100]il of Penicillin (5000 units/ml)
Streptomycin (5000 units/ml)
Neomycin (10 mg/ml) [cibco
200pl of 5.6% Na bicarbonate
1 drop phenol red
^  MEDIUM A
6ml of medium A
4ml of glass redistilled water
■> MEDIUM B (See Table A. I)
6ml of medium A at 37^
4ml of sterile 2% aqueous agar at 37°C 
------------   ^  MEDIUM C (See Table A.I)
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Table A. I. Concentrations of constituents of tissue culture media used 
for organ culture of foetal rat genital tracts on solid media.
Constituent Medium B Medium C
Medium 199 (with Hank’s salts) X 1 X 1
H E P E S  buffer 20 mM 20 mM
Agar 0 0.8  %
Bicarbonate 0. 56 g/1 0. 56 g/1
Foetal calf serum 20% 20%
Penicillin /  streptomycin 25 units/m l 25 units/m l
Neomycin 50 /ig /m l 50 jug/ml
Amphotericin 1. 25 jug/ml 1. 25 p g /m l
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The 2% aqueous solution of agar Is sterilised by autoclaving 
at 15 Ibs/sq, in. for 20 minutes and allowed to cool to 37°C 
at which time 4ral is added to 5ml of -medium A, immediately 
mixed, and 1 ml aliquots pipetted into special moulds placed 
in sterile Petri dishes. When medi-um C cools to room temperature 
it forms a solid gel and the special moulds are carefully 
removed leaving a rectangular ridge of solid culture medium 
measuring 30 x 7 x 4mm in the Petri dish.
The final concentration of the constituents of media B & C are 
shown in Table A.I.
2. Preparation of liquid medium
16 ml of medium 199 [X 1 concentration) [f I o w  laboratories] 
with Hank's balanced salt solution 
with 20mD4 HEPES buffer 
with glutamine 
with phenol red 
with bicarbonate 
4ml foetal calf serum [oibco] 
lOOyl of Penicillin (5000 units/ml)
Streptomycin (5000 units/ml)
Neomycin (10 mg/ml) [cibco]
200pl of Amphotericin (2 50mg/ml) [oibco]
— ----------------------------------  > MEDIUM D
Final concentration of constituents of medium D is similar 
to that of medium B.
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B. CULTURE MEDIA FOR MONOLAYER CULTURE QF FOETAL TESTES
1 • ^'Dissecting medium"
lOOml of medium 199 [f I o w  laboratories] 
with Earles' salts 
with 20mM HEPES buffer 
with glutamine 
without bicarbonate 
2ml of Penicillin (5000 units/ml)
-Streptomycin (5000 units/ml) [oibco]
2ml of Kanamycin (lOmg/ml) [oibco]
400pl of Amphotericin (250mg/ml) [cibco]
16.7ml of Foetal calf serum (virus and mycoplasma screened)
[Gibco]
2. "Enzyme solution"
12.5rag collagenase (Sigma)
12.5mg hyaluromidase (Sigma)
Stored dry at -20°c in sterile plastic universal container.
Before use, 5ml of "dissecting medium" is added to give 
a final concentration of 2.5mg/ml of each enzyme.
3. Dialysed foetal calf serum
The monolayer cultures were maintained in a glutamine 
restricted environment to minimise cell proliferation, therefore 
the foetal calf serum used in the culture medium was dialysed 
to remove amino acids, especially glutamine. Dialysis also 
removes steroid hormones, which could interfere with the 
steroid assays, and polypeptide hormones which could stimulate 
the cells in culture.
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Vir.ua and mycoplasma screened foetal calf serum 
(Gibco) was poured into Visking dialysis tubing which was 
then knotted at each end and placed in a 2 litre beaker 
full of sterile 0,09% NaCl (Steriflex:BDH). Usually 4 x 50ml 
of serum was dialysed in each batch. The saline was agitated 
with a magnetic stirrer. The serum was dialysed for 48 hours, 
the saline being renewed twice daily.
4. "Culture medium"
lOOml MEM. (Eagle) [cibco]
with Earles' salts 
without 1-glutamine 
2ml of 7.5% Na bicarbonate [cibco]
2ml of Penicillin (5000 units/ml)
Streptomycin (5000 units/ml) [cibco]
200pl of 1-glutamine (100 x concentration) [cibcc]
16ml dialysed foetal calf serum
The medium was depleted of glutamine in order to reduce 
cell division because the metabolism of non-proliferating cells 
was under study. However, over-zealous glutamine restriction 
was found to be toxic to some cultures and subsequently a small 
amount of 1-glutamine was added to maintain cell viability.
When all the ingredients were added, the medium was - 
sterilised by filtration through 0.45pm and O.22pm (pore size) 
Millipore or Sartorius filters at 10 Ibs/sq.in, pressure 
supplied by a cylinder of 10% CO^ in air. The filtered medium 
was collected in sterile bottles and stored at 4°C.
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APPENDIX VIII
HIGH PRESSURE LIQUID CHROMATOGRAPHY CHPLC?
1. Extraction of tissue culture media for HPLC
Five ml of tissue culture medium was collected each 
day from the monolayer cultures of foetal rat testes. Each 
5ml sample was stored individually at -20^c in polystyrene 
screw-capped bijoux (Falcon) bottles until ready for extraction
a) Thaw tissue culture medium at room temperature.
b) Pipette 2-3ml medium into cleaned glass 25ml Sovirel 
extraction tube at 4*^ c.
c) Add lOml of nanograde dichloromethane (Mallinckrodt) at 
4^C and tightly replace Teflon coated screw cap.
d) Extract steroids into dichloromethane by manual inversion 
lo o  times at 4°C.
e) Separate aqueous and solvent layers by centrifugation at 
4°C for 7^ minutes at 2000 rpm (Minstral 6L centrifuge). 
Discard upper aqueous layer.
f) Add 3ml of O.IN NaOH, replace screw cap and invert 100 times 
at 4^C. Separate aqueous and solvent layer by centrifugation 
and discard upper aqueous layer. Repeat O.lN NaOH extraction 
This helps to remove saponified lipids which may interfere
in the chromatogram.
g) Transfer dichloromethane layer to clean glass scintillation 
vial and evaporate to dryness at 40^c under a jet of oxygen- 
free-nitrogen (BOG).
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hi Rediaaolve residue in approximately 0,5ml of dichloromethane
and transfer to a bacteriological glass bijoux tube.
o
Evaporate to dryness under at 40 C and redissolve in 
20pl of 50% ethanol, 
i) Inject lOyl of ethanolic extract into HPLC and obtain 
corresponding chromatogram.
Recovery experiments show that lOpl of the ethanolic 
extract contain 42.5 - 1.5% of the total steroid in the original 
2-3ml of tissue culture medium. Therefore, total recovery of 
steroids in 20]j1 of ethanolic extract is 85 - 3% (O'Hare et al. , 
1976b).
2. HPLC systems used
For the separation of the steroids produced by the testis
in tissue culture, reversed-phase chromatography with gradient
elution through a stainless steel precision bore tubing column
25cm long and 2.1mm internal diameter, commercially packed with
Zorbax-ODS (Du Pont) was used. "Zorbax" packings consist of
totally porous small particles of 5-lOpm diameter. ODS (octadecyl
hydrocarbon stationary phase) is the stationary non-polar phase
chemically bonded to the Zorbax particles and can be used with
aqueous or polar mobile phases of pH values between 2 and 9 at
o
temperatures up to 75 c.
Two solvent systems were used for separation of steroids: 
acetonitrile/water, and dioxane/water. In the acetonitrile system.
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the column was. equilibrated with 32% (y/vl acetonitrile in 
glass redistilled water, and the steroid sample in 50% ethanol 
injected into the column. The solvent strength was increased 
from 32% to 100% acetonitrile over 50 minutes using a concave 
exponential gradient with the configuation y ^ x^. The elution 
of UV absorbing steroids was detected spectrophotometrically 
at 2 40mm, and the retention time was measured from the moment 
of injection. The column was washed for 10 minutes with 100% 
acetonitrile to remove non-polar compounds in the media 
(cholesterol, etc.) and re-equilibrated with 32% acetonitrile 
for 25 minutes before injection of the next sample. The 
temperature of the column was 45°C and the inlet pressure was 
2000 psi giving an initial flow rate (32% acet.onitrile). of 
0.38ml/min, and a final flow rate (100% acetonitrile). of 0.80ml/min 
Elution with dioxane as mobile phase was similar to 
acetonitrile. The solvent strength was increased from 20%
(V/V) dioxane in glass redistilled water, to 100% dioxane 
over 50 minutes using the same y = x gradient. With the column 
temperature at 45^C and inlet pressure of 2500psi, the initial 
flow rate was 0.38ml/rain falling to 0.3ml/min at the end of the 
gradient. Steroids were detected spectrophotometrically by 
absorbance at 254nm.
Highly purified acetonitrile and dioxane (Nanograde; 
Mallinckrodt, St. Louis, Mo. USA; or HPLC grade : Rathburn, 
Walkerburn, Scotland) gave low background noise and 2ng of steroid 
resulted in detectable elution peaks on the chromatograph.
The peak heights were directly proportional to the quantity of 
steroid injected over a 50-fold range up to 2000ng. Forty-seven 
standard steroids have been applied to the column
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The steroids produced by the testis in tissue culture can 
be separated adequately by the acetonitrile or dioxane 
systems, and other less polar steroids have been separated 
by a methanol/water system so that all 47 steroids can be 
identified as separate peaks. The retention times for the 
standard steroids using acetonitrile and dioxane systems are 
shown in Table 2 .,11 and the chromatograph for a series of 7 
standard steroids is shown in Fig. 2".4.
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